12 June 2024
Cells Receives an Increased CiteScore of 9.9

We are pleased to inform you that Cells (ISSN: 2073-4409) has received an increased CiteScore of 9.9.

CiteScore provides transparent metrics that enable well-informed publishing strategy, library collection development, and the benchmarking of journal performance. It is now a standard citation metric alongside SNIP and SJR that gives an up-to-date view of a journal’s impact.

The 2023 CiteScore provides an assessment of the scientific influence of journals in the 2020 to 2023 period.

This is a reflection of the excellent performance, support, and dedication of all journal editors, reviewers, authors, and readers.

Cells’ CiteScore ranks 35 among 221 titles (Q1) in the “General Biochemistry, Genetics and Molecular Biology” category.

For more journal statistics, please visit

Thank you to everyone who has contributed to the journal.

Cells Editorial Office

7 June 2024
MDPI Calls for Greater Open Access to Science for Ocean Protection

On UNESCO’s 2024 Oceans Day, MDPI encourages the scientific community to increase the accessibility of ocean research to accelerate ocean conservation.

Basel, Switzerland, June 7, 2024: MDPI, a leading open access (OA) publisher, is proud to announce its active support for World Oceans Day 2024, celebrated under UNESCO’s Ocean Decade framework. MDPI’s CEO, Stefan Tochev hopes that “the latest ocean research can be made freely accessible to help empower scientists and communities at large to save our oceans,” under UNESCO’s Ocean Decade until 2030.

Open Access: A Catalyst for Ocean Action

MDPI’s presence at the UNESCO Ocean Decade Conference 2024 highlights our unwavering commitment to using OA to advance ocean science, support research communities, and promote sustainable ocean management.

"Our involvement in the UNESCO Ocean Decade Conference underscores MDPI's commitment to the underfunded Ocean SDG. By promoting OA to scientific articles and books on SDGs, we aim to inspire critical actions," said Tochev. "Our initiatives, like the World Sustainability Award and Emerging Sustainability Award, further demonstrate our dedication to advancing sustainability.”

Showcasing MDPI’s Contributions to Ocean Research

Over the past three years, MDPI has published 30,000 papers focused on ocean research and related topics. Key MDPI journals contributing to this body of work include:

  • Journal of Marine Science and Engineering (4.9k papers)
  • Remote Sensing (2.6k papers)
  • Sustainability (2k papers)
  • International Journal of Molecular Sciences (IJMS) (1.7k papers)
  • Marine Drugs (1.5k papers)
  • Water (1.5k papers)

These publications highlight MDPI’s contributions to ocean science, reinforcing our role in the broader sustainability agenda by promoting blue innovation and economy.

Additionally, MDPI has launched Oceans, an international, peer-reviewed forum specifically aimed at publishing studies related to all branches of oceanography with an emphasis on the functioning of the ocean and the sustainable use of its resources and ecosystem services.

Affirming MDPI’s Commitment to Ocean Science

MDPI’s commitment to OA is pivotal in addressing critical global challenges, from climate change to ocean sustainability. Our efforts resonate with Outcome 4 of the UNESCO Ocean Decade action roadmap: an accessible ocean with open and equitable access to data, information, technology, and innovation. By aligning with UNESCO’s goals, MDPI continues to contribute to shaping a sustainable future for our oceans, reinforcing our position as a forward-thinking publisher dedicated to environmental stewardship and scientific excellence.

For more information, contact Rui Duarte at [email protected] or +41764313242.

About MDPI

A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of over 6000 professional, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully open access titles.


5 June 2024
MDPI Sets a New Benchmark for Publishing Excellence

95% of authors rate MDPI’s publication process as excellent or good, setting a new benchmark in scientific publishing – reveals 2023 Annual Report. 

Basel, Switzerland, June 4, 2024: MDPI, the leading open access (OA) publisher, proudly announces the release of its 2023 Annual Report, detailing remarkable achievements and reaffirming its leadership in advancing OA publishing. In 2023, MDPI received 655,065 submissions, of which 285,244 articles were published. The company now commands a 17% market share in gold open access articles, with a median publication time of six weeks.

Stefan Tochev, MDPI's CEO, stated, "As a pioneer in open access publishing, MDPI has long been a game-changer in the scholarly community, serving millions of authors around the world to ensure the latest research is freely available. Reflecting on our incredible journey at MDPI, 2023 has been marked by growth in paper submissions, ambitious projects and initiatives aimed at improving our internal processes and delivering top-notch services to our scientists."

MDPI's 2023 Annual Report highlights several key achievements:

  • 17% market share in gold open access articles across all disciplines.
  • Record satisfaction rates: 95% of authors, 82% of reviewers, and 85% of guest editors.
  • Enhanced editorial standards and feedback processes.
  • Increased reach and impact with 54 new MDPI journal inclusions in Scopus, 29 in Web of Science, and 77 in DOAJ.

MDPI’s unwavering commitment to advancing OA has transformed the landscape of scholarly publishing, making high-quality research freely accessible to the global scientific community. The continuous improvement in our editorial standards and feedback processes underscores MDPI’s dedication to ensuring academic integrity and excellence.

Global Reach and Collaboration

MDPI’s global footprint continues to expand, with authors from diverse regions: 37% from Asia/Pacific, 36% from Europe, 15% from the Americas, and 12% from other parts of the world. The company’s fully OA platform attracted nearly 14 million monthly visitors in 2023, reflecting its widespread influence in the scientific community.

Commitment to Partnerships

With over 800 institutional partners, MDPI continues to demonstrate its dedication to providing reliable and collaborative publishing services. The introduction of a transparent flat-fee model highlights MDPI's ongoing efforts to enhance affordability and support to the academic community. For more details read our 2023 Annual Report.

For more information, contact Rui Duarte at [email protected] or +41764313242.

About MDPI

A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of over 6000 professional, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully open access titles.


5 June 2024
Meet Us at the ESMO Congress 2024, 13–17 September 2024, Barcelona, Spain

The ESMO Congress is a globally influential oncology platform that unites clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2024 will disseminate the latest cutting-edge data, providing high-quality education and excellent networking opportunities for oncologists and other stakeholders on an international level.

The following MDPI journals will be represented:

If you are participating in this conference, please feel free to engage with us online prior to attendance. Our delegates look forward to meeting you in person at booth #P627 and answering any questions you may have. For more information regarding the conference, please visit the following link:

4 June 2024
MDPI Insights: The CEO's Letter #12 - First Term as CEO, Tu Youyou Award, Books Report

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.

Opening Thoughts

Renewed Term as CEO of MDPI

I released the first CEO Letter at the end of June 2023, reflecting on my first month as CEO. Looking back at the first release, I’m pleased to see a marked consistency of content – from talking about open access (OA) and highlighting the great work being done at MDPI, to bringing together the science community with our conferences and building relations with our editorial board members and our industry as a whole.

For example, in the first letter, I highlighted our meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief (EiC) of our journal Viruses. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal. 

On 21 May, 2024 we met with EiC Prof. Dr. Antonino Carbone, and Section EiC Prof. Dr. Alberto Signore (pictured on the left), of our journal Hemato (tracked for Impact Factor, and indexed in Scopus), showing our continued and active collaboration with our chief editors to develop the visions for the journal. Over the course of the day, we gathered feedback and gained an understanding of the journal's expectations and focus on strategic growth.

Reflections on my first year as CEO: achievements and initiatives

During my first year as CEO, there have been many remarkable moments, including a strong focus on bringing people together, focusing on company communications and performance.

According to a recent study of 3,400 people across 10 countries, “Managers impact employees’ mental health (69%) more than doctors (51%) or therapists (41%) — and even the same as a partner (69%).” This is an important topic for me, and perhaps that’s why I place a high value on management culture due to its tangible impact on people’s lives.

When I joined MDPI, I created a weekly meet-up for the Corporate Marketing department and their team leads. On the final Thursday of every month, we hold a Global Marketing meet-up to present projects, share knowledge, and conduct training. For years, I’ve maintained the tradition of ending each of our monthly global calls with a group photo to boost morale, motivation, and productivity, and to finish on a positive note.

In keeping with this, when I stepped into the role of CEO, I launched a bi-weekly management meeting, chairing over 20 MDPI Management Team meetings in my first year. These sessions provide an opportunity for managers to present their team’s work, focusing on their achievements and the challenges they face, while at the same time creating space for sharing knowledge.

“I firmly believe that OA is the future of publishing”

I co-organized and co-led the 2023 MDPI Strategy Management meeting this past October, from which we established an Executive Task Force that meets monthly to prioritize projects aimed at building MDPI into the world’s most trusted publisher. To achieve our goals, we as managers need to maintain collaborative communication and connect to the bigger picture.

As CEO, I focused on leadership communication by publishing 12 CEO Letters, one for each month of my tenure, to share more about MDPI news and achievements. I also produced ten videos to help further communicate our message.

I was happy to attend eight publishing and conference events, including STM in Frankfurt and Washington, APE, and R2R, and facilitate critical company meetings with Elsevier, Web of Science, ResearchGate, DOAJ, and others. It was a pleasure to meet and have discussions with key organizations and governing bodies such as CAS in China and ANVUR in Italy.

The best part was the opportunity to visit seven MDPI offices across Europe and Asia-Pacific, meeting with local managers and colleagues and supporting them in person. As part of this, I conducted training sessions while continuing to lead the Corporate Marketing department.

Looking ahead

My goal for my second year as CEO is to continue building on the initiatives from the past, including leadership communications, public relations, educational marketing, and company culture, while representing MDPI to the best of my ability. Additionally, I have a few new projects I hope to launch that I believe will be valuable to MDPI and the industry at large.

I firmly believe that OA is the future of publishing, and I am grateful to be in a position to advocate for this belief as part of MDPI, the world's leading open access publisher.

Thank you to our staff and industry friends for your genuine support in this role.

Impactful Research

Nominations Open for the Prestigious Tu Youyou Award 2024

I am pleased to share that MDPI has opened nominations for the 2024 Tu Youyou Award, a prestigious recognition established in honour of Professor Tu Youyou, Nobel Laureate, whose work has significantly transformed the global fight against malaria.

The Tu Youyou Award offers CHF 100,000

In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine for her discovery of artemisinin, significantly reducing mortality rates from malaria and shaping global health policies. Artemisinin-based combination therapies (ACTs) are now the standard treatment endorsed by the World Health Organization (WHO), saving countless lives, especially in regions heavily burdened by malaria.

MDPI Special Issue

To mark Professor Tu’s 80th birthday in 2009, MDPI’s journal Molecules issued a Special Issue focusing on her contributions to medical research. Recognizing her continuous contribution, MDPI created the Tu Youyou Award in 2016 to honour outstanding achievements in natural products and medicinal chemistry.

The deadline for nominations is 31 December 2024

Nominations are open to scientists excelling in natural products and medicinal chemistry. Eligible nominators include academic institutes, universities, and societies. The deadline for nominations is 31 December 2024, with the winners to be announced on 30 April 2025. The Tu Youyou Award offers CHF 100,000, split equally among the winners.

MDPI encourages the academic community to nominate individuals who have demonstrated excellence and innovation in line with Professor Tu’s legacy. This award not only honours individual achievement but also encourages further scientific exploration and discovery in critical areas of medicine.

This award embodies our deep commitment to groundbreaking research that drives societal progress and celebrates the legacy of one of the greatest medical innovators of our time.

Inside MDPI

2023 MDPI Books Report

In past CEO letters, I have highlighted our publishing process and the impactful peer-reviewed articles that represent the core output of scholarly publishing. However, scholarly books are another pillar of publishing that MDPI also services, which our core audience may not be fully aware of. In this section, I highlight the 2023 MDPI Books report, released by our MDPI Books team in May 2024.

Download the 2023 MDPI Books Report

In the report, you will find a summary of MDPI Books’ 10th anniversary, the books indexed in the Web of Science Book Citation Index, our market outreach, and our outlook for 2024.

MDPI Books celebrated its 10th anniversary in 2023

MDPI Books published its first OA Reprint, “From the Renaissance to the Modern World,” in 2013. Over the past ten years, MDPI Books has seen a significant increase in both the volume and nature of published Reprints. As of December 2023, our catalogue includes a total of 7,369 Reprints, with 1,811 of them added in 2023 alone. MDPI Books includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.

We’re also celebrating the 10-year MDPI anniversary of Laura Wagner, Head of MDPI Books.

Laura Wagner (Head of Books Division)

Laura holds a Bachelor’s degree in Art History and History from the University of Basel. After her studies, she started her career at an art gallery in Basel.

Since joining MDPI in 2014, Laura has held several roles within the company. This included editorial work, development of reprint and book services, and the temporary management of the journal Arts.

Currently Laura holds the role of Head of Books Division and is in charge of the development and strategic direction of MDPI Books.

MDPI Books indexed in Web of Science Book Citation Index

Another milestone in 2023 was the indexing of four book titles in the Web of Science Book Citation Index. The indexing of our open access books is crucial for their reach and accessibility, ensuring higher visibility within the open science community.

  1. Self-Representation in an Expanded Field: From Self-Portraiture to Selfie, Contemporary Art in the Social Media Age by editor Ace Lehner
  2. Towards Socially Integrative Cities: Perspectives on Urban Sustainability in Europe and China by editors Bernhard Müller, Jian Liu, Jianming Cai, Paulina Schiappacasse, Hans-Martin Neumann, and Baojun Yang
  3. Transitioning to Gender Equality by editors Christa Binswanger and Andrea Zimmermann
  4. Under Construction: Performing Critical Identity by editor Marie-Anne Kohl

If you would like to learn more about MDPI Books, please visit:

If you are thinking of writing or editing a book, you can submit your proposal at, or email us at [email protected].

Coming Together for Science

Polymers 2024 – Polymers for a Safe and Sustainable Future

Our conference team successfully managed the Polymers 2024 – Polymers for a Safe and Sustainable Future international conference which took place from 28–31 May 2024 in Athens, Greece. The conference was chaired by Prof. Dr. Dimitrios Bikiaris and Prof. Dr. Konstantinos Triantafyllidis from the Aristotle University of Thessaloniki, Greece, and Dr. Ioanna Deligkiozi from AXIA Innovation, Germany. In total, the conference had 259 accepted abstracts and over 300 attendees from 22 different countries.

The conference featured three keynote speakers and 12 invited speakers, including esteemed scholars from Europe, Asia, Africa, and Canada. It included 60 selected talks and 189 posters, chosen by the 24 members of the Scientific Committee along with the three Conference Chairs. The event explored the latest scientific advancements and innovations in polymer science, focusing on creating safe, sustainable, and environmentally friendly materials. Emphasizing green polymer chemistry and the use of bioresources, the conference promoted the synthesis of biobased and biodegradable polymers.

The conference featured esteemed scholars from Europe, Asia, Africa, and Canada

Conference awards

The conference also presented three awards: two sponsored by the journal Polymers – The Best Poster Award (€500) and the Best Oral Presentation Award (€600) – and one sponsored by Ossila, the Best Student Poster Award (€500).

Thank you to our 16 sponsors, three partnering societies (Hellenic Polymer Society, European Polymer Federation, and North American Thermal Analysis Society [NATAS]) and eight media partners.

Upcoming in-person event

1–4 August, 2024
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
Location: Singapore

The AI Sensors 2024 Conference will unite innovators and experts in the realms of sensors, sensing technology, and artificial intelligence.

Find more upcoming MDPI events here.

Closing Thoughts

3rd World Forum Principles of Scientific Publications

I’m pleased to share that MDPI sponsored and attended the 3rd World Forum on Principles of Scientific Publications, which took place from 22–24 May in Malaga, Spain. The event brought together academic professionals and leading researchers to discuss critical topics in the realm of publishing and research. Presentation topics included Open Science, AI in Publishing, Predatory Journals, Fake Publications, Challenges for Non-native English Speakers, and more.

“It was great to see strong support from MDPI authors in the audience”

MDPI presentations

Stefan Tochev (CEO, MDPI) presenting at the 3rd World Forum Principles of Scientific Publications

I had the privilege of attending and presenting at the event, along with my colleague Dr. Enric Sayas (Business Analyst, MDPI) from our Barcelona office, who explored the ethical concerns and opportunities brought by AI in publishing.

I took the opportunity to present on Open Science, the benefits of Open Access, and MDPI’s performance, operations, and investment in ethics. Special thanks to Evan Escamilla (Project Manager, MDPI Books) and Facundo Santomé (Sr. Marketing Manager, MDPI) who also joined the conference.

It was great to see strong support from MDPI authors in the audience who shared their positive experiences publishing with us. Their story reflects the experience of the vast majority of authors who choose to work with MDPI.

We also encountered some conservative views on OA, which created an opportunity for open discussion aimed at addressing concerns about OA and MDPI. Engaging in such discussions is important, as scepticism sometimes arises from misinformation or from a misunderstanding of who we are and how we operate. When we engage in open and honest discussion, we tend to see people getting a better understanding of MDPI, which helps address any misconceptions they may have had.

Left to right: Dr. Enric Sayas (Business Analyst, MDPI), Stefan Tochev (CEO, MDPI), Facundo Santomé (Sr. Marketing Manager, MDPI), and Evan Escamilla (Project Manager, MDPI Books) at 3rd World Forum Principles of Scientific Publications

Stefan Tochev
Chief Executive Officer

31 May 2024
Meet Us at the 10th Congress of the European Academy of Neurology, 29 June–2 July 2024, Helsinki, Finland

MDPI will attend the 10th Congress of the European Academy of Neurology, held in Helsinki, Finland, from 29 June to 2 July 2024, at booth #E28. We invite researchers from different backgrounds to visit and share their latest ideas with us.

The EAN Congress covers “big diseases” such as multiple sclerosis, movement disorders, headache, muscle disorders, epilepsy, dementia, and stroke, as well as breakthrough research on rare diseases. This edition will celebrate 10 years of the EAN with over 8000 professionals. The 10th EAN Congress's overarching theme is “Neuromodulation: Advances and Opportunities in Neurological Diseases”. Leading specialists will tackle hot topics in invasive and non-invasive neuromodulation in movement and cognitive disorders, chronic pain, and refractory epilepsy. The current state and future directions of neuromodulation will be addressed with relevant questions regarding which techniques are available as diagnostic tools or therapeutic interventions; how to precisely target specific cortical regions, deep brain structures, and head nerves for therapeutic purposes; and how to advance neuromodulation in new areas of neurology such as chronic minimally conscious state or limb prosthesis.

The following MDPI journals will be represented at the conference:

If you are planning to attend the conference, please feel free to start a conversation with us at our booth #E28. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website:

31 May 2024
Meet Us at the FENS Forum 2024, 25–29 June 2024, Vienna, Austria

Conference: FENS Forum 2024
Date: 25–29 June 2024
Vienna, Austria

MDPI will be attending FENS Forum 2024 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference has been organized by the Federation of European Neuroscience Societies (FENS), the Austrian Neuroscience Association (ANA) and and the Hungarian Neuroscience Society. The FENS Forum is Europe’s largest neuroscience congress, covering all areas of neuroscience from basic to translational research.

The following MDPI journals will be represented:

  • Brain Sciences;
  • Journal of Clinical Medicine (JCM);
  • Cells;
  • NeuroSci;
  • Neuroglia;
  • Biomedicines;
  • Neurology International;
  • Behavioral Sciences;
  • Psychoactives.

If you are planning on attending this conference, please do not hesitate to contact us. Our delegates look forward to meeting you in person at booth #1003, and answering any questions that you may have. For more information about the conference, please visit the following website:

24 May 2024
Topics Webinar | Recent Advances in Oxidoreductases Biochemistry and Biotechnology, 28 May 2024

Welcome message by webinar chair, Prof. Grzegorz Janusz:

Dear colleagues,

Thank you for your participation in this webinar which will allow us to promote our conference, Oxizymes in Lublin, Poland, 2024, which is related to the MDPI Topic “Recent Advances in Oxidoreductases Biochemistry and Biotechnology”.

Oxidoreductases comprise a large number of enzymes of industrial relevance: peroxidases, peroxygenases, laccases, flavin–containing oxidases, and dehydrogenases, unspecific peroxygenases (UPOs), dye–decolorizing peroxidases (DyPs), copper–containing lytic polysaccharide monooxygenases (LP.M.Os), etc.

This conference and MDPI Topic aim to cover all aspects of this field, from the discovery of novel oxidoreductases, their mechanisms of action, and their structure–activity relationships to their applications in the production of fine chemicals and polymer building blocks, biosensors, and biomaterials, and their use in biorefineries for a bio–based economy.

Today, I a.m. pleased to introduce three of my colleagues who are involved in this webinar: Prof. Magdalena Jaszek, whose major research area is bioactive compounds, oxidoreductases, and proteases; next, Prof. Clemens Peterbauer, whose main research area is the expression and engineering of microbial enzymes for biomass degradation and biocatalysis; and finally, Dr. Katarzyna Szałapata, whose research interests focus on the bioactive aspects of polymer biomaterials.

Date: 28 May 2024
Time: 9:00 a.m. CEST | 3:00 a.m. EDT | 3:00 p.m. CST Asia
Webinar Announcement:–23

Register now for free!


Time in CEST

Time in CST Asia

Prof. Grzegorz Janusz
Chair Introduction

9:00 a.m.–9:10 a.m.

3:00 p.m.–3:10 p.m.

Prof. Magdalena Jaszek
Polysaccharides and Proteolytic Digestion as A New Proposal for the Modification of the Catalytic Potential of Fungal Laccase

9:10 a.m.–9:30 a.m.

3:10 p.m.–3:30 p.m.

Q&A Session

9:30 a.m.–9:40 a.m.

3:30 p.m.–3:40 p.m.

Prof. Clemens Peterbauer
Oxidative Auxiliary Activities for Lignocellulose Degradation in Bacteria

9:40 a.m.–10:00 a.m.

3:40 p.m.–4:00 p.m.

Q&A Session

10:00 a.m.–10:10 a.m.

4:00 p.m.–4:10 p.m.

Dr. Katarzyna Szałapata
Lublin—City of Multiculturalism, Youth, and OxiZymes!

10:10 a.m.–10:20 a.m.

4:10 p.m.–4:20 p.m.

Q&A Session

10:20 a.m.–10:30 a.m.

4:20 p.m.–4:30 p.m.

Prof. Grzegorz Janusz
Closing of Webinar

10:30 a.m.

4:30 p.m.

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway and we will inform you when the recording is available.

Webinar Chair and Keynote Speakers:

  • Grzegorz Janusz (Chair), Department of Biochemistry and Biotechnology, Institute of Biological Sciences, Maria Curie–Skłodowska University, Lublin, Poland;
  • Magdalena Jaszek, Department of Biochemistry and Biotechnology, Institute of Biological Sciences, Maria Curie–Skłodowska University, Lublin, Poland;
  • Clemens Peterbauer, Department of Food Sciences and Technology, BOKU—University of Natural Resources and Life Sciences, Vienna, Austria;
  • Katarzyna Szałapata, Department of Biochemistry and Biotechnology, Institute of Biological Sciences, Maria Curie–Skłodowska University, Lublin, Poland.

Relevant Topic:

Recent Advances in Oxidoreductases Biochemistry and Biotechnology

Topic Editors: Prof. Dr. Grzegorz Janusz, Dr. Anna Pawlik and Dr. Clemens Karl Peterbauer

Manuscript Submission Deadline: 31 October 2024

23 May 2024
Transfer Service in MDPI

We are pleased to announce MDPI’s Transfer Service.

This service provides a convenient method of transferring your manuscript file, along with any reviewer comments, to another journal within our publishing portfolio.

We are committed to helping authors find the right home for their research, and we will provide authors with guidance and technical support through all stages of the transfer process. Authors will be able to choose to transfer in the following two situations:

1. Select alternative journals on submission.

2. Authors are encouraged to transfer manuscripts to other MDPI journals.

More details about the Transfer Service can be found at the following link:

17 May 2024
Tu Youyou Award—Open for Nominations

In acknowledgment of the groundbreaking achievements of Professor Tu Youyou, the Nobel laureate credited with the discovery of artemisinin, MDPI is proud to announce the Tu Youyou Award. This award, inaugurated in 2016, seeks to honor scholars who excel in the fields of natural products chemistry and medicinal chemistry.


  • CHF 100,000 in total (If there is more than one winner, the prize will be divided equally amongst the winners);
  • An award medal for each winner.

Who should be nominated?

  • Scientists with outstanding achievements and contributions in the fields of natural products chemistry and medicinal chemistry.

Who can submit a nomination?

  • Academic research institutes
  • Universities
  • Academic societies

Any personal nominations are not accepted.

How do I submit a nomination?
Candidates’ institutional affiliations need to submit their nominations for final candidates to the Tu Youyou Award Team directly by email after internal screening, and each institution can only nominate a maximum of two candidates for each edition of the Tu Youyou Award. Please note that the nominations cannot be modified once they are submitted and confirmed by the Tu Youyou Award Team.

Required nomination materials:
Nomination Form (Download)

Nomination deadline: 31 December 2024;
Winner announcement: 30 April 2025.

Tu Youyou Award Team ([email protected])

More information can be found on the Tu Youyou Award official website. For any inquiries, do not hesitate to contact the Tu Youyou Award Team.

16 May 2024
MDPI Romania Author Training Academic Events in April

MDPI Romania sponsored four events over the month of April, contributing author training sessions to each event.

The NutriSciLabs 2024 conference was held at the Carol Davila University of Medicine and Pharmacy on 12 April 2024. Organized by the Association of Students from the Faculty of Pharmacy Studies, the conference aimed to enhance students’ academic writing and research skills, and bolster their confidence in participating in the academic world. Ioana Paunescu, journal relations specialist for MDPI Romania, led the training session. Paunescu first outlined MDPI’s history and core values, then explained academic writing techniques, ethics, and similarity percentages. The presentation covered the entire editorial process, highlighting the amount of attention paid to details throughout manuscript processing. Paunescu also discussed common errors that authors make while writing, and how to avoid such errors.

On 13 April 2024, the NextGEN 2.0 Student Conference took place at the Babes-Bolyai University of Cluj-Napoca. NextGen Healthcare organized this event with the university’s European Students’ Society to discuss European and international current affairs. MDPI Romania contributed an author training session called Steps of the Publication Process. Irina Codruta Zaharia, journal relations specialist, began the session with a general introduction of MDPI before diving into different article types, different layout formats, possible journals to submit to, the MDPI submission checklist, and the MDPI editorial process. By explaining the fundamentals of writing and publishing academic papers, Zaharia imparted valuable industry knowledge to the curious minds present. Participants were eager to engage with Zaharia in the subsequent Q&A session.

Celebrating its 20th anniversary this year, the International Conference “Students for Students” has long been a gathering place for undergraduate and postgraduate students of all nationalities to present their work and exchange ideas with each other. This year’s conference was held on 18 April 2024, with MDPI Romania contributing an author training session called The World of Open Access. Key speakers included Dr. Norbert Kiss from MDPI Romania and Prof. Dragos Horvath from Strasbourg University. Dr. Kiss discussed the history of open access, differences between open access publishing and traditional publishing, and implications for open access in the future. Attendees expressed keen interest in the subject, approaching Dr. Kiss with questions about academic publishing as well as his career trajectory.

Most recently, on 26 April 2024, MDPI Romania sponsored the National Symposium of Students from Geology and Geophysics Faculties. The AAPG Students Chapter at the Babes-Bolyai University organized this event as an opportunity for geology students from all Romanian universities to present their work and confer with other researchers. Dr. Kiss gave his lecture The World of Open Access at this event as well.

MDPI is thankful to all the participants, speakers, and organizers who attended these events. Through their enthusiasm and dedication, these events were great successes.

8 May 2024
Meet Us at the 61st ERA Congress, 23–26 May 2024, Stockholm, Sweden

MDPI will be attending the 61st ERA Congress, which will be held from 23 to 26 May 2024 in Stockholm, Sweden.

The ERA Annual Congress remains committed to advancing the understanding and treatment of kidney disease to improve the well-being of patients. Our aim is to disseminate knowledge with a focus on clinical assessment and treatment, with the overarching theme for this year being “Rethinking Kidney Health and Transforming Kidney Care”. The ERA 2024 will also mark the 60th anniversary of the ERA Registry. Four special sessions (Creative Labs), organized by the ERA Registry group, will provide insight into their expertise and knowledge.

The following MDPI journals will be represented:

If you plan on attending this conference, feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please visit the following link:

2 May 2024
MDPI Insights: The CEO's Letter #11 – 2023 Annual Report, MDPI Awards, STM

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.

Opening Thoughts

2023 Annual Report

This is an exciting time of year at MDPI, as we have just released our annual report 2023, recapping the past year and sharing the progress and changes that took place during it.

Stefan Tochev (CEO, MDPI)

Reflecting on 2023, I can't help but think of the changes that have occurred not only at MDPI but also within our industry as a whole. In light of this, I’m reminded that change is the only constant, and that for a publishing enterprise that has experienced rapid growth, adapting to change becomes not only a necessity but also a catalyst for sustained success.

Looking back on the significant ground we covered in 2023, I am pleased to report that the year was marked by a rise in paper submissions, along with a range of initiatives aimed at improving our internal processes and delivering top services to our scientists.

2023 Top-line MDPI Numbers

An important priority for 2023 was to strengthen our editorial policies. Despite a notable increase in the number of papers submitted from 603,000 to 655,000 (+8.6%), there was a decrease in the number of papers published from 303,000 to 285,000 (-5.9%), consistent with the overall trend in the scholarly publishing market. MDPI’s market share in gold open access articles published reached 17% in 2023 (according to Dimensions data).

2023 Open Access Numbers

For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment to, and vision for, an open future. This momentum continued in 2023, with 39% of the 4.16 million articles and reviews published as gold full-OA, 15% as gold hybrid-OA, 8% as bronze-OA, and 3% as green-OA, relative to 35% behind a paywall. In terms of gold OA (full or hybrid) articles and reviews published, MDPI leads the way in terms of total articles published in 2023.

MDPI is the trusted and preferred OA publisher for the scholarly community

However, in 2023, we saw a downward trend in publication numbers compared to 2022. This trend was also seen in total OA publications. While the number of submissions increased, the decline in MDPI publications can be attributed to several factors, such as improved scrutiny in our peer-review process, including the evaluation of content scope and higher rejection rates, and a post-pandemic decrease in research related to COVID-19 papers.

Download 2023 MDPI Annual Report.
Access 2023 Digital Report.

Impactful Research

Recognizing Scholars – MDPI Awards

MDPI is committed to empowering young researchers as they embark on their careers. In 2023, our journals hosted a total of 400 awards, receiving 8,839 applications and nominations. The evaluation committees selected 959 winners, with the total budget for these awards amounting to CHF 546,500.

For more information about MDPI awards, applications, and winners, please click here

The following awards recognize scholars and the impact of their research, including Young Investigator Awards, Best PhD Thesis Awards, and Travel Awards for junior researchers.

MDPI Awards – The following awards require an application or a nomination.

Young Investigator Award (CHF 1000–2000 for each winner)
This award acknowledges the achievements of young investigators in research areas relevant to the journal’s scope. Candidates must have received their PhD no more than 10 years prior to the award announcement date and must be nominated.

Best PhD Thesis Award (CHF 500–800 for each winner)
This award recognizes young scholars who have completed outstanding PhD theses in research areas relevant to the journal’s scope. It aims to encourage them to continue their excellent work and make further contributions to their field.

Travel Award (CHF 500–800 for each winner)
This award encourages junior scientists to present their latest research at academic conferences relevant to the journal’s scope, thereby increasing their impact.

Distinguished Scholars
Additionally, 220 awards were granted to the most distinguished authors and reviewers in our journals through Best Paper Awards and Outstanding Reviewer Awards. The following awards are selected by the editorial staff of the journal and do not require an application or a nomination. They exemplify the excellent contributions made by our authors, reviewers, and editors.

These awards exemplify the excellent contributions made by our authors, reviewers, and editors

Best Paper Award (CHF 200–500 for each winner)
This award is granted annually to highlight publications of high quality, scientific significance, and extensive influence.

Outstanding Reviewer Award (CHF 500 for partial winners)
This award is given annually to recognize reviewers who generously contribute their time to reviewing papers and demonstrate thoroughness, professionalism, and timeliness in their reviews.

MDPI also offers awards for specific topics in various research fields:

Carbon Neutrality Award (CHF 500–800 for each winner)
Sponsored by MDPI journal Sustainability, this award recognizes applicants who have made exceptional academic or societal contributions to carbon neutrality, either in general or in relation to a specific carbon-neutrality-related issue.

Intelligent Manufacturing Award (CHF 500–800 for each winner)
Administered by MDPI journal Machines, this award is presented to an individual who has made outstanding academic or societal contributions to the field of intelligent manufacturing.

Granted: World Sustainability Awards

Inside MDPI

MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager

As CEO of the world’s leading OA publisher, I am pleased to announce the official opening of our Korean branch office. With this addition, MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher. This expansion represents more than just an increase in our physical footprint; it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible across the globe.

MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher

Claude Seo (MDPI Korea Office Manager, Seoul)

Claude Seo, who has over 15 years of experience in the academic publishing industry, has been appointed as the Office Manager of the Seoul office. The launch of our Seoul office allows us to better support the Korean scientific community and to further promote the publication of OA journals in the region.

Reflecting on his role, Claude shared that he is:

“Delighted to have been entrusted with this position within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating ourselves into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”

Sungkyunkwan University Joins MDPI’s Institutional Open Access Program

Additionally, I am pleased to share that Sungkyunkwan University has joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDP’s online submission system for institutions and provides APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyunghee University, Chung-Ang University, and the Catholic University of Korea, have adopted IOAP in Korea.

Learn more about MDPI’s collaboration in Korea in my previous CEO Letter, in which I recap our visit to Seoul, South Korea.

Coming Together for Science

4th MMCS: Harnessing the Power of New Drug Modalities

Our conference team successfully managed the 4th Molecules Medicinal Chemistry Symposium, held from 24–26 April in Barcelona, Spain. It was chaired by Prof. Dr. Diego Muñoz-Torrero from the Institute of Biomedicine (IBUB), University of Barcelona, Spain, and Prof. Dr. Simona Collina from the University of Pavia, Italy. In total, there were 84 accepted abstracts and 102 conference attendees from 22 different countries.

From left to right: Prof. Dr. Rino Ragno (Scientific Committee), Dr. Maria Emilia Sousa (Scientific Committee), Prof. Dr. Claudio Viegas Jr. (Scientific Committee), Prof. Dr. Simona Collina (Chair), Prof. Dr. Diego Muñoz-Torrero (Chair), Alvina Wu (Managing Editor, MDPI), Prof. Dr. Roman Dembinski (Scientific Committee), Prof. Dr. Mariana Spetea (Scientific Committee).

The event comprised 12 Invited Speakers, 35 Selected Talks, 10 Flash Poster Presentations, and 39 Posters. The overarching topic of the conference was the impact of the emergence of new drug modalities on drug discovery, with thematic sessions covering topics such as photoactivatable drugs, candidates targeting RNA and epigenetic targets, covalent modifiers, and the development of new anti-cancer agents, among other medicinal chemistry projects.

We are pleased to have received feedback from attendees highlighting the professional approach of the conference chairs and participants, the high quality of the talks, and the overall outstanding organization on the part of the MDPI conference team.

Thank you to the conference sponsors, Fluorochem and IBUB, and to our partnering societies, The Spanish Society for Biochemistry and Molecular Biology (SEBBM), and the Spanish Society of Medicinal Chemistry (SEQT).

Upcoming In-Person Event

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Athens, Greece
Conference Chairs: Prof. Dr. Dimitrios Bikiaris, Prof. Dr. Konstantinos Triantafyllidis, Dr. Ioanna Deligkiozi
We look forward to welcoming experts Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.

Find more upcoming MDPI events here.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

A Report from the Future – STM US Annual Conference 2024

Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board.

MDPI has for a long time been a sponsor of the STM Annual Conferences, held yearly in the US and Frankfurt, and is a trusted partner and supporter of the STM organization. While I have attended the Frankfurt conference for the past three years, this was my first time visiting the Washington, DC session, and I am glad I did.

Although it was a brief trip, I greatly appreciated the opportunity to attend in the company of my colleagues Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board. They always help map some of the new industry trends against MDPI’s operational framework and guidelines. It’s a great group for kicking ideas back and forth on what we can apply at MDPI.

In my experience, STM never fails to deliver. It’s always a great conference for reconnecting with fellow publishers, industry friends, and vendors. As usual, STM this year curated a diverse range of speakers and panels, who proferred valuable knowledge and insights from outside our industry, delivering thought-provoking insights into our field. An example of this was the ‘Trust Panel’ session, which included Alan Schiffres (Managing Director, InfoLinx), who shared a number of the learnings about fraud and risk management from his 40 years in financial services, to help address some of the challenges we are currently facing in the area of publishing integrity.

Launch of STM Trends 2028 Panel

I particularly enjoyed the ‘Launch of STM Trends 2028 Panel’, which presented a report focused on the integration of humans and machines in scholarly publishing. The session highlighted themes such as AI, digitization, and the evolving research ecosystem. The report envisions a future where technology blurs the lines between human and machine involvement in research processes, with significant implications for trust, reputation, and equity. While this presents opportunities for connectivity and knowledge dissemination, it also poses challenges such as disinformation, fragmentation, and geopolitical tensions. We must rely on a wise combination of technology and human agency to navigate this complex landscape and will have to carefully examine its potential impacts on communication and scholarly publishing.

MDPI has joined the STM Integrity Hub. Click here to learn more.

While every presenter brought their own knowledge and personal touch, I was particularly pleased to encounter new speakers such as Heather Whitney (Research Assistant Professor, Radiology, University of Chicago) and Igor Grossmann (Professor of Psychology, University of Waterloo, Canada). Having studied Sociology at the University of Guelph, I have a soft spot for fellow social scientists from Canada, and I was very impressed by Igor’s presentation on ‘The Social Scientist: A View from the Future’ and his participation in the panel session ‘The Future Beyond the Article,’ which was one of my favourites from the conference, given the diversity of perspectives from the panel speakers.

Memorial Park in Washington, DC

On a personal note, this was my first-time visiting Washington, DC, and I’m glad we took an afternoon to visit the Memorial Park, with its incredible monuments to figures ranging from Martin Luther King, Jr. to Abraham Lincoln. The magnitude of the monuments is deeply impressive. I particularly appreciated the Thomas Jefferson memorial and the following quote, which I think speaks to the importance of change and adaptation. It’s something we can apply not only in our industry but also in our personal lives.

"I am not an advocate for frequent changes in laws and constitutions, but laws and institutions must go hand in hand with the progress of the human mind. As that becomes more developed, more enlightened, as new discoveries are made, new truths discovered and manners and opinions change, with the change of circumstances, institutions must advance also to keep pace with the times. We might as well require a man to wear still the coat which fitted him when a boy as a civilized society to remain ever under the regimen of their barbarous ancestors."

– Excerpted from a letter to Samuel Kercheval, July 12, 1816.

Stefan Tochev
Chief Executive Officer

30 April 2024
MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager

MDPI, the leading Open Access (OA) publisher, announced on Monday that it opened its Korean branch office on 29th April 2024. With this addition, MDPI now operates 21 offices in 12 countries worldwide. Claude Seo, with over 20 years of experience in the academic journal publishing industry, including Nature Publishing Group (NPG), has been appointed as the Office Manager of the Seoul office.

With the establishment of a Seoul office, MDPI aims to actively support Korea scientific communities to further promote the publication of OA journals in the region. As of the end of 2023, Korea ranked sixth worldwide in both submissions and publications of MDPI research papers. MDPI is the number one OA publisher in Korea.

Sungkyunkwan University Joins MDPI’s Institutional Open Access Program

In addition, MDPI announced that Sungkyunkwan University joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDPI online submission system for the institutions and APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyung Hee University, Chung-Ang University and Catholic University of Korea, have adopted IOAP in Korea.

OA aims to break down barriers that have traditionally restricted access to science, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Authors, academia, and scientific communities are rapidly moving toward OA. MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020.

MDPI CEO Visits Seoul, Korea

In March, Stefan Tochev, Chief Executive Officer (CEO) of MDPI, visited Korea and met with various stakeholders including government agencies, research and academic institutions, universities. During his visit, Stefan highlighted that MDPI continues to pave the way for a world where science is accessible to all, supporting a global community of inclusive innovation and collaborative solutions.

Stefan expressed excitement about the new venture, stating, "Today marks a significant milestone for MDPI as we celebrate the opening of our new office in Seoul, Korea. This expansion is more than just an increase in our physical footprint, it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible, participatory, and inclusive across the globe."

Claude Seo, reflecting on his new role, commented, "I am delighted to have been offered this position of trust within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”

For further inquiries, please contact our Seoul office directly.

About MDPI

A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.3 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6000 diligent, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully OA titles.

2 April 2024
Join Us for the 2024 Annual Congress of the European Association for Cancer Research (EACR 2024), 10–13 June 2024, Rotterdam, the Netherlands

The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) is a four-day congress engaged in basic, preclinical and translational cancer research across a myriad of topics that is aiming to spotlight, inspire and unite the cancer research community to innovate, build knowledge, and create collaborations.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to contact us online. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following link:

2 April 2024
MDPI Insights: The CEO's Letter #10 - South Korea, IWD, U2A, Japan

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.

Opening Thoughts

Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Stefan Tochev (CEO, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), during media meetings at Prain Agency office in Seoul, South Korea.

Visit to Seoul, South Korea

During my recent visit to South Korea, I had the privilege of meeting various stakeholders, including representatives of government, research institutions, and academia, to understand their needs and communicate MDPI’s commitment to accessible science. Accompanied by my colleagues Dr. Giulia Stefenelli and Dr. Jisuk Kang, I engaged with the Korean scientific community, which is increasingly embracing open access (OA).

As the leading OA publisher in South Korea, MDPI is trusted by local authors and in 2023 enjoyed an approximately 30% share of the OA market. South Korea ranks sixth globally for MDPI in terms of research papers submitted and published.

MDPI and South Korea by Numbers

As at 30 March, over 76,000 MDPI articles have been authored by individuals affiliated with Korean institutions. We have over 1,800 active editorial board members (EBMs) from South Korea, with more than 880 EBMs having an H-index between 26 and 50, including 10 serving as Chief Editors.

“South Korea is the sixth-largest contributor to our total publications”

Over the past five years (2019–2023), nearly 120,000 authors affiliated with South Korean institutes have published with MDPI. Specifically in 2023, we received approximately 25,000 submissions from South Korean authors, publishing close to 13,000 articles, resulting in a rejection rate of 47.4%, which is not far below MDPI’s overall rejection rate of 56.4% in 2023.

Institutional Partnerships with South Korea

I am pleased to share that MDPI has more than 825 institutional partnerships worldwide, with 12 in South Korea, including Kyunghee University, Chung-Ang University, and Inha University, among others.

Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), and Stefan Tochev (CEO, MDPI) fielding media questions at Prain PR Agency office in Seoul, South Korea.

Over the past three years (2021–2023), we have had some of the most prestigious academic universities ranked among the top 10 Korean institutions publishing with MDPI. Seoul National University had the highest number of publications with MDPI during those three years, publishing nearly 6,000 papers. Universities such as Korea University and Yonsei University also rank among the top 10 Korean institutions publishing with MDPI.

MDPI Hosts Seminar for Academia and Media

As the world’s leading OA publisher, MDPI is actively democratizing science. This is reflected in the seminars we hosted on 21 March to address questions about our editorial processes and ethical standards. The visit garnered media coverage, reflecting our mission to providing high-quality services and fostering open dialogue in the community.

“MDPI is actively democratizing science”

MDPI in the News

Stefan Tochev (CEO, MDPI) leading a seminar on OA and MDPI at Prain PR Agency office in Seoul, South Korea.

Media coverage generated by our visit to Seoul included the following stories:

“Open access is an unstoppable trend…it will lead the development of the knowledge ecosystem.”

“Papers that the public needs, anyone can use quickly… low-quality publishing is a misunderstanding.”

I greatly appreciate the contributions of everyone who took the time to meet with us, share their stories, and hold us accountable for continuing to provide high-quality publishing services while identifying areas for improvement. I am also excited to announce that we have opened an MDPI office in Seoul and will release a press release on, with details, by the end April 2024. The purpose of the office is to establish a local presence to connect with and support the South Korean academic community through institutional partnerships, conferences, author workshops, stakeholder communications, and more.

Impactful Research

Featured Articles on Women’s Leadership and Healthcare

In celebration of International Women’s Day (8 March 2024), MDPI curated a collection of research articles on various topics, including women’s leadership, reproductive health, preventive healthcare, and a selection of articles from our journal Women.

Women’s Leadership

Women’s Reproductive Health

Women’s Preventive Healthcare

Featured Articles in MDPI Journal Women

Below are a few articles from Women, our journal focused on women’s health, the social determinants of health, and the healthcare system that serves women. The aim of Women is to encourage academics to publish their experimental and theoretical results in detail, to aid reproducibility, and in an engaging style, to aid comprehensibility.

Inside MDPI


Championing Women’s Healthcare and Access to Healthcare Information

MDPI colleagues from our offices joined in celebrating #IWD2024. In doing so, we emphasized key missions that encompass:

  • Empowering women to assume leadership and decision-making roles in both business and science.
  • Helping women and girls make informed decisions about their health.
  • Recruiting and developing female talent and fostering inclusive workplace environments.

“We are thrilled to recognize the accomplishments of women scientists”

I am proud to see our colleagues enthusiastically supporting the International Women’s Day call to ‘Inspire Inclusion!’ The heart-hands in the collage below symbolize our appreciation of the achievements of women researchers and the recognition of the trailblazers who have courageously made a mark on societies past and present.

We are thrilled to recognize the accomplishments of women scientists through our many MDPI awards and by highlighting success stories. As inspirational figures, female scientists are paving the way for the next generation of women aspiring to pursue careers in engineering, life sciences, computing, and various other STEM fields.

“I consider myself lucky because I work with incredibly talented women who inspire me every day.”
– Dr. Alessandra Pasut, Winner of MDPI's ‘Biology 2023 Young Investigator Award’

“It’s really important to find a supportive and enabling environment in which to do your science; it would have a big impact on you as a person and on your scientific outputs.”
– Dr. Rhea Longley, Winner of the ‘Pathogens 2023 Young Investigator Award’

Open-access publishing, in particular, allows early-career women researchers to share their work more widely, potentially attracting mentorship opportunities and collaborations. This support is crucial for career development and advancement.

Coming Together for Science

MDPI Joins United2Act in Collective Fight to Stop Paper Mills

In my February 2024 CEO Letter, I highlighted some of our recent initiatives aimed at bolstering our commitment to research integrity, including joining the STM Integrity Hub and expanding our Research Integrity and Publication Ethics team (RIPE). Continuing our efforts in coming together for science, I am pleased to share our participation in the United2Act initiative.

The text below is taken from our official announcement:

United2Act represents an international group of stakeholders in the publishing industry committed to addressing the collective challenge posed to research integrity by paper mills.

Scientists and academic publishers have increasingly noted the alarming proliferation of paper mills, recognized as fraudulent entities seeking to manipulate the publication process for financial profit. These entities engage in fraudulent practices such as falsifying or fabricating data, selling co-authorship of fake papers, manipulating peer review, and including inappropriate citations. These actions pose a significant threat to the integrity of the scholarly record, prompting widespread concern among those involved in the academic community.

MDPI has been actively contributing to combat the undermining of the scientific record. Our editors employ a set of tools to detect potential ethical breaches within a manuscript and to tackle the issue of fake papers.

United2Act’s consensus statement is the outcome of a virtual summit held in May 2023. It involved the participation of research bodies, publishers, researchers/sleuths, universities, and publishing infrastructure from 15 countries and resulted in a Consensus Statement outlining five key areas of action for all stakeholders:

  • Education and awareness
  • Improve post-publication corrections
  • Facilitate and organise research on paper mills
  • Enable the development of trust markers
  • Facilitate dialogue between stakeholders

MDPI is committed to promoting transparency and integrity in scholarly publishing and is continuing to work closely with the scientific community toward this goal.

Closing Thoughts

Left to right: Ryo Hirayama (Marketing Specialist, MDPI), Takashi Sasabe (Marketing Specialist, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Stefan Tochev (CEO, MDPI), at MDPI’s office in Tokyo, Japan.

Visit to Tokyo and Kyoto, Japan

In March, I had the opportunity to visit our Tokyo office and engage with stakeholders in Tokyo and Kyoto. During the visit, I also recorded a video message to welcome Japanese scholars working with MDPI and to highlight our operations in Japan.

We held meetings with Editors-in-Chief, librarians, scholars, and external consultants to gather feedback on our efforts to enhance our reputation and explore additional steps we can take in that direction. Japan's rich cultural heritage, characterized by tradition, respect, and formality, provided valuable insights into meeting the publishing needs specific to Japan.

Japan’s Open Access statistics

Over the years, we have seen a shift from subscription-only to gold OA publishing in Japan, despite the lack of an official mandate. Here are some statistics:

  • 2012: 68% of articles were subscription-only, 6% were green Open Access, and 8% were gold Open Access.
  • 2016: 55% of articles were subscription-only, 6% were green Open Access, and 20% were gold Open Access.
  • 2022: 43% of articles were subscription-only, 7% were green Open Access, and 39% were gold Open Access.

To learn more about the history of OA in Japan as well as about future trends, please read this blog post.

“Japan is the ninth-largest contributor to our total publications”

Left to right: Stefan Tochev (CEO, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI) visiting Kyoto University in Kyoto, Japan.

MDPI and Japan by Numbers

As at 1 April, over 50,000 MDPI articles have been authored by scholars affiliated with Japanese institutions, making the country the ninth-largest contributor to our total publications. Over the past three years (2020–2023), nearly 90,000 authors affiliated with Japanese institutes have published with MDPI, and we have collaborated with over 4,600 Guest Editors from Japan.

In 2023, we published over 8,200 papers from authors associated with Japanese institutions. MDPI collaborates with 41 institutional partnerships in Japan, including the University of Tokyo, Hokkaido University, and Nagoya University. We have over 2,100 active EBMs from Japan, more than 1,050 EBMs having an H-index between 26 and 50, including 13 serving as Editors-in-Chief.

General Feedback – a side note

A general takeaway from our discussions with stakeholders from around the world is that negative perceptions of MDPI often stem from misinformation, misconceptions, or misunderstandings about MDPI and our practices. While we acknowledge our mistakes and work diligently to address them, maintaining a strong editorial procedure and robust peer-review process, I find that educating stakeholders about our how we do what we do and our ongoing improvements tends to help shift opinions.

That said, we recognize the importance of addressing individual concerns. We take feedback seriously and are continuously working to get better while not compromising the core principles that millions of authors appreciate about MDPI.

Stefan Tochev
Chief Executive Officer

29 March 2024
Meet Us at the 20th Annual International Conference of the Metabolomics Society (Metabolomics 2024), 16–20 June 2024, Osaka, Japan

MDPI will be attending the 20th Annual International Conference of the Metabolomics Society (Metabolomics 2024) held in Osaka, Japan, from 16 to 20 June 2024. The conference is the official annual meeting of the Metabolomics Society, and the largest metabolomics meeting worldwide. This is the third time that the conference will be held in Japan, following the 2005 and 2014 conferences held in Tsuruoka. We look forward to welcoming the metabolomics community, building strong connections, and discussing world-class research in a relaxed collegial environment. Let us build on the momentum of the incredible Niagara Falls and Valencia conferences that brought us back together in person, and make it the best meeting of 2024 together!

During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest views and research with us.

The following MDPI journals will be represented:

  • Metabolites;
  • Biomolecules;
  • Plants;
  • IJMS;
  • Life;
  • Cells;
  • Agronomy;
  • Nutrients;
  • Cancers;
  • CIMB;
  • Genes;
  • Antioxidants.

If you plan on attending this conference, feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit the following link:

4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.

Opening Thoughts

Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.

MDPI’s Impact on Romania

In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.

Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.

With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.

Romania ranks as a top 20 contributing country.

The Numbers: 2019–2023

MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.

With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).

Institutional Open Access Programs

Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.

Our growth and presence in Romania are a true testament.

We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.

Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.

Impactful Research

MDPI Joins the STM Integrity Hub

MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.

“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”

Joris van Rossum, Director of Research Integrity, STM

MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.

I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.

Inside MDPI

MDPI Expands Research Integrity and Publication Ethics Team (RIPE)

In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.

We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.

The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.

Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”

Introducing our Research Integrity and Publication Ethics Team

Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).

Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.

With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.

Quality Updates to Special Issues Oversight

At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.

The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.

PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.

Read more:

Coming Together for Science

Viruses 2024 – A World of Viruses

I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.

Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.

Recap on the #Viruses2024 Conference

Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!

Below are calls to action from the keynote speakers encouraging collaboration and communication:

“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA

“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain

Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.

Upcoming In-Person Event

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain

Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.

Find more upcoming MDPI events here.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Researcher to Reader (R2R) Conference

From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.

We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.

R2R Peer Review Innovations Workshop

I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.

Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.

The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.

At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.

Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!

Stefan Tochev
Chief Executive Officer

31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.

Opening Thoughts

MDPI and Digital Science Meeting

At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.

As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.

Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.

During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.

What is Altmetric?

You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.

Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.

“Almetric provides visual insights into where research is being discussed”

Sources Tracked by Altmetric

Altmetric badge showing the Altmetric score and colour-coded mention sources.

Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.

The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.

Read more:

Impactful Research

Ten High-Altmetric Articles Published by MDPI

As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.

So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.

Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.

“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort”

J. Pers. Med. 2017, 7(2), 3;

Altmetric page:

Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News.

“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis”

J. Clin. Med. 2019, 8(3), 404;

Altmetric page:

Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times.

“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia”

Quaternary 2021, 4(3), 24;

Altmetric page:

Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic.

“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability”

Animals 2020, 10(6), 1007;

Altmetric page:

Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian.

“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study”

Animals 2022, 12(15), 1933;

Altmetric page:

Altmetric shows that this article appeared in 192 news stories from 186 outlets.

How do I use altmetrics?

Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.

Sharing Research Online

For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.

“An Update on Eukaryotic Viruses Revived from Ancient Permafrost”

Viruses 2023, 15(2), 564;

Altmetric page:

Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN.

“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications”

Healthcare 2019, 7(1), 1;

Altmetric page:

Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes.

“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health”

Int. J. Environ. Res. Public Health 2020, 17(4), 1212;

Altmetric page:

Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum.

“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health”

Int. J. Environ. Res. Public Health 2018, 15(3), 431;

Altmetric page:

Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review.

“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens”

Animals 2023, 13(4), 590;

Altmetric page:

Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC.

Inside MDPI

MDPI Annual Meeting Celebrations in China

On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.

The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.

“It is essential that we stay connected and share best practices”

I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.

Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.

Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.

The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.

I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!

Coming Together for Science

MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership

We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.

“This initiative reflects our dedication to transparent and inclusive publishing”

TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.

For further details on our Institutional Open Access Program (IOAP), please contact us.

Benefits to MDPI’s IOAP

At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.

For further information, see our IOAP FAQ.

Closing Thoughts

Reflections on the 2024 APE Conference

MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.

The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.

“It's fascinating to see how other publishers are leveraging AI”


Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.

In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.

“We can share best practices and lessons learned”

Incorporating MDPI’s Insights into Conferences

I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.

Stefan Tochev
Chief Executive Officer

25 January 2024
Acknowledgment of the Reviewers of Cells in 2023

In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Cells. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.

In 2023, Cells received 9924 review reports, from 8245 reviewers. This past year, we worked with reviewers from 91 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Cells family throughout 2023, and we look forward to their continued support in 2024.

The following are the reviewers who have consented to show their names:

A. N. M. Mamun-Or-Rashid Lisa Deloch
Abbas F. Almulla Lisa Mapelli
Abdelaziz Amrani Lisardo Boscá
Abdellatif Bouazzaoui Liubov Gorbacheva
Abhik Sen Livius V. d'Uscio
Abhinav Joshi Ljubica Harhaji-Trajkovic
Abhishek Anant Kulkarni Loren Fong
Abhishek Bhattacharya Lorenzo Bonetti
Abhishek Jha Lorenzo Nanetti
Addolorata Pisconti Loretta Tuosto
Adelina Vlad Lu Cai
Adi Sarig-Axelrod Lu Kong
Aditya Joshi Luc Swevers
Aditya Sharma Luca Filippi
Adriana Geisinger Luca Giannella
Adriana Ortiz Luca Magistrelli
Adriana Silva Lucia Anna Muscarella
Aftab Ahmad Lucian Birsa
Agata Stanek Luciana Bordin
Agata Zmijewska Luciana Corrêa
Agnes W. Boots Ludmilla Thome Chinen
Agnieszka Fus-Kujawa Ludovic Tricoire
Agnieszka Krawczenko Luigi Menghini
Agnieszka Owczarczyk-Saczonek Luis G. Celis-Regalado
Agnieszka Zdzislawa Robaszkiewicz Luis Ibarra
Ahmad Albaghdadi Luis Jave-Suarez
Ahmad Salti Luis M. Quirós
Ahmed Abu-Zaid Luis Meseguer-Olmo
Ahmed Doghish Luisa Rocha
Ahmed Hamdan Lukas Schroeder
Ahmed Mekkawy Lydia Muranova
Ahmed Mostafa Lyudmila Bel'skaya
Ahmed Noreldin Maciej Lalowski
Ahmet Cingoz Maciej Serda
Aiguo Tian Madankumar Ghatge
Aijaz Bhat Magdalena Izdebska
Aiping Liu Magdalena Mizerska-Kowalska
Ajay Akhade Magdalena Stasiak
Akiyoshi Takami Magdalena Szymanska
Alberto Correia Magdalena Zemelka-Wiacek
Aleix Cases Mahara Valverde
Aleksander Czogalla Mahesh Gupta
Aleksander Tworak Mahesh Kandasamy
Aleksandra Asaturova Mahmood Mozaffari
Aleksandra Orzechowska Maja Cemazar
Aleksey Zaitsev Majid Ghareghani
Alessandra Colombini Maki Katuhara
Alessandra De Giani Małgorzata Godala
Alessandra Maresca Małgorzata Reda
Alessandra Murabito Manesh Nautiyal
Alessandra Pelagalli Manfred Frasch
Alessandro Castorina Manigandan Venkatesan
Alessandro Ieraci Manikandan Samidurai
Alessia Remigante Manish Charan
Alevtina Grishanova Manish Dhawan
Alex F. de Vos Manish Kumar
Alexa Klettner Manohar Kodavati
Alexander Deryabin Manohar Kugaji
Alexander Laemmle Manoj B. Menon
Alexander Lang Manoj Pandey
Alexander Ljubimov Mansor Hakiman
Alexander Nosov Manuel Díez-Alonso
Alexander Sapozhnikov Manuela Antonioli
Alexander Timoshenko Manuela Lanzafame
Alexander Voronkov Marawan Abdelbaset
Alexandra Senegaglia Marc-André Lécuyer
Alexandra Zakharenko Marcella Reale
Alexandre Silva Marcello Delitala
Alexandros Katranidis Marcelo Barros
Alexandros Rovas Marcelo Ferreira
Alexei Chukhlovin Marcelo Gois
Alexei Muravyov Marcelo Moura
Alexey Bogdanov Marcia Bastos Convento
Alexey P. Bolshakov Marco Calvaruso
Alexi Kiss Marco Cavaco
Alexis Ribas Salvador Marco Invernizzi
Alexis Stamatikos Marco Piccoli
Alfonso Blanco Marco Roverso
Ali H. Ad’hiah Marco Tafani
Alice Berardo Marcus Corat
Alina Deshpande Marcus Lettau
Alina Uifalean Marcus Scotti
Alina-Andreea Zimta Marcy Martin
Alisa Sokolovskaya Mardelle Atkins
Aliz Barakonyi Marek K. Bernard
Allison B. Reiss Margarita Apostolova
Alsu Saifitdinova Margarita Ivanova
Álvaro Plaza Reyes Maria A. Mariggiò
Amandine Magnaudeix Maria Adriana Neag
Amany Tawfik Maria Almeida
Amin Tamadon Maria Antonietta Panaro
Amir Ashoorzadeh Maria Bariani
Amir Shemirani Maria De Angioletti
Amit Kumar Maria De Grandis
Amit Pandey Maria E. Stefanova
Amiya Patra Maria Egle De Stefano
Ammad Ahmad Farooqi María Elvira López-Oliva
Ammar Saleem Maria Eugenia Gonzalez
Amr Ahmed El-Arabey Maria Frosini
Ana B. Ramos-Hryb Maria Grazia Giansanti
Ana Cláudia Ferreira Souza Maria Grazia Narducci
Ana Dascalu Maria J. Ruedas-Rama
Ana Isabel Fraguas-Sánchez Maria Jose Ferrandiz
Ana Luísa De Sousa-Coelho Maria Julia Lamberti
Ana Luzio Maria Luiza Mello
Ana Podolski-Renić Maria Notara
Ana Rita Jesus Maria Paola Castelli
Ana Silva Maria Perepechaeva
Ana Sofia Vallés Maria Rubtsova
Ana Urzainqui Maria Salagianni
Anand Desai Maria Spletter
Anand Paramasivam Maria Swanberg
Ananth Pannala María Teresa Hernández-Huerta
Anastasia Nijnik María Teresa Soto-Navarrete
Anca Colita Maria Teresa Villarreal Molina
Anders Lade Nielsen Maria V. Chatziathanasiadou
André Antonio Pelegrine Maria Wróbel
Andre Silva Maria Xilouri
Andrea Amaroli Mariapaola Marino
Andrea Borghini Mariia Ivanova
Andrea Brancaccio Marija Stojmenović
Andrea C. F. Ferreira Marika Mokou
Andrea Del Fattore Marina Gottikh
Andrea Ghelli Luserna di Rorà Marino Paroli
Andrea Ghiroldi Mario Diaz
Andrea Moriondo Mario Ganau
Andrea Morrione Mario Ruiz
Andrea Teufelberger Mario Simirgiotis
Andreas Brodehl Mário Sousa
Andreas Werner Marjorie Pion
Andrei Ivanov Mark Musch
Andreia Carvalho Mark R. Krystal
Andrés Humberto Uc-Cachón Mark Spritzer
Andres Quesada Marlena Godlewska
Andrew Leask Marlon De Ita
Andrew Moorhouse Marouane Chemek
Andrey Kolobov Marta Camprubí Rimblas
Andrey Nagdalian Marta Gaburjáková
Andrey Sudarikov Marta Gonzalez-Alvarez
Andy T. Y. Lau Marta Ostrowska-Lesko
Andy Tan Marta Szachniuk
Anelia Horvath Marta Zagrebelsky
Ang Li Martin Hufbauer
Ange Maguy Martin Michel
Ángel Emilio Martínez De Alba Martin Schmidt
Angel Llamas Martina Kleber
Ángel Núñez Martina Maggi
Angela Scott Martina Smolic
Angelica Facoetti Marvin Soriano-Ursua
Angelika Buczynska Mary O'Sullivan
Angelo Mazzaglia Mary Taub
Ani Gasparyan Masaaki Miyazawa
Aniello Maiese Masahiko Tanaka
Anik Karan Masahiro Niikura
Anil Kumar Masaki Nagaya
Aniruddha Das Masaki Ueno
Anisoara Cimpean Masami Yoshimura
Anita Kloss-Brandstätter Masamichi Kamihira
Anja C. Nagel Masaru Tanaka
Anjali Geethadevi Masashi Fujitani
Anjan Motamarry Masato Noguchi
Ankit Shroff Masoud Keikha
Ann Foley Massimo Conese
Anna Bizoń Massimo Mariotti
Anna Colell Massimo Nabissi
Anna Hadjihambi Mateja Sirše
Anna Makuch-Kocka Matija Rijavec
Anna Maria Bassi Matjaz Rokavec
Anna Maria Pinto Mats Eriksson
Anna Piotrowska Mats W. Johansson
Anna Pittaluga Matteo Russo
Anna Sobiepanek Matthew Wilson
Anna Timofeeva Matthias Eckhardt
Anna Trybala Matthias Jung
Anna Urciuolo Matthias Müller
Anna V. Goncharenko Matthias Raedle
Annalisa Bernareggi Matti Waris
Anne Kasus-Jacobi Mattia Volta
Anne-Sophie Wozny Mau-Ern Poh
Ann-Joy Cheng Maurizio Falconi
Anton Burakov Maurizio Manera
Anton Jetten Maurizio Orlandini
Antonella Ferrante Mauro Cancian
Antonella Ragnini-Wilson Mauro Cozzolino
Antonella Virgilio Mauro Lago-Docampo
Antonietta Bernardo Mauro Pistello
Antonino Di Pino Mauro Sérgio Gonçalves Pavão
Antonio Apicella Max Gong
Antonio Casado Díaz Maya Dymova
Antonio Mirijello Mayra Alvarez
Antony Mcnamee Md. Rajib Sarkar
Anu Paul Melanie Foecking
Anurag Satpathy Melanie Gartz
Aranganoor K. Thiruvenkadan Melvin Ambele
Archana Rajagopalan Melvin Rincon
Arianna D'Angelo Menachem Hanani
Arianna De Mori Mengdi Bao
Arianna Scuteri Mengze Lyu
Armanda Santos Mercedes Fernandez
Armando Varela-Ramirez Mercedes Lopez-Santalla
Arong Gaowa Mi Chen
Arthur Lustig Michael A. Firer
Artur Słomka Michael Dodd
Arturo G. Valdivia-Flores Michael Eller
Arun Kumar Hanumana Gouda Patil Michael Fritz
Arun Renganathan Michael Grusch
Arunaksharan Narayanankutty Michael Kim
Arunava Ghosh Michael Landowski
Ashfaqul Hoque Michael Morgan
Ashok Bidwai Michael Poteser
Ashu Johri Michael Robert Horsman
Asif Mahmood Michael Robinson
Asif Naeem Michael Trakselis
Asmat Ullah Michael Vansaun
Athanasios A. Panagiotopoulos Michael Woeltje
Atkinson Irina Michael Wolin
Attila Frigy Michał Kulus
Attila Zsolnai Michał Strzelecki
Atul Dhall Michał Zarobkiewicz
Atul Rathore Michela Cortesi
Aurélie Philippe Michela Ferrucci
Aurora Nedelcu Michela Rigoni
Avik Dutta Michele Bernasconi
Avinash Kundadka Kudva Michele Samaja
Avinash Mishra Miguel A. Ortega
Ayaz Ahmed Miguel Angel Alcántara Ortigoza
Ayman Mahmoud Miguel Ángel Rodríguez-Milla
Ayman Oweida Miguel Japón
Ayokanmi Ore Miguel Moreira
Azizah Ugusman Miguel Sanchez-Aleman
Babhrubahan Roy Mihajlo Erdeljan
Babu Sajesh Mikhail Dubinin
Bac Viet Le Mikhail Kostik
Baiba Gillard Mikhail Proskurnin
Bal Lokeshwar Mikhail Shepelev
Balázs Sarkadi Mikihiro Yoshie
Balenahalli Ramesh Mikko Laukkanen
Banhi Biswas Mikołaj Maga
Baojin Ding Milan Stankovic
Baoquan Liu Milena Rizzo
Barbara Kaplan Milica Manojlović-Stojanoski
Barbara Ruaro Milica Pešić
Bart Van Hoek Milos Lazarevic
Bartłomiej Górski Min Deng
Bartosz Sikora Min Soon Cho
Bassam Janji Min Zhao
Basveshwar Gawali Minerva Codruta Badescu
Beata Bystrowska Ming-Chi Lu
Beata Morak-Młodawska Ming-Wei Lin
Becky Talyn Minodora Dobreanu
Béla Gyurcsik Minseon Park
Beng Fye Lau Miriam Hickey
Bennett Elzey Miriam Rodriguez-Sosa
Bernadett Papp Mirjam Gerwing
Bernard Roelen Mirjana Jerkic
Bernd Kaina Mirko Manetti
Bernhard Zdársky Mirna Jovanović
Bhanu Tewari Mirolyuba Ilieva
Bhaswati Bhattacharya Miron Sopic
Bhaumik Pandya Mislav Mikuš
Bhavna Murali Mitchell Holland
Bhim Rai Mititelu Magdalena
Bhoomika Patel Moema Hausen
Bi-He Cai Mohamed Jaber
Bikash Sahoo Mohammad Alfhili
Binbin Wang Mohammad Jafar Molaei
Bing Yuan Mohammad Mobashir
Bipradas Roy Mohammad Mofatteh
Björn Neumann Mohammad Qneibi
Blanca Estela García-Pérez Mohammed Ramadan
Blanca Miriam Torres-Mendoza Mohammed Zayed
Bo Liu Mohd Imran
Boaz Mohar Mohd. Kamran Khan
Bodhisattwa Banerjee Mohsen Niazian
Boguslawa Luzak Monica Fedele
Boris Bilčík Monica Muratori
Boris Chernyak Monika Adori
Borja Herrero De La Parte Monika Turska-Kozłowska
Bouchra Edderkaoui Monique M. A. Verstegen
Bouke P. Hazenberg Moon Nyeo Park
Božena Ćurko-Cofek Mudasir Gugjoo
Brian Ackley Muhamad Noor Alfarizal Kamarudin
Brijesh Kumar Singh Muhammad Ahsan
Bruce Bunnell Muhammad Jameel Mughal
Burcu Gemici Başol Muhammad Sajid Hamid Akash
Byung-Hoon Jeong Muhammad Sarfaraz Iqbal
Cameron Metcalf Muhammed Batir
Cara J. Westmark Mukul Vij
Carla Di Stefano Munendra Tomar
Carla Lopes Münir Aktaş
Carla Petrella Mwila Kabwe
Carla Zannella Myra Villareal
Carlene Moore Myron Szewczuk
Carlo Galli Nada Sallam
Carlo Lavalle Nadège Kindt
Carlo Santambrogio Nadezda Apostolova
Carlos Avendaño Nadezhda S. Dyrkheeva
Carlos Fernandez-Patron Nagalakshmi Nadiminty
Carlos Gamarra-Luques Nagaraja Nagre
Carlos Tristan Nanako Kawaguchi
Carmen Ramírez Nancy Saad
Carmine Selleri Napoleão Argôlo Neto
Carminia Maria Della Corte Narasimman Gurusamy
Carol Wadham Natalia Díaz-Valdivia
Carole Ayoub Moubareck Natalia Kreshchenko
Carolina Otero Natalia Rudenko
Caroline Santos Natalia Soshnikova
Catharina Moniaga Natalia Stepanova
Catherine Angel Natalia Yanguas Casás
Catherine Pears Nataliya Yaglova
Celia Strunz Nathachit Limjunyawong
Chaiyaboot Ariyachet Nathalie Lalevée
Chandler Walker Nathaniel Jue
Chandra Mishra Nathaniel Szewczyk
Chandrabose Selvaraj Nauman Khan
Chandramani Pathak Nawal Khadka
Chang Guo Neelam Sharma
Chang Ho Kang Neeraj Thakur
Chang-En Yu Nejc Umek
Chao Ma Nemat Ali
Chao Wang Nesrein Hashem
Charlie Rice Neven Papić
Che Hsueh Yang Nianqiao Gong
Chen Xie Nicholas Peake
Chen-Che Huang Nicola Marziliano
Cheng Chang Nicolas Dumaz
Cheng Liu Nicoletta Cordani
Cheng Wang Nidhi Jalan-Sakrikar
Cheng-Rong Yu Nikolaos Fragakis
Cheng-Ying Chu Nikolay Brustovetsky
Cheng-Yu Wu Nilmani Singh
Chi Zhou Nima Rafati
Chiara Calabrese Nima Sanadgol
Chiara Cerletti Nina Graffmann
Chiara Fenoglio Nirmalya Dasgupta
Chiara Foglieni Nitin Khandelwal
Chiara Gomiero Nitin Saksena
Chiara Reale Nityanand Srivastava
Chi-Chun Pan Nobuo Shimamoto
Chih-Wei Zeng Noriko Takegahara
Chinmayi Prasanna Norma Sofía Torres Pabón
Chin-Yo Lin Nur Hanisah Azmi
Chisato Kinoshita Nuray Acar Aydemir
Chiung-Hui Liu Nuria Sanchez
Chong Chen Olan Jackson-Weaver
Christian Cortes-Rojo Oleg Shuvalov
Christian Wiraja Oleh Berezsky
Christina Kostara Olga Anatskaya
Christoph Klenk Olga Chernova
Christophe Bressac Olga Krestinina
Christopher Lupfer Olga Lebedeva
Christopher Plaisier Olga Lyublinskaya
Christopher Reynolds Olga Musskaya
Christopher Riley Olga Tarasova
Christos A. Gogos Olgica Nedic
Christos Kourek Oliver Felthaus
Chuanfeng An Oliver Gross
Chuan-Guo Shi Oliver Thews
Chunxin Wang Oliver Zeitz
Chuqian Liang Omid Akhavan
Chwen-Lih Chen Omid Mirmosayyeb
Claude Prigent Omprakash Shriwas
Claudia Ollauri-Ibáñez Ornella Cominetti
Claudio Lazzari Oscar Briz Sanchez
Clemens Gögele Oscar Cabrera-Marante
Concetta Altamura Ovidiu Samoila
Conrad Hodgkinson Pablo Martín-Vasallo
Constantin Munteanu Panagiotis Karakaidos
Corinne Prevostel Pankaj Gaur
Cornelius Krasel Paola Faverio
Costantino Balestra Paolo Rosa
Cristiana Soldani Parasuraman Subramani
Cristiane Gil Parisa Gazerani
Cristian-Tudor Matea Partha Narayan Dey
Cristina Capatina Parvaneh Karimzadeh
Cristina Moliner Pascal Escher
Cristina Sena Paschalis Theotokis
Cristina Zbârcea Pasquale Marrazzo
Dae-Hyun Kim Pasquale Pagliaro
Daisuke Ariyasu Patrice Fort
Dana Akilbekova Patrice X. Petit
Daniel Alonso-Alconada Patricio Fernandez-Silva
Daniel López Malo Patrick G. Arndt
Daniel Ortega Patrick Sullivan
Daniel Ortuño-Sahagún Patrick Weydt
Daniel Shin Paul A. Tooney
Daniel Souza Monteiro De Araujo Paul Donaldson
Daniela Buchaim Paul Mozdziak
Daniela De Totero Paul Reynolds
Daniela Hozbor Paul Talbert
Daniela Marchini Paula Fernández-Palanca
Daniele Nosi Paula Paulo
Danijela Cvetković Paul-Emmanuel Vanderriele
Danijela Laketa Paulina Dumnicka
Danilo Fiore Pauline Po Yee Lui
Danyang Wang Paulo Santos
Daria Chudakova Paulo Victor Sgobbi Souza
Dario Balestra Pavel Makarevich
Darko Jevremovic Pavel Solopov
Daryoush Babazadeh Pavla Jendelova
David Li-Kroeger Pawan Raghav
David S. Y. Ong Pawan Raut
David Tulis Paweł Grzmil
Davor Čarić Pawel Matulewicz
Dayane Alvares Payal Ganguly
Debasish Dey Pedro Lei
Debbie Guest Peggy Farnham
Debdeep Dutta Peggy Stock
Deborah Keszenman Pei Li
Deependra Singh Pekka Määttänen
Deepti Shrivastava Peng Chen
Delavar Shahbazzadeh Pengfei Ding
De-Li Shi Petar Ozretić
Denis Nazarov Peter Anderson
Désirée Baruffaldi Peter Barbuti
Désirée Forstner Peter Dubovskii
Dhananjay Yadav Peter Hauser
Dharambir Kashyap Peter Karachunski
Dharmendra Choudhary Peter Mitro
Dhiraj Bhatia Peter Reinach
Dhiraj Srivastava Péter Szentesi
Diaa Abd El Moneim Petr Menshanov
Diana Kata Petra Zusterzeel
Diana Mechtcheriakova Philipp Kaldis
Diego A. Esquivel-Hernandez Philippe Gallay
Dieter Riethmacher Philippe Lewalle
Dihao Wang Pierluigi Scalia
Dilip Kumar Swain Piero Antonio Zecca
Dimitris Kardassis Pierre Larraufie
Dina Manetti Pietro Cacialli
Dinesh Gawande Pietro Mazzeo
Dinesh Verma Pilar Negredo
Dinoop Ravindran Menon Pinelopi Arvaniti
Dinora Gonzalez Esquivel Ping K. Yip
Dirk Henrich Piotr Czekaj
Divya Jyothi Madipally Piotr Mamczur
Dmitry Bogolyubov Piya Temviriyanukul
Dmitry Gruzdev Piyush Gondaliya
Dmitry Zorov Ponti Donatella
Doaa Zineldeen Porfirio Nava
Doina Todea Prajish Iyer
Domenico Plantone Prakash Adhikari
Domenico Russo Pranjal Biswas
Dominique Modrowski Prashant Sharma
Donald M. Coen Prashant Tarale
Dong Zhou Prathyusha Bagam
Donghwa Kim Pravin Sehgal
Dongxu Wang Predrag Jovanovic
Dora Visnjic Premranjan Kumar
Dorival Mendes Rodrigues Junior Priti Prasanna Maity
Dorota Bartusik-Aebisher Priya Prabhu
Dorota Wloga Priyanka Dogra
Dorothea Alexander Priyanka Sahu
Dragana Kopanja Priyanka Sharma
Dung-Fang Lee Przemysław Danek
Eberhard Korsching Purushoth Ethiraj
Ebrahim Asadi Purushothaman Kuppan
Ecem Saygili Pyung-Hwan Kim
Edina Pandur Qian Zhang
Edoardo Peroni Qifei Li
Eeva-Liisa Eskelinen Qingjun Pan
Efrosyni Paraskeva Qingming Fang
Egor Dzyubenko Qingsen Shang
Eishin Morita Qiqi Tian
Ekaterina V. Zubareva Qiuping Zhang
Elaine Gavioli Qiuyun Xu
Elaine Yee Lin Chung Qixin Wang
Elena Andreeva Qudratullah Kalwar
Elena Donetti Qun Tang
Elena Fico R. William Caldwell
Elena Ionica Rabbani Syed
Elena Mitroshina Radu Miftode
Elena Moretti Rafael Baltiérrez-Hoyos
Elena Nemtsova Rafael Coveñas Rodríguez
Elena Obrador Rafael Kuradomi
Elena Panizza Rafal Moszynski
Elena Porumb-Andrese Raffaele Dubbioso
Elena Puris Raghavendra Basavaraja
Elena Ryabchikova Raghbendra Dutta
Elena Zavyalova Raghuveera Goel
Eleni Karligiotou Raheel Ahmad
Eleonora Lai Raheleh Farahzadi
Eleonora Scarlata Rahul Kumar
Elham Haghparast Raj Kumar
Elisa Belluzzi Raj Luxmi
Elisa Schena Rajesh Kumar Gandhirajan
Elisabeth Pinart Rajkumar Vutukuri
Elisavet Vasilopoulou Raju Senthil Kumar
Elise Nassif Rakesh Patel
Ellen Breen Ram Babu Undi
Elon Donald Gullberg Ramachandran Srinivasan
Eloy Bejarano Fernandez Raman Jegadeesh
Elsayed Mansour Raman Sood
Elvira Grigorieva Ramaswamy Kannappan
Elvira Parrotta Ramchander Rohit Kongari
Elżbieta Łopieńska-Biernat Ramiro Araya-Maturana
Elzbieta Salinska Ramiro López-Medrano
Eman Mady Ramkumar Kunka Mohanram
Eman Mehanna Ramona Meanti
Emanuele Bernardinelli Ramona Palombo
Emilio Camafeita Ramya Tokala
Emilio Vélez Raniki Kumari
Emma Borrelli Raquel Esteves
Emmanuel Hermans Rashi Kalra
Emmanuel Moyse Ravi Sonani
Emre Bektik Ravindra P. Veeranna
Ennio Prosperi Ravindra Samarth
Enno Klussmann Razeghian-Jahromi Iman
Enrico Moro Rebeca Alonso-Monge
Enrique Estudillo Recai Ergun
Enrique Morales Villegas Reiko Tokuyama-Toda
Eric Hamlett Remo Campiche
Eric Ramirez Rena Hirani
Erica Valencic Renata Ciccarelli
Ericsson Coy-Barrera Renata Neves
Erin Norris Renata Szydlak
Ernest Adeghate Renqiang Yu
Ernesto Doncel-Pérez Renshi Xu
Ernő Zádor Revathy Nadhan
Eros Di Giorgio Reynaldo Garcia
Erwin Goldberg Reza Heidari
Esma Isenovic Reza Shirazi
Esra Demir Rhalena Thomas
Esther Julián Rhitajit Sarkar
Esther Vicente-Rabaneda Ricard Marcos
Estrela Neto Ricardo Marques
Eugenia V. Gurevich Ricardo Rodrigues
Eugenio Scanziani Riccardo Cristofani
Eva Kudova Riccardo Leinardi
Evangelia Sarantopoulou Riccardo Pecori
Evgeny Ermakov Riccardo Vago
Ewa Rajpert-De Meyts Richard J. Noel
Ewa Tomaszewska Richard Zuellig
Ewa Wiesik-Szewczyk Riikka Martikainen
Ewoud B. Compeer Ripon Sarkar
Ewy Mathé Rita Araújo
Ezzatollah Fathi Rita Rezzani
Fabiana Crispo Robert Burghardt
Fabiana Geraci Robert Kleszcz
Fabien Delaspre Robert Liefke
Fabio Gasparri Robert Mallet
Fabio Guolo Robert Marshall
Fabio Sallustio Robert Rekawiecki
Fabrizio Vincenzi Robert Sobol
Faezeh Vakhshiteh Roberto Berra-Romani
Faisal Alzahrani Roberto Cannataro
Faizan Ullah Roberto De Masi
Fan Zhang Roberto Gualtieri
Farid Ahmed Roberto Piergentili
Farman Khan Robin Cooper
Farzad Taghizadeh-Hesary Rodolfo Garcia
Fatih Zor Rodolfo Pinto-Almazán
Federica Facchin Rodolfo Valtuille
Federica Riva Rodrigo Herrera-Molina
Federico Castro-Munozledo Rodrigo Madurga
Federico Galvagni Rodrigo Moore
Federico Manai Roger Grand
Felix Clanchy Rogerio Buchaim
Fenglei Li Rogerio Margis
Ferenc Fenyvesi Rohit Sinha
Fernanda Lopes Roland Bourette
Fernanda Mesquita Rolf Heumann
Fernanda Van Petten Azevedo Roman Lesyk
Fernando Cardona Rong Fang
Fernando Monroy Rosa Fernandes
Fernando Vonhoff Rosa Suades
Filipe Duarte Rosa Ventrella
Filomena Fezza Rosa Vona
Fiorella Colasuonno Rosaria Greco
Flávia Leão Barbosa Rosaria Meccariello
Flor H. Pujol Roseline Ogundokun
Florence Van Tienen Roslyn Noar
Florin Burada Rossella Di Stasi
Francesca Agriesti Rudian Zhang
Francesca Bianchi Rui Vitorino
Francesca Mari Rui Xi
Francesca Paola Luongo Ru-Jeng Teng
Francesca Rossi Rukang Zhang
Francesca Zito Runwen Yao
Francesco Boccalatte Rupert Strauss
Francesco Bruno Rut Valdor
Francesco Claps Rute Pereira
Francesco Formaggio Ruth Hemmersbach
Francesco Pezzella Ryo Saga
Francesco Suriano Ryoichi Yamaji
Francisco Lázaro-Diéguez Ryoma Yoneda
Francisco M. Nadal-Nicolas Ryota Hosomi
Francisco Martin-Saavedra Sabina Sevcikova
Franciska Erdő Sabine Groesch
Franco Lucchini Sabine Matou-Nasri
Frank Balzer Sabira Mohammed Jazir
Frank Nelson Sabrina Hupp
Franz-Georg Hanisch Sabzali Javadov
Fredrik Schjesvold Sachin Sharma
Fulden Ulucan Karnak Sadahiro Iwabuchi
Gabriel Gutiérrez-Ospina Saeed Mohammadi
Gabriel Rufino Estrela Saeid Ghavami
Gabriela Egly Feresin Sai Pranathi Meda Venkata
Gabriele Roccuzzo Said Hashemolhosseini
Gabriella Minchiotti Saifei Lei
Gabriella Panuccio Sainitin Donakonda
Gabriella Silvestri Sakineh Kazemi Noureini
Gaetan Jego Salil Varshney
Gaetano Leto Salvatore Valiante
Gaetano Santulli Samo Fokter
Gagan D. Gupta Samreen Sadaf
Gaia Scabia Samuel F. Bunting
Galileo Escobedo Samuele Raccosta
Galina Shepelkova Sanda Win
Ganesh Nikalje Sandeep Kumar Chavan
Gang Wang Sandeep Singh
Gang Xu Sandra Guidi
Gatha Thacker Sandra Sakalauskaite
Ge Xiang Sandra Sobocanec
Gemma Manich Sandra Sousa
Gennadi Saiko Sandro Massao Hirabara
Georg Johnen Sang Ki Lee
George Karpouzas Sang Tae Choi
George Magoulas Sanika Suvarnapathaki
George Sharbeen Sanja Ivkovic
George Zanazzi Sanjit Mukherjee
Gerald Radziwill Sankar Jagadeeshan
Gerard Hoyne Santanu Maji
Gerhard Wiche Santi Mandal
Gerhild Euler Santosh Jadhav
Germán Domínguez-Vías Sara Caceres
Germana Meroni Sara Campinoti
Gerrit Wolters-Eisfeld Sara Spinelli
Gesine Paul Sarah Beck
Ghanim Ullah Sarah Tettamanti
Ghazala Mustafa Sarita Lagalwar
Giampiero Cai Sathish Kumar Reddy Padi
Gianandrea Pasquinelli Satoshi Komasa
Giedre Silkuniene Saulius Sumanas
Gijs Afink Saumya Shah
Gilles Lemaître Sayoko Ihara
Gina-Cecilia Pistol Sebastian Knitter
Giorgio Costagliola Sebastian Yu
Giorgio Malpeli Seema Kumari
Giorgio Mangino Selçuk Yüksel
Giorgio Prantera Selma Mlinarić
Giovanna Lattanzi Serge Candéias
Giovanna Romano Serge P. Bottari
Giovanni Casini Sergei Gaidin
Giovanni Corsetti Sergey Kolomeichuk
Giovanni Mario Pes Sergio Comincini
Girish Rajendraprasad Sergio Martinez Huenchullan
Girish Srivastava Serkan Yílmaz
Gisela Gaina Seung Kyu Lee
Giulia Baldini Seung-Joon Ahn
Giulia Bivona Sezer Okay
Giulia Ricci Shadma Wahab
Giulio Fracasso Shailendra Maurya
Giuseppe Barisano Shailesh Kumar
Giuseppe Biagini Sham Kakar
Giuseppe Bronte Shamaila Zafar
Giuseppe Mazzarella Shamimul Hasan
Giuseppe Nasso Shangkun Ou
Giuseppina Basini Shanmuga S. Mahalingam
Giuseppina Catanzaro Shantanu Gupta
Giusi Zaina Shaobin Wang
Glaucia Machado-Santelli Shao-Ming Wang
Glória Queiroz Shaoquan Zheng
Gopinath M. Sundaram Shatadal Ghosh
Göran Larson Shayma Al-Sahlany
Graça Soveral Shek Man Chim
Graham Leggatt Sherien Eldaly
Graham Mcginnis Sherif Elbasiouny
Grazia Maria Virzì Shibo Yu
Gregory Cole Shigao Huang
Grigol Keshelava Shigeki Sugawara
Grzegorz Panasiewicz Shigemi Matsuyama
Guanglin Zhang Shimaa Amer
Guangyan Wu Shinichi Miyatake
Guan-Jun Yang Shinji Takamatsu
Guglielmo Sorci Shinya Imada
Guido Gembillo Shitou Xia
Guido Merlotti Shivraj Yabaji
Guillaume St-Jean Shixiang Sun
Guillermina Ferro-Flores Shona Murphy
Guillermo Guerrero Vásquez Shreya Nagar
Gundula Schulze-Tanzil Shruti Singh Kakan
Guoli Hu Shu Nakao
Guoqiang Wu Shuzhen Wang
Guoqing Qian Shweta Saran
Gurjeet Kaur Shyam Kumar Gudey
Guy R. Adami Siddhita Mhatre
Györgyi Műzes Silvia Carloni
Hafiz Muhammad Umer Farooqi Silvia Dossena
Haijun Liu Silvia Galbiati
Haina Huang Silvia Gonzali
Haixin Sui Silvia Leoncini
Haizhen Wang Silvia Palma
Halilibrahim Ciftci Silvia Ravera
Hamed Hamishehkar Silvia Vidal
Hamed Nosrati Silvio Tundo
Hamid Tebyaniyan Silvio Veiga
Hani Saudy Simon Pfisterer
Hannes Vietzen Simona Damiano
Hans Binder Simone Carotti
Hans Neubauer Simone Cilio
Hans-Arno Müller Simone Fideles
Hans-Werner Denker Simone Patergnani
Hanying Chen Singh Avishek
Hao Du Sirajudheen Anwar
Hariharan Subramanian Sirasit Srinuanpan
Harikumar Rajaguru Sivaprasad Vankadara
Hariom Kumar Sharma Sjoerd T. chetters
Harish Sankarasubramanian Slađana Popović
Harun Albayrak Sladjan Pavlovic
Harunori Yoshikawa Slavko Mojsilovic
Hassan Kassassir Sławomir Borek
Haya Lorberboum-Galski Snježana Kaštelan
He Huang So Hee Kwon
He Xu Socorro Retana-Marquez
Heather D. Durham Sofia Costa-de-Oliveira
Héctor Quezada Sofie Deschoemaeker
Heidi Olzscha Sohail Mumtaz
Heiko Mühl Sohrab Ahmadivand
Heinz D. Osiewacz Solaleh Emamgholipour
Helen Knowles Somnath Pandey
Helene Boeuf Sonali Barwe
Hélène Dubois-Pot-Schneider Song Chen
Heloisa De Araujo Song Yu
Hemant Prajapati Songli Zhu
Hengbo Zhou Sonia Aroni
Henk Van Hamersvelt Sonia Do Carmo
Henrik Oster Sonia Gera
Henrik Ronnberg Sooseong You
Henrique Von Gersdorff Soyar Sari
Henry Sutanto Srdjan Kesic
Herson Antonio González Ponce Srijit Das
Hervé Tostivint Srinivas Akula
Hidetoshi Saitoh Srinivasa Reddy Bonam
Hiroaki Neki Stanislav Keranov
Holger Zetzsche Stefan Pusch
Hong Jin Stefania Ceruti
Hong Wan Stefania Scialla
Hong Yu Stefano Castellani
Hongbing Liu Stefano De Virgiliis
Hongdou Li Stefano Fais
Hongwei Cheng Stefano Gotti
Hongwei Li Stefano Marullo
Hooman Razi Stefano Palomba
Hossein Moeini Steffan T. Nawrocki
Houshang Nemati Steffen Maak
Howard Boudreau Stéphanie Grandemange
Howard Donninger Stephen Alway
Howard Takiff Stephen Ginsberg
Hsi-Lung Hsieh Stephen Safrany
Hsin-Yu Ho Steven Bernstein
Hua Mei Steven Glassman
Huaifu Deng Steven Singer
Huang Li Subhadip Mukhopadhyay
Hugh Watson Subramanya Pandruvada
Hui Lu Subrata Mondal
Huihua Yuan Sudarshan Bhattacharjee
Hung-Chi Cheng Sudhir Kshirsagar
Hyuck Jin Lee Sue Cotterill
Hyun Jin Kwun Suman Chowdhury
Iakowos Karakesisoglou Suman Mukhopadhyay
Ichiro Taniuchi Sumeet Nayak
Ichiro Terashima Sunandini Chandra
Ieva Janulaityte Suneesh Kumar Pachathundikandi
Igor Slivac Sunghyun Yoon
Igor Sokolov Sunilgowda Sunnagatta Nagaraja
Ik-Hwan Kim Suphi Oncel
Ilaria Ferrarotti Suprasanna Penna
Ilaria Martinelli Supriya Chakraborty
Ilias Kazanis Suraiya Ansari
I-Lun Hsin Suresh Veeramani
Ilya Klabukov Susanna Amadio
Ilyas Sahin Susanna Negrisolo
Ilze Strumfa Susanne Milatz
Iman Dehzangi Sushan Zhang
Imtiaj Hasan Sushil Shakyawar
Inês Correia Suzana Žunec
Ines Drenjancevic Sven Rutkowski
Ingo Rustenbeck Svetlana Guryanova
Inna Rabinovich-Nikitin Swaran Flora
Inna S. Midzyanovskaya Swarnali Roy
Ioannis Eleftherianos Syed Azmal Ali
Ioannis Tomos Syed Mohd Faisal
Ioannis Tsamesidis Syed Zaidi
Irene Rosa Sylvain Bourgoin
Irina Bakloushinskaya Sylvain Broussy
Irina Bogolyubova Sylvain Fraineau
Irina Milisav Sylvain Peuget
Irina Naletova Sylwia Bobis-Wozowicz
Irina Ogneva Tae-Young Choi
Irina Petrushanko Tahira Sultan
Irina Shipounova Takaaki Sato
Isabel Mendez Takato Hara
Isabel Soto-Cruz Takatsune Shimizu
Isabelle A. Leclercq Takeru Makiyama
Isac Medeiros Taku Kouro
Issa Al-Amri Takujiro Homma
Iulia-Ioana Stanescu-Spinu Takuma Matsubara
Ivan Ivanov Talal Zari
Ivan Luzardo-Ocampo Tamás Bellák
Ivana Grković Tamas Lazar
Ivana Guševac Stojanović Tamás Letoha
Ivana Restović Tamer Kaoud
Ivana Škrlec Tangliang Li
Iwona Wertel Tanja Miličić
J. Kelly Smith Tao Li
Jaana Lahdetie Tarek M. A. Abdel-Fatah
Jacqueline Donoghue Tariq Ali
Jacqueline Leite Tariq Munir
Jacqueline Stephens Tarun Pant
Jae Kyu Ryu Tatiana Antipova
Jaehong Kim Tatiana Arefieva
James D. West Tatsuo Kanda
James Goldman Tatsuo Kido
Jan W. Eriksson Tatsuro Mutoh
Jana Kocourkova Tayyab Rehman
Jana Riegger Tea Glonti
Janaina Fernandes Tejeshwar Rao
Jane Wang Teresa Adell
Janice Garcia-Quiroz Teresa Thiel
Janos Filep Tetsuro Tamaki
Jaroslava Halper Thanaset Senawong
Jaroslaw Smieja Thangarajeswari Mohan
Jasmin Knopf Thayne Kowalski
Jason Bubier Theodore Wensel
Javier Manzano-López Theodoros Ntallaris
Jay Mishra Theofanis Vavilis
Jean Regal Theresa Whiteside
Jean-Marie Exbrayat Thierry Franck
Jean-Marie Frachisse Thippa Reddy Gadekallu
Jeannette Hübener-Schmid Thomas Forbes
Jean-Pierre Baudoin Thomas Greither
Jeff Bronstein Thomas Heinbockel
Jeffrey Schelling Thomas Hieronymus
Jeiha Lee Thomas Klarić
Jekaterina Erenpreisa Thomas Miethke
Jelena Nesovic Ostojic Thomas Van Groen
Jelena Prpić Thomas Weiss
Jeni Prosperi Tianjie Pu
Jennifer Norman Tijana Išić Denčić
Jennifer Van Wyk Tilahun Debele
Jens Kockskämper Tina Didari
Jerel A. Fields Ting-I Lee
Jeremy W. Chopek Tino Emanuele Poloni
Jer-Ming Chang Tiziana Cabras
Jerry Malayer Tiziana Guarnieri
Jessica Mingardi Tiziana Maria Sirangelo
Jessica Zuñiga-Hernandez Tobias Kretschmer
Jesus Adriana Soto Guzman Tom Broderick
Jesús Hernández Tom Gallagher
Jesús Palomero Tomáš Čajka
Jia Li Tomasz Gębarowski
Jiajie Chen Tomislav Bulum
Jiali Wang Tomislav Tosti
Jian Xu Tomoyuki Furuyashiki
Jianan Zhang Tony Le Gall
Jianchao Zhang Torben Sølbeck Rasmussen
Jianfeng Jin Toshiaki Ohara
Jianfeng Xiang Toshihiro Nomura
Jianguo Wu Toshiyuki Habu
Jianli Niu Toyofumi Suzuki
Jianmin Zhang Tracey Woodlief
Jianxun Song Tsutomu Nakazawa
Jianyuan Chai Tulasigeri M. Totiger
Jianzhou Cui Ubaldo Armato
Jie Yang Ufuk Degirmenci
Ji-Hong Lim Ulrich Eisel
Jimin Han Ulrich Rass
Jin Wang Ulrike Baranyi
Jing Han Ulrike Resch
Jing Ma Usein M. Dzhemilev
Jinghua Wang Ute Wölfle
Jinlong Liu Vaibhav Deshmukh
Jinming Han Valentin Pavlov
Jinyan Zhang Valentina Giudice
Jiří Fajkus Valeria Panzetta
Joachim Fandrey Valérian Dormoy
Joana Damásio Vanessa D'Antongiovanni
Joanna Boncela Van-Nghia Nguyen
Joanna Listos Vasile Valeriu Lupu
Joanna Szczepanek Vasily Aleshin
Joanna Wessely-Szponder Vassilios Papadopoulos
Joanna Zarzyńska Velmarini Vasquez
Jochen Maurer Venkatesh Katari
Jochen Salber Venkateshwar Madka
Joe Mymryk Vera M. Chesnokova
Joel Bornstein Verena Tretter
Johannes Grillari Veronica Filetti
Johannes Hofer Verónica García
John Dirk Vestergaard Nieland Veronica González-Nuñez
John Parrish Veronica Marrella
John Sinclair Víctor Carriel
John Steele Victor Garcia
John-David Aubert Victor I. Sevastianov
Jolanta Orzelska-Gorka Victor Martin
Jonasz Jeremiasz Weber Victor Tortorici
Jonatan Dorca-Arévalo Victoria Bunik
Jong-Won Kim Victoria P. Connaughton
Joni H. Ylostalo Vijaya Anand Arumugam
Jorge Azevedo Vikas Yadav
Jorge Campusano Vilma Yuzbasiyan-Gurkan
Jorge Cancino Vincenza Gragnaniello
Jorge Flores-Hernandez Vincenzo Sorrentino
Jorge Gutiérrez-Cuevas Vipin Shankar Chelakkot
Jorge Oliveira Viswanathan Rajagopalan
Jorge Rodriguez-Gil Vitale Del Vecchio
Jose Carlos Garcia-Borron Vito De Novellis
Jose Manuel Fuentes Vittorio Unfer
Jose Martin-Garcia Vivek Anand
José Pedraza-Chaverri Vivek Chavda
José Peña-Amaro Vivien Chavanelle
José Rafael De Almeida Vjekoslav Peitl
Joseph Kwong Vladimir Arkhipov
Joseph Westrich Vladimir Bilim
Josko Osredkar Vladimir Binhi
Jovana Jasnic Vladimir Gureev
Joy Mitra Vladimir Jurisic
Jozsef Dudas Vladimir Pisarev
Juan Carlos Espinosa Vladimir Pletser
Juan Carlos Gomora Vladimir Yeremeev
Juan Carlos Illera Vladislava Gusar
Juan Manuel Velázquez-Enríquez Vyacheslav Dyachuk
Juan Montesinos Vyron Gorgogietas
Juan Pablo Rigalli Waldemar Wagner
Judit Doczi Wan Namkung
Judit Oláh Wassim Abou-Kheir
Judith Walters Wei Fan
Julia Mwangi Wei Guo
Julia Schueler Wei Ni
Julian Freen-Van Heeren Wei Wang
Julian Muñoz Wei-Hsiung Yang
Jun Wang Weihua Huang
Junchao Wei Weiren Luo
Junichi Inaba Weiwei Xu
Junji Xing Weizhi Xu
Junqing Guo Wen Sheng
Junquan Liu Wenbin Bao
Jürg Kesselring Wen-Bing Chen
K. Sreedhara Ranganath Pai Wendell Albuquerque
Kah Hui Wong Wenji Piao
Kai Bin Liew Wen-Jun Shen
Kaili Ma Wildan Mubarok
Kaimeng Huang Wilfrido Contreras
Kaitlyn Liu Wilhelm Mistiaen
Kajo Bucan William Baldwin
Kamal Joshi William N. Setzer
Kamal Sharma Wing Wong
Kamil Gareev Wioleta Kowalska
Kampon Kaeoket Władysława Daniel
Kandi Sridhar Wojciech Jacheć
Kangfu Chen Wolfram Antonin
Kant Sangpairoj Wolfram Gerlich
Kanwal Rehman Xianda Zhao
Kaori Ueda Xiang (Eric) Ma
Kapil Sirohi Xiang Ma
Karen Boehme Xiao Yang
Kari Naylor Xiao Zhang
Karim Dorgham Xiaochun Peng
Karin Schwarz Xiaogang Zhang
Karl Mckinstry Xiaohua Teng
Karolina Kłoda Xiaojing Mao
Karthikkumar Venkatachalam Xiaokang Wu
Katalin Goda Xiaoling Zhou
Katalin Szaszi Xiaoming Lyu
Katarina Savic Vujovic Xiaonan Zhang
Katarina Smiljanic Xiaoqiang Yao
Katarzyna Górska Xiaosheng Tan
Katarzyna Otulak Xiaoshu Pan
Katerina Chlichlia Xiaoyun Wang
Katherine Theken Xi-Ming Yuan
Kathryn Meier Xin Bi
Katia Mareschi Xin Liu
Katinka Döhner Xin Xiong
Katrin Schäfer Xing Zhang
Kautilya Jena Xingchun Gao
Kazuhiko Nakadate Xingyi Yang
Kazuo Katoh Xinxu Yuan
Kazuto Tajiri Xinyu Li
Kenji Hayashida Xuan Fang
Kenji Nakano Xuchang Zhou
Kenji Saitoh Yahya Sohrabi
Kenneth N. White Yamamoto Hayashi
Kerstin Menck Yan Liu
Kevin Kiesler Yan Zeng
Kevin O'Connell Yana Zorkina
Khurshid Ahmad Yanan Liu
Kichang Lee Yang Liu
Kim Van Vliet Yang Wang
Kimberley Wang Yang Zhao
Kiran Sapkota Yang Zhao
Kishor Pant Yanjun Yang
Kishore Kumar S. Narasimhan Yannis Karamanos
Ko Miyoshi Yao Yao
Kohei Homma Yasser Majeed
Kok Lun Pang Yasser Mostafa Kamel
Konrad Stępień Yasumasa Okazaki
Konstantin Agladze Yasuyuki Tanahashi
Konstantin Chegaev Yelena Parfyonova
Konstantinos E. Vlachonasios Yi Liu
Konstantinos Papamichael Yi-Chiang Hsu
Konstantinos Papanikolaou Yingqian Chen
Konstantinos Seretis Yingxue Zhang
Korhan Kilic Yi-Shiuan Liu
Kouacou Konan Yoelsis Garcia-Mayea
Kouichi Hirayama Yogeswaran Lokanathan
Koustav Sarkar Yolanda Gómez
Koyeli Girigoswami Yongmin Yan
Krista Heinonen Yoshihiro Shidoji
Kristina Sharlo Yosuke Senju
Kristy Welshhans Youakim Saliba
Krisztián Pajer Youness Limami
Krzysztof Czaja Young Woo Eom
Krzysztof Czamara Young Zoon Kim
Krzysztof Dołowy Younghan Lee
Krzysztof Treder Youssra Al-Hilaly
Kui Zhang Yu Zhang
Kulandaisamy Arulsamy Yuan Tang
Kumar Digvijay Yuanyuan Zhao
Kumara Swami Konda Yubao Wang
Kunihiro Tsuchida Yubin Ma
Kwang Choi Yubing Liu
Kwang Youl Lee Yuen Gao
Kyriaki Thermos Yu-Feng Xie
Kyung Mok Park Yuhong Fan
Kyung Won Kim Yuichi Sekine
Lai-Hua Xie Yujia Jing
Lalit Kaurani Yung-Hsiang Chen
Lan Zhao Yun-Hong Li
Lara Baticic Yuqing Feng
Larisa Ryskalin Yurii Shepelytskyi
László Szilák Yury Rubtsov
Laura Carolina Zanetti-Domingues Yusuke Imagawa
Laurence Lafanechère Yutao Liu
Laurent Soustelle Yutian Ma
Lei Nie Yves Combarnous
Lei Wang Zahra Beyzaei
Leila Maouche-Chretien Zahra Chinipardaz
Lesley J. Bruce Zaira Kharaeva
Leszek Kotula Zakhar O. Shenkarev
Letao Fan Zekiye Altun
Letizia Mezzasoma Zhanna Nepiyushchikh
Li Fu Zheng Fu
Li Sun Zhengwei Huang
Li Wang Zhenlin Li
Lianping Sun Zhenyu Zhang
Lianwu Fu Zhichuan Zhu
Liaqat Hussain Zhiwei Yang
Liliana Torres-López Zhiying Shan
Liliya Nikitina Zhuqiu Jin
Lilli Winter Ziqing Chen
Liming Hou Zong Jie Cui
Linlin Guo Zorana Dobrijević
Linlin Zhang Zsolt Galla
Liqian Zhu Zuohui Zhang
Liqiang Xi

15 January 2024
Cells | Selected Papers in 2022

We are pleased to invite you to read the selected papers in Cells (ISSN: 2073-4409) from 2022, where they have been listed by the following Sections. You are welcome to read manuscripts in your research areas by clicking on the titles of the following Sections.


4 January 2024
Cells | Top Cited Papers in 2022 in the Section “Cellular Pathology”

“Detection of Hypoxia in Cancer Models: Significance, Challenges, and Advances”
by Inês Godet, Steven Doctorman, Fan Wu and Daniele M. Gilkes
Cells 2022, 11(4), 686;
Available online:

“Molecular Mechanism of Lipotoxicity as an Interesting Aspect in the Development of Pathological States—Current View of Knowledge”
by Katarzyna Lipke, Adriana Kubis-Kubiak and Agnieszka Piwowar
Cells 2022, 11(5), 844;
Available online:

“Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma”
by Jaafar Khaled, Maria Kopsida, Hans Lennernäs and Femke Heindryckx
Cells 2022, 11(4), 632;
Available online:

“The Role of IL-6 in Cancer Cell Invasiveness and Metastasis—Overview and Therapeutic Opportunities”
by Magdalena Rašková, Lukáš Lacina, Zdeněk Kejík, Anna Venhauerová, Markéta Skaličková, Michal Kolář, Milan Jakubek, Daniel Rosel, Karel Smetan Jr. and Jan Brábek
Cells 2022, 11(22), 3698;
Available online:

“Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions”
by Maryam Ebadi, Cynthia Tsien, Rahima A. Bhanj, Abha R. Dunichand-Hoedl, Elora Rider, Maryam Motamedrad, Vera C. Mazurak, Vickie Baracos and Aldo J. Montano-Loza
Cells 2022, 11(7), 1216;
Available online:

“Therapeutic Targeting of Intestinal Fibrosis in Crohn’s Disease”
by Giovanni Santacroce, Marco Vincenzo Lenti and Antonio Di Sabatino
Cells 2022, 11(3), 429;
Available online:

“Epithelial Mesenchymal Transition (EMT) and Associated Invasive Adhesions in Solid and Haematological Tumours”
by David Greaves and Yolanda Calle
Cells 2022, 11(4), 649;
Available online:

“Emerging Roles of Airway Epithelial Cells in Idiopathic Pulmonary Fibrosis”
by Ashesh Chakraborty, Michal Mastalerz, Meshal Ansari, Herbert B. Schiller and Claudia A. Staab-Weijnitz
Cells 2022, 11(6), 1050;
Available online:

“Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option”
by Martina Korfei, Poornima Mahavadi and Andreas Guenther
Cells 2022, 11(10), 1626;
Available online:

“Açaì (Euterpe oleracea) Extract Protects Human Erythrocytes from Age-Related Oxidative Stress”
by Alessia Remigante, Sara Spinelli, Elisabetta Straface, Lucrezia Gambardella, Daniele Caruso, Giuseppe Falliti, Silvia Dossena, Angela Marino and Rossana Morabito
Cells 2022, 11(15), 2391;
Available online:

“Sarcopenia Is a Cause and Consequence of Metabolic Dysregulation in Aging Humans: Effects of Gut Dysbiosis, Glucose Dysregulation, Diet and Lifestyle”
by James W. Daily and Sunmin Park
Cells 2022, 11(3), 338;
Available online:

“Roles of Podoplanin in Malignant Progression of Tumor”
by Hiroyuki Suzuki, Mika K. Kaneko and Yukinari Kato
Cells 2022, 11(3), 575;
Available online:

“Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with Cirrhosis”
by Maryam Ebadi, Cynthia Tsien, Rahima A. Bhanji, Abha R. Dunichand-Hoedl, Elora Rider, Maryam Motamedrad, Vera C. Mazurak, Vickie Baracos and Aldo J.Montano-Loza
Cells 2022, 11(8), 1345;
Available online:

“CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France”
by Lucile Regard, Clemence Martin, Esperie Burnet, Jennifer Da Silva and Pierre-Regis Burgel
Cells 2022, 11(11), 1769;
Available online:

“Role of Immuno-Inflammatory Signals in Liver Ischemia-Reperfusion Injury”
by Christof Kaltenmeier, Ronghua Wang, Brandon Popp, David Geller, Samer Tohme and Hamza O. Yazdani
Cells 2022, 11(14), 2222;
Available online:

“Açaì Berry Mitigates Vascular Dementia-Induced Neuropathological Alterations Modulating Nrf-2/Beclin1 Pathways”
by Daniela Impellizzeri, Ramona D'Amico, Roberta Fusco, Tiziana Genovese, Alessio Filippo Peritore, Enrico Gugliandolo, Rosalia Crupi, Livia Interdonato, Davide Di Paola, Rosanna Di Paola et al.
Cells 2022, 11(16), 2616;
Available online:

“Sex Hormones, Growth Hormone, and the Cornea”
by Tina B. McKay, Shrestha Priyadarsini and Dimitrios Karamichos
Cells 2022, 11(2), 224;
Available online:

“S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent”
by Rosa M. Pascale, Maria M. Simile, Diego F. Calvisi, Claudio F. Feo and Francesco Feo
Cells 2022, 11(3), 409;
Available online:

“EGFR Signaling in Lung Fibrosis”
by Fabian Schramm, Liliana Schaefer and Malgorzata Wygrecka
Cells 2022, 11(6), 986;
Available online:

“Oxidative Stress and Mitochondrial Dysfunction in Chronic Kidney Disease”
by Hsin-Jung Ho and Hitoshi Shirakawa
Cells 2023, 12(1), 88;
Available online:

“Neuronal-Derived EV Biomarkers Track Cognitive Decline in Alzheimer’s Disease”
by Erden Eren, Jeannie-Marie Leoutsakos, Juan Troncoso, Constantine G. Lyketsos, Esther S. Oh and Dimitrios Kapogiannis
Cells 2022, 11(3), 436;
Available online:

“Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas”
by Ana Belen Griso, Lucia Acero-Riaguas, Beatriz Castelo, Jose Luis Cebrian-Carretero and Ana Sastre-Perona
Cells 2022, 11(3), 561;
Available online:

“Hashimoto Encephalopathy—Still More Questions than Answers”
by Marta Waliszewska-Prosot and Maria Ejma
Cells 2022, 11(18), 2873;
Available online:

“Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance”
by Daiyong Deng, Riya Patel, Cheng-Yao Chiang and Pingping Hou
Cells 2022, 11(19), 2952;
Available online:

“Carnosic Acid Attenuates the Free Fatty Acid-Induced Insulin Resistance in Muscle Cells and Adipocytes”
by Danja J. Den Hartogh, Filip Vlavcheski, Adria Giacca, Rebecca E. K. MacPherson and Evangelia Tsiani
Cells 2022, 11(1), 167;
Available online:

“CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis”
by Francesca Saluzzo, Luca Riberi, Barbara Messore, Nicola Ivan Lore, Irene Esposito, Elisabetta Bignamini and Virginia De Rose
Cells 2022, 11(7), 1243;
Available online:

“Association of Oral Function and Dysphagia with Frailty and Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis”
by Kotomi Sakai, Enri Nakayama, Daisuke Yoneoka, Nobuo Sakata, Katsuya lijima, Tomoki Tanaka, Kuniyoshi Hayashi, Kunihiro Sakuma and Eri Hoshino
Cells 2022, 11(14), 2199;
Available online:

“Serum of Post-COVID-19 Syndrome Patients with or without ME/CFS Differentially Affects Endothelial Cell Function In Vitro”
by Lavinia Flaskamp, Constanze Roubal, Steven Uddin, Franziska Sotzny, Claudia Kedor, Sandra Bauer, Carmen Scheibenbogen and Martina Seifert
Cells 2022, 11(15), 2376;
Available online:

“The Contribution of Lipotoxicity to Diabetic Kidney Disease”
by Jeffrey R. Schelling
Cells 2022, 11(20), 3236;
Available online:

“Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS”
by Francesca Provenzano, Sophie Nyberg, Debora Giunti, Carola Torazza, Benedetta Parodi, Tiziana Bonifacino, Cesare Usai, Nicole Kerlero de Rosbo, Marco Milanese, Antonio Uccelli et al.
Cells 2022, 11(23), 3923;
Available online:

“Immunity and Nutrition: The Right Balance in Inflammatory Bowel Disease”
by Bartolo Tamburini, Marco Pio La Manna, Lidia La Barbera, Leila Mohammadnezhad, Giusto Davide Badami, Mojtaba Shekarkar Azgomi, Francesco Dieli and Nadia Caccamo
Cells 2022, 11(3), 455;
Available online:

“Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside”
by Antonio Ungaro, Marcello Tucci, Alessandro Audisio, Lavinia Di Prima, Chiara Pisano, Fabio Turco, Marco Donatello Delcuratolo, Massimo Di Maio, Giorgio Vittorio Scagliotti and Consuelo Buttigliero
Cells 2022, 11(5), 803;
Available online:

“Hsp90 in Human Diseases: Molecular Mechanisms to Therapeutic Approaches”
by Mamta P. Sumi and Arnab Ghosh
Cells 2022, 11(6), 976;
Available online:

“Adaptive Remodeling of the Neuromuscular Junction with Aging”
by Michael R. Deschenes, Rachel Flannery, Alexis Hawbaker, Leah Patekand and Mia Mifsud
Cells 2022, 11(7), 1150;
Available online:

“Iron-Induced Oxidative Stress in Human Diseases”
by Teruyuki Kawabata
Cells 2022, 11(14), 2152;
Available online:

“Intraocular RGD-Engineered Exosomes and Active Targeting of Choroidal Neovascularization (CNV)”
by Dimitrios Pollalis, Dongin Kim, Gopa Kumar Gopinadhan Nair, Changsun Kang, Arjun V. Nanda and Sun Young Lee
Cells 2022, 11(16), 2573;
Available online:

“Role of Epigenetic Mechanisms in Chronic Pain”
by Daniela Mauceri
Cells 2022, 11(16), 2613;
Available online:

“PICALM and Alzheimer’s Disease: An Update and Perspectives”
by Kunie Ando, Siranjeevi Nagaraj, Fahri Kugukali, Marie-Ange de Fisenne, Andreea-Claudia Kosa, Emilie Doeraene, Lidia Lopez Gutierrez, Jean-Pierre Brion and Karelle Leroy
Cells 2022, 11(24), 3994;
Available online:

“The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies”
by Heidi Braumuller, Bernhard Mauerer, Johanna Andris, Christopher Berlin, Thomas Wieder and Rebecca Kesselring
Cells 2023, 12(1), 138;
Available online:

“Differential Discontinuation Profiles between Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis”
by Kazutaka Takehara, Yasuhiko Koga, Yoshimasa Hachisu, Mitsuyoshi Utsugi, Yuri Sawada, Yasuyuki Saito, Seishi Yoshimi, Masakiyo Yatomi, Yuki Shin, lkuo Wakamatsu et al.
Cells 2022, 11(1), 143;
Available online:

“New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond”
by Alessandro Audisio, Consuelo Buttigliero, Marco Donatello Delcuratolo, Elena Parlagreco, Marco Audisio, Antonio Ungaro, Rosario Francesco Di Stefano, Lavinia Di Prima, Fabio Turco and Marcello Tucci
Cells 2022, 11(3), 357;
Available online:

“Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus?”
by Anna Zakrzewicz, Celina Wurth, Benedikt Beckert, Simon Feldhoff, Katrien Vanderheyden, Stian Foss, Jan Terje Andersen, Hans de Haard, Peter Verheesen and Vladimir Bobkov
Cells 2022, 11(6), 942;
Available online:

“The DREADDful Hurdles and Opportunities of the Chronic Chemogenetic Toolbox”
by Marie Claes, Lies De Groef and Lieve Moons
Cells 2022, 11(7), 1110;
Available online:

“Selected Methods of Resistance Training for Prevention and Treatment of Sarcopenia”
by Tomohiro Yasuda
Cells 2022, 11(9), 1389;
Available online:

“Loss of Proximal Tubular Sirtuin 6 Aggravates Unilateral Ureteral Obstruction-Induced Tubulointerstitial Inflammation and Fibrosis by Regulation of β-Catenin Acetylation”
by Jixiu Jin, Wenjia Li, Tian Wang, Byung-Hyun Park, Sung Kwang Park and Kyung Pyo Kang
Cells 2022, 11(9), 1477;
Available online:

“Programmed Cell Death-1/Programmed Cell Death-1 Ligand as Prognostic Markers of Coronavirus Disease 2019 Severity”
by Paulina Niedzwiedzka-Rystwej, Adam Majchrzak, Bogusz Aksak-Wąs, Karol Serwin, Zenon Czajkowski, Ewelina Grywalska, lzabela Korona-Glowniak, Jacek Rolifiski and Mitosz Parczewski
Cells 2022, 11(12), 1978;
Available online:

“Structural Aspects of LIMK Regulation and Pharmacology”
by Deep Chatterjee, Franziska Preuss, Verena Dederer, Stefan Knapp and Sebastian Mathea
Cells 2022, 11(1), 142;
Available online:

“Adoptive Cellular Therapy for Multiple Myeloma Using CAR- and TCR-Transgenic T Cells: Response and Resistance”
by Franziska Fuchsl and Angela M. Krackhardt
Cells 2022, 11(3), 410;
Available online:

“Combining HDAC and MEK Inhibitors with Radiation against Glioblastoma-Derived Spheres”
by Eno I. Essien, Thomas P. Hofer, Michael J. Atkinson and Nataša Anastasov
Cells 2022, 11(5), 775;
Available online:

“Stevioside Enhances the Anti-Adipogenic Effect and β-Oxidation by Activating AMPK in 3T3-L1 Cells and Epididymal Adipose Tissues of db/db Mice”
by Miey Park, Hana Baek, Jin-Young Han and Hae-Jeung Lee
Cells 2022, 11(7), 1076;
Available online:

2 January 2024
MDPI Insights: The CEO’s Letter #7 - Nobel Laureates Entrust MDPI with Their Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.

Opening Thoughts

Nobel Prize Laureates Entrust MDPI with Their Research

The Nobel Prize stands as a hallmark of distinction, honouring ground-breaking research across disciplines. Annually, the Nobel Prizes are awarded in six categories: Physics, Chemistry, Medicine or Physiology, Literature, Peace, and Economic Sciences.

Through the years, renowned scholars have entrusted MDPI with their work. As at December 2023, 26 Nobel laureates have contributed to more than 75 articles across 25 MDPI journals, including: Antibiotics, Applied Sciences, Biology, Biomedicines, Cancers, Catalysts, Cells, Crystals, Entropy, Games, IJMS, Life, Materials, Micromachines, Molecules, Pharmaceuticals, PharmaceuticsPhotonics, Quantum Beam Science, Remote Sensing, Sensors, Solids, Universe, Vaccines, and Viruses.

The best of the best trust us with their work.

Nobel Prize Laureates Who Have Published with MDPI

We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath.

The privilege of hosting such contributors resonates deeply with our editorial teams. For instance, in this interview, the Editor-in-Chief (EiC) of Universe speaks on the significance of publishing a paper by Nobel laureate Gerard ’t Hooft within the journal.

2023 Nobel Prize Winners Published by MDPI

Nobel Prize Winners, 2023: Katalin Karikó, Drew Weissman, Anne L’Huillier (Ill. Niklas Elmehed © Nobel Prize Outreach)

Three laureates from the 2023 Nobel Prize cohort have trusted MDPI as their publishing platform. Notably, in a 2022 Pharmaceutics paper, molecular biologist Katalin Karikó and her team presented a methodology for evaluating mRNA capping efficiency, pivotal for therapeutic applications. Pharmaceutics had previously dedicated a Special Issue to “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, spotlighting ten articles from August 2021 to February 2022.

In the journal Vaccines, Professor Drew Weissman, collaborating with scholars from Pennsylvania University and George Mason University, contributed an influential review titled “Nanomaterial Delivery Systems for mRNA Vaccines”. His collaborative efforts spanned five papers across MDPI journals between 2021 and 2023.

Furthermore, Anne L'Huillier of Lund University, only the fifth female recipient of the Physics Prize, co-authored an article in Applied Sciences focusing on "Advanced EUV and X-Ray Optics". Similarly, Pierre Agostini, an Emeritus Professor from Ohio State University, co-authored an article featured in the special issue "Attosecond Science and Technology: Principles and Applications".

We extend heartfelt congratulations to all Nobel Prize laureates and express sincere gratitude for their confidence in MDPI as a platform for their scholarly contributions.

Read more:

Impactful Research

MDPI Journals Newly Indexed in 2023

The aim of indexing is to enhance the quality and credibility of published research, ensuring that researchers access the most credible resources available. While the principle behind citation indexing is straightforward, it remains one of the most dependable methods for tracking an idea's evolution across various scientific disciplines.

Throughout the year, MDPI works to expand the reach of our publications across premier multidisciplinary databases like Web of Science, Scopus, EBSCO, and ProQuest. This initiative is spearheaded by MDPI's Indexing team, under the leadership of Dr. Constanze Schelhorn.

In 2023, MDPI achieved 54 new acceptances in Scopus, 29 in Web of Science, 52 in EBSCO, and 83 in DOAJ: Directory of Open Access Journals.

The team prioritizes ensuring that our journals feature in numerous specialized databases, including PMC, PubMed, MEDLINE, Inspec, CAS, and FSTA, among others. Currently, MDPI collaborates with over 65 renowned international databases, consistently enhancing our database affiliations annually.

MDPI’s journals are indexed in all major global databases.

Furthermore, we collaborate with universities and government organizations to list our journals in country-specific ranking lists and relevant institutional repositories. This ensures compliance with requirements often set by funders or institutions for authors to publish in specific journals.

Web of Science Adds 24 MDPI Journals to Emerging Sources Citation Index (ESCI)

Clarivate recently analysed MDPI’s new journals, resulting in 24 journals, mainly established in 2020, being added to the ESCI in November and December 2023. Additionally, five journals passed this assessment earlier in the year. For a complete list of our journals in Web of Science, refer here. Journals in the ESCI meet 24 quality criteria, ensuring editorial rigor. They may be considered for inclusion in broader indices like the Science Citation Index Expanded (SCIE), the Social Sciences Citation Index (SSCI), or the Arts and Humanities Citation Index (AHCI), based on four impact criteria.

Read more:

Inside MDPI

MDPI Appoints New Chief Operating Officer (COO)

Alistair Freeland returned to MDPI and assumed the role of Chief Operating Officer in November 2023, a position he previously held from 2013 to 2019. He succeeds Dr. Yu Lin, who will remain a member of MDPI’s Board of Directors, overseeing significant financial decisions for the company. I would like to express my sincere thanks to Dr. Yu Lin for his service as COO.

Alistair brings extensive experience not only in scholarly publishing but also in technology and business management. Prior to rejoining MDPI, he was associated with SIX Group, the entity responsible for Switzerland's financial market infrastructure. There, he played a pivotal role in developing the blockchain-based platform SDX (SIX Digital Exchange), which has gained traction among major Swiss banks and the Swiss National Bank.

As COO, Alistair will collaborate with the MDPI management team to improve the practices and services we offer to scholarly communities. I am pleased to welcome Alistair back to MDPI and look forward to his contributions going forward.

Coming Together for Science

MDPI’s 2024 In-Person Academic Events Schedule

MDPI's Conference Team is dedicated to organizing and hosting in-person academic events across Europe, Asia-Pacific, and North America. We recognize conferences as invaluable platforms for scientific collaboration, scholarly exchange, discussions on contemporary topics, networking, and forging collaborations.

Here's a glimpse of the notable events we currently have scheduled for 2024:

14–16 February, 2024
Viruses 2024 – A World of Viruses
Location: Barcelona, Spain
We are honoured to feature Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes as keynote speakers for this 5th edition.
Event details

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities 
Location: Barcelona, Spain
Esteemed speakers include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.
Event details

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Athens, Greece
We look forward to welcoming renowned experts like Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.
Event details

1–4 August, 2024
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
Location: Singapore
The AI Sensors 2024 Conference will unite innovators and experts in the realms of sensors, sensing technology, and artificial intelligence.
Event details

Upcoming events with details to be announced:

  • September 2024, Materials 2024 – Basel, Switzerland
  • 1921 September 2024, International Conference on Nanomaterials Sciences 2024 – Beijing, China
  • October 2024, ncRNA 2024 – Basel, Switzerland
  • November 2024, Pharmaceuticals 2024 – Barcelona, Spain
  • 2226 November 2024, International Conference on Science of Electronics – Wuhan, China
  • Stay tuned for more details on the Sustainable Publishing Forum 2024.

Click here for all upcoming MDPI events.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Reflecting on 2023 and Looking Ahead to 2024

As we approach 2024, I reflect on the incredible journey we’ve had together at MDPI this year. The past 12 months have been marked by ambitious projects and initiatives to improve our internal processes, and a commitment to continue delivering top-notch services to our stakeholders. I’d like to thank each and every one of our staff members for contributing to the positive experiences our stakeholders have reported in our surveys. Your dedication to speed, efficiency, and effective communication with our stakeholders is very much recognized and appreciated.

Becoming a stronger organisation

While we have encountered challenges in 2023, it’s important to understand that these are a part of our growth process. Difficulties provide us with opportunities to reflect, address problems at their roots, and ultimately evolve into a stronger organization. Our stakeholders expect us to overcome tough times, and it’s an expectation that we have for ourselves.

I extend my sincere appreciation to every MDPI employee, from our editorial office and IT department to marketing, indexing, IOAP, societies, Scientific Office board, products, production, conferences, finance, operations, admin, and beyond. To our newest team members, a warm welcome; to our longstanding colleagues, your dedication is invaluable.

“I am committed to taking MDPI to a new level of excellence.”

Interacting with many of you during my visits to our offices and representing MDPI at external events has been a personal highlight. I am deeply grateful to Dr. Lin for entrusting me with the role of CEO of MDPI. Looking forward, I am committed to working closely with our management team to lead MDPI and take it to a new level of excellence, aiming to establish it as the most trusted publisher in open access worldwide. This is a collective endeavour, with each of us shaping MDPI’s reputation. I therefore encourage us to take pride in our work, as it represents not only our craft but also MDPI as a whole.

Accountability and communication

As we look forward to 2024, there’s a lot to be excited about. Together, we’ll navigate challenges, seize growth opportunities, and refine our practices. To solidify MDPI’s position as the premier open access publisher globally, we must bolster accountability, improve stakeholder communication, share MDPI’s best practices, champion the open access philosophy, and educate stakeholders about our mission, methodologies, and motivations.

Thank you for engaging with the CEO Letter over the past six months of 2023. I will continue to release this newsletter as a method of sharing the great work being done at MDPI. Please feel free to connect directly with any insights or questions.

Here’s to a joyous and prosperous 2024!

Stefan Tochev
Chief Executive Officer

29 December 2023
Cells | Top Cited Papers in 2022 in the Section “Plant, Algae and Fungi Cell Biology”

“Crocin Inhibits Angiogenesis and Metastasis in Colon Cancer via TNF-α/NF-kB/VEGF Pathways”
by Hamid A. Bakshi, Gerry A. Quinn, Mohamed M. Nasef, Vijay Mishra, Alaa A. A. Aljabali, Mohamed El-Tanani, Ángel Serrano-Aroca, Mateus Webba Da Silva, Paul A. McCarron and Murtaza M. Tambuwala
Cells 202211(9), 1502,
Available online:

“Regulation of Conidiogenesis in Aspergillus flavus
by He-Jin Cho, Sung-Hun Son, Wanping Chen, Ye-Eun Son, Inhyung Lee, Jae-Hyuk Yu and Hee-Soo Park
Cells 202211(18), 2796,
Available online:

“Role of Plant-Derived Active Constituents in Cancer Treatment and Their Mechanisms of Action”
by Abdul Waheed Khan, Mariya Farooq, Muhammad Haseeb and Sangdun Choi
Cells 202211(8), 1326,
Available online:

“Lichen Secondary Metabolites Inhibit the Wnt/β-Catenin Pathway in Glioblastoma Cells and Improve the Anticancer Effects of Temozolomide”
by Aleksandra Majchrzak-Celińska, Robert Kleszcz, Elżbieta Studzińska-Sroka, Agnieszka Łukaszyk, Anna Szoszkiewicz, Ewelina Stelcer, Karol Jopek, Marcin Rucinski, Judyta Cielecka-Piontek and Violetta Krajka-Kuźniak
Cells 202211(7), 1084,
Available online:

“PYR/PYL/RCAR Receptors Play a Vital Role in the Abscisic-Acid-Dependent Responses of Plants to External or Internal Stimuli”
by Justyna Fidler, Jakub Graska, Marta Gietler, Małgorzata Nykiel, Beata Prabucka, Anna Rybarczyk-Płońska, Ewa Muszyńska, Iwona Morkunas and Mateusz Labudda
Cells 202211(8), 1352,
Available online:

“Modes of Viroid Transmission”
by Ahmed Hadidi, Liying Sun and John W. Randles
Cells 202211(4), 719,
Available online:

“LbCas12a-D156R Efficiently Edits LOB1 Effector Binding Elements to Generate Canker-Resistant Citrus Plants”
by Hongge Jia, Yuanchun Wang, Hang Su, Xiaoen Huang and Nian Wang
Cells 202211(3), 315,
Available online:

“CORK1, A LRR-Malectin Receptor Kinase, Is Required for Cellooligomer-Induced Responses in Arabidopsis thaliana
by Yu-Heng Tseng, Sandra S. Scholz, Judith Fliegmann, Thomas Krüger, Akanksha Gandhi, Alexandra C. U. Furch, Olaf Kniemeyer, Axel A. Brakhage and Ralf Oelmüller
Cells 202211(19), 2960,
Available online:

“Revisiting the Non-Coding Nature of Pospiviroids”
by Konstantina Katsarou, Charith Raj Adkar-Purushothama, Emilios Tassios, Martina Samiotaki, Christos Andronis, Purificación Lisón, Christoforos Nikolaou, Jean-Pierre Perreault and Kriton Kalantidis
Cells 202211(2), 265,
Available online:

“Legume Lectins with Different Specificities as Potential Glycan Probes for Pathogenic Enveloped Viruses”
by Annick Barre, Els J. M. Van Damme, Bernard Klonjkowski, Mathias Simplicien, Jan Sudor, Hervé Benoist and Pierre Rougé
Cells 202211(3), 339,
Available online:

“Applications of CRISPR/Cas13-Based RNA Editing in Plants”
by Naga Rajitha Kavuri, Manikandan Ramasamy, Yiping Qi and Kranthi Mandadi
Cells 202211(17), 2665,
Available online:

“Rhizobia Contribute to Salinity Tolerance in Common Beans (Phaseolus vulgaris L.)”
by Clabe Wekesa, George O. Asudi, Patrick Okoth, Michael Reichelt, John O. Muoma, Alexandra C. U. Furch and Ralf Oelmüller
Cells 202211(22), 3628,
Available online:

“The Spermidine Synthase Gene SPD1: A Novel Auxotrophic Marker for Chlamydomonas reinhardtii Designed by Enhanced CRISPR/Cas9 Gene Editing”
by Robert A. Freudenberg, Luisa Wittemeier, Alexander Einhaus, Thomas Baier and Olaf Kruse Cells 202211(5), 837,
Available online:

“To Be or Not to Be? Are Reactive Oxygen Species, Antioxidants and Stress Signalling Universal Determinants of Life or Death?”
by Magdalena Szechyńska-Hebda, Roshanak Zarrin Ghalami, Muhammad Kamran, Frank Van Breusegem and Stanisław Karpiński
Cells 202211(24), 4105,
Available online:

“Cell Wall Properties Determine Genotype-Specific Response to Cold in Miscanthus × giganteus Plants”
by Anna Bilska-Kos, Aleksandra Pietrusińska, Szymon Suski, Agnieszka Niedziela, Anna M. Linkiewicz, Włodzimierz Majtkowski, Grzegorz Żurek and Jacek Zebrowski
Cells 202211(3), 547,
Available online:

28 December 2023
Cells | Top Cited Papers in 2022 in the Section “Reproductive Cells and Development”

“The Pivotal Role of the Placenta in Normal and Pathological Pregnancies: A Focus on Preeclampsia, Fetal Growth Restriction, and Maternal Chronic Venous Disease”
by Miguel A. Ortega, Oscar Fraile-Martínez , Cielo García-Montero , Miguel A. Sáez, Miguel Angel Álvarez-Mon, Diego Torres-Carranza, Melchor Álvarez-Mon, Julia Bujan, Natalio García-Honduvilla, Coral Bravo et al.
Cells 2022, 11(3), 568;
Available online:

“New Aspects of Corpus Luteum Regulation in Physiological and Pathological Conditions: Involvement of Adipokines and Neuropeptides”
by Ewa Mlyczyńska, Marta Kieżun, Patrycja Kurowska, Monika Dawid, Karolina Pich, Natalia Respekta, Mathilde Daudon, Edyta Rytelewska, Kamil Dobrzyń, Barbara Kamińska et al.
Cells 2022, 11(6), 957;
Available online:

“The Relationship between Obesity and Pre-Eclampsia: Incidental Risks and Identification of Potential Biomarkers for Pre-Eclampsia”
by Talitha Abraham and Andrea M. P. Romani
Cells 2022, 11(9), 1548;
Available online:

“The Role of Mitochondria in Human Fertility and Early Embryo Development: What Can We Learn for Clinical Application of Assessing and Improving Mitochondrial DNA?”
by Amira Podolak, Izabela Woclawek-Potocka and Krzysztof Lukaszuk
Cells 2022, 11(5), 797;
Available online:

“Endogenous Retroviruses and Placental Evolution, Development, and Diversity”
by Kazuhiko Imakawa, Kazuya Kusama, Tomoko Kaneko-Ishino, So Nakagawa, Koichi Kitao, Takayuki Miyazawa and Fumitoshi Ishino
Cells 2022, 11(15), 2458;
Available online:

“Endocrine Regulation of Maturation and Sex Change in Groupers”
by Kiyoshi Soyano, Takafumi Amagai, Tomofumi Yamaguchi, Yuji Mushirobira, Wen-Gang Xu, Nhan Thành Phạm and Ryosuke Murata
Cells 202211(5), 825;
Available online:

“The Effect of Interaction NGF/p75NTR in Sperm Cells: A Rabbit Model”
by Cesare Castellini, Simona Mattioli, Elisa Cotozzolo, Alessandra Pistilli, Mario Rende, Desirée Bartolini, Gabriele Di Sante, Laura Menchetti, Alessandro Dal Bosco and Anna Maria Stabile
Cells 202211(6), 1035;
Available online:

“Mechanisms of Sperm–Egg Interactions: What Ascidian Fertilization Research Has Taught Us”
by Hitoshi Sawada and Takako Saito
Cells 202211(13), 2096;
Available online:

“Chemerin Impact on Alternative mRNA Transcription in the Porcine Luteal Cells”
by Karol G. Makowczenko, Jan P. Jastrzebski, Lukasz Paukszto, Kamil Dobrzyn, Marta Kiezun, Nina Smolinska and Tadeusz Kaminski
Cells 202211(4), 715;
Available online:

“Cerebral Biomarkers and Blood-Brain Barrier Integrity in Preeclampsia”
by Therese Friis, Anna-Karin Wikström, Jesenia Acurio, José León, Henrik Zetterberg, Kaj Blennow, Maria Nelander, Helena Åkerud, Helena Kaihola, Catherine Cluver et al.
Cells 202211(5), 789;
Available online:

“Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility”
by Piotr Przybycień, Danuta Gąsior-Perczak and Wojciech Placha
Cells 202211(16), 2569;
Available online:

27 December 2023
Cells | Top Cited Papers in 2022 in the Section “Cells of the Nervous System”

“Microglia Phenotypes in Aging and Neurodegenerative Diseases”
by Menbere Y. Wendimu and Shelley B. Hooks
Cells 2022, 11(13), 2091;
Available online:

“Hydrogen Sulfide Produced by Gut Bacteria May Induce Parkinson’s Disease”
by Kari Erik Murros
Cells 2022, 11(6), 978;
Available online:

“Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker”
by Anastasios I. Birmpilis, Antonios Paschalis, Apostolis Mourkakis, Panayiota Christodoulou, Ioannis V. Kostopoulos, Elina Antimissari, Georgia Terzoudi, Alexandros G. Georgakilas, Christina Armpilia, Panagiotis Papageorgis et al.
Cells 2022, 11(9), 1415;
Available online:

“Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation”
by Giulia Di Benedetto, Chiara Burgaletto, Carlo Maria Bellanca, Antonio Munafò, Renato Bernardini and Giuseppina Cantarella
Cells 2022, 11(17), 2728;
Available online:

“Mitochondrial Neurodegeneration”
by Massimo Zeviani and Carlo Viscomi
Cells 2022, 11(4), 637;
Available online:

“New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer’s Disease and Its Potential for Therapeutic Intervention”
by Tiantian Li, Li Lu, Eloise Pember, Xinuo Li, Bocheng Zhang and Zheying Zhu
Cells 2022, 11(12), 1925;
Available online:

“The Role of Microglia in Neuroinflammation of the Spinal Cord after Peripheral Nerve Injury”
by Tana S. Pottorf, Travis M. Rotterman, William M. McCallum, Zoë A. Haley-Johnson and Francisco J. Alvarez
Cells 2022, 11(13), 2083;
Available online:

“Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study”
by Pietro De Luca, Angelo Camaioni, Pasquale Marra, Giovanni Salzano, Giovanni Carriere, Luca Ricciardi, Resi Pucci, Nicola Montemurro, Michael J. Brenner and Arianna Di Stadio
Cells 2022, 11(16), 2552;
Available online:

“The Influence of Gut Microbiota on Neurogenesis: Evidence and Hopes”
by Fiorella Sarubbo, Virve Cavallucci and Giovambattista Pani
Cells 2022, 11(3), 382;
Available online:

“Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives”
by Gary Álvarez Bravo, René Robles Cedeño, Marc Puig Casadevall and Lluís Ramió-Torrentà
Cells 2022, 11(13), 2058;
Available online:

“Gene Therapy in Amyotrophic Lateral Sclerosis”
by Ton, Goun Je Fang, Peter Pacut, Kiandokht Keyhanian, Jeff Gao and Mehdi Ghasemi
Cells 2022, 11(13), 2066;
Available online:

“Pharmacotherapy Evolution in Alzheimer’s Disease: Current Framework and Relevant Directions”
by Denisa Claudia Miculas, Paul Andrei Negru, Simona Gabriela Bungau, Tapan Behl, Syed Shams ul Hassan and Delia Mirela Tit
Cells 2023, 12(1), 131;
Available online:

“Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition”
by Alessandro Papa, Silvia Pasquini, Chiara Contri, Sandra Gemma, Giuseppe Campiani, Stefania Butini, Katia Varani and Fabrizio Vincenzi
Cells 2022, 11(3), 471;
Available online:

“Adult Neurogenesis under Control of the Circadian System”
by Amira A. H. Ali and Charlotte von Gall
Cells 2022, 11(5), 764;
Available online:

“MicroRNA Networks in Cognition and Dementia”
by Grace S. Blount, Layton Coursey and Jannet Kocerha
Cells 2022, 11(12), 1882;
Available online:

“Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation”
by Arielle Kasindi, Dieu-Trang Fuchs, Yosef Koronyo, Altan Rentsendorj, Keith L. Black and Maya Koronyo-Hamaoui
Cells 2022, 11(9), 1578;
Available online:

“Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients”
by Maria Antonella Zingaropoli, Marco Iannetta, Lorenzo Piermatteo, Patrizia Pasculli, Tiziana Latronico, Laura Mazzuti, Laura Campogiani, Leonardo Duca, Giampiero Ferraguti, Manuela De Michele et al.
Cells 2022, 11(16), 2480;
Available online:

“Molecular Mechanisms in Pentanucleotide Repeat Diseases”
by Joana R. Loureiro, Ana F. Castro, Ana S. Figueiredo and Isabel Silveira
Cells 2022, 11(2), 205;
Available online:

“LEAP-2 Counteracts Ghrelin-Induced Food Intake in a Nutrient, Growth Hormone and Age Independent Manner”
by Javier Lugilde, Sabela Casado, Daniel Beiroa, Juan Cuñarro, Montserrat Garcia-Lavandeira, Clara V. Álvarez, Rubén Nogueiras, Carlos Diéguez and Sulay Tovar
Cells 2022, 11(3), 324;
Available online:

“Single-Cell RNA-Seq Analysis of Olfactory Mucosal Cells of Alzheimer’s Disease Patients”
by Riikka Lampinen, Mohammad Feroze Fazaludeen, Simone Avesani, Tiit Örd, Elina Penttilä, Juha-Matti Lehtola, Toni Saari, Sanna Hannonen, Liudmila Saveleva, Emma Kaartinen et al.
Cells 2022, 11(4), 676;
Available online:

“L-Thyroxine Improves Vestibular Compensation in a Rat Model of Acute Peripheral Vestibulopathy: Cellular and Behavioral Aspects”
by Guillaume Rastoldo, Emna Marouane, Nada El-Mahmoudi, David Péricat, Isabelle Watabe, Agnes Lapotre, Alain Tonetto, Alejandra López-Juárez, Abdessadek El-Ahmadi, Philippe Caron et al.
Cells 2022, 11(4), 684;
Available online:

“Antagonism of CGRP Receptor: Central and Peripheral Mechanisms and Mediators in an Animal Model of Chronic Migraine”
by Rosaria Greco, Chiara Demartini, Miriam Francavilla, Anna Maria Zanaboni and Cristina Tassorelli
Cells 2022, 11(19), 3092;
Available online:

“Levodopa-Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Emerging Treatment Strategies”
by Destany K. Kwon, Mohit Kwatra, Jing Wang and Han Seok Ko
Cells 2022, 11(23), 3736;
Available online:

“Fibrotic Scar in CNS Injuries: From the Cellular Origins of Fibroblasts to the Molecular Processes of Fibrotic Scar Formation”
by Maryam Ayazi, Sandra Zivkovic, Grace Hammel, Branko Stefanovic and Yi Ren
Cells 2022, 11(15), 2371;
Available online:

“ATP-Sensitive Potassium Channels in Migraine: Translational Findings and Therapeutic Potential”
by Amalie Clement, Song Guo, Inger Jansen-Olesen and Sarah Louise Christensen
Cells 2022, 11(15), 2406;
Available online:

“Increased Numbers of Enteric Glial Cells in the Peyer’s Patches and Enhanced Intestinal Permeability by Glial Cell Mediators in Patients with Ileal Crohn’s Disease”
by Olga Biskou, Felipe Meira de-Faria, Susanna M. Walter, Martin E. Winberg, Staffan Haapaniemi, Pär Myrelid, Johan D. Söderholm and Åsa V. Keita
Cells 2022, 11(3), 335;
Available online:

“Physiological Function during Exercise and Environmental Stress in Humans—An Integrative View of Body Systems and Homeostasis”
by Gavin Travers, Pascale Kippelen, Steven J. Trangmar and José González-Alonso
Cells 2022, 11(3), 383;
Available online:

“Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer’s Disease”
by Sudhir Kshirsagar, Rainier Vladlen Alvir, Ashly Hindle, Subodh Kumar, Murali Vijayan, Jangampalli Adi Pradeepkiran, Arubala P. Reddy, Bhagavathi Ramasubramanian and P. Hemachandra Reddy
Cells 2022, 11(4), 733;
Available online:

“LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss”
by Dong-Hwan Ho, Daleum Nam, Mikyoung Seo, Sung-Woo Park, Wongi Seol and Ilhong Son
Cells 2022, 11(5), 861;
Available online:

“Medicinal Herbs in the Relief of Neurological, Cardiovascular and Respiratory Symptoms after COVID-19 Infection A Literature Review”
by Joanna Nawrot, Justyna Gornowicz-Porowska, Jaromir Budzianowski, Gerard Nowak, Grzegorz Schroeder and Joanna Kurczewska
Cells 2022, 11(12), 1897;
Available online:

“MiRNAs as Promising Translational Strategies for Neuronal Repair and Regeneration in Spinal Cord Injury”
by Serena Silvestro and Emanuela Mazzon
Cells 2022, 11(14), 2177;
Available online:

“Current Understanding of the Neural Stem Cell Niches”
by Vicente Llorente, Pedro Velarde, Manuel Desco and María Victoria Gómez-Gaviro
Cells 2022, 11(19), 3002;
Available online:

“Endosomal Recycling Defects and Neurodevelopmental Disorders”
by Shinji Saitoh
Cells 2022, 11(1), 148;
Available online:

“How Is Peripheral Injury Signaled to Satellite Glial Cells in Sensory Ganglia?”
by Menachem Hanani
Cells 2022, 11(3), 512;
Available online:

“Dual Effects of Korean Red Ginseng on Astrocytes and Neural Stem Cells in Traumatic Brain Injury: The HO-1–Tom20 Axis as a Putative Target for Mitochondrial Function”
by Minsu Kim, Sunhong Moon, Hui Su Jeon, Sueun Kim, Seong-Ho Koh, Mi-Sook Chang, Young-Myeong Kim and Yoon Kyung Choi
Cells 2022, 11(5), 892;
Available online:

“Thyroid and Corticosteroid Signaling in Amphibian Metamorphosis”
by Bidisha Paul, Zachary R. Sterner, Daniel R. Buchholz, Yun-Bo Shi and Laurent M. Sachs
Cells 2022, 11(10), 1595;
Available online:

“Different Methods for Evaluating Microglial Activation Using Anti-Ionized Calcium-Binding Adaptor Protein-1 Immunohistochemistry in the Cuprizone Model”
by Mariela Wittekindt, Hannes Kaddatz, Sarah Joost, Anna Staffeld, Yamen Bitar, Markus Kipp and Linda Frintrop
Cells 2022, 11(11), 1723;
Available online:

“The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow”
by Mária Dux, Birgit Vogler, Annette Kuhn, Kimberly D. Mackenzie, Jennifer Stratton and Karl Messlinger
Cells 2022, 11(11), 1768;
Available online:

“Single Cell/Nucleus Transcriptomics Comparison in Zebrafish and Humans Reveals Common and Distinct Molecular Responses to Alzheimer’s Disease”
by Mehmet Ilyas Cosacak, Prabesh Bhattarai, Philip L. De Jager, Vilas Menon, Giuseppe Tosto and Caghan Kizil
Cells 2022, 11(11), 1807;
Available online:

“Targeting the Subventricular Zone to Promote Myelin Repair in the Aging Brain”
by Arthur Morgan Butt, Andrea Dominico Rivera, Daniel Fulton and Kasum Azim
Cells 2022, 11(11), 1809;
Available online:

“Pathophysiology and Therapy of Associated Features of Migraine”
by Maria Dolores Villar-Martinez and Peter J. Goadsby
Cells 2022, 11(17), 2767;
Available online:

“Remodeling of the Neurovascular Unit Following Cerebral Ischemia and Hemorrhage”
by Yoshimichi Sato, Jaime Falcone-Juengert, Teiji Tominaga, Hua Su and Jialing Liu
Cells 2022, 11(18), 2823;
Available online:

“Branched-Chain Amino Acids Are Linked with Alzheimer’s Disease-Related Pathology and Cognitive Deficits”
by Md Abu Bakkar Siddik, Caitlyn A. Mullins, Alyssa Kramer, Harsh Shah, Ritchel B. Gannaban, Masoud Zabet-Moghaddam, Ryan M. Huebinger, Vijay K. Hegde, Sheba M. J. MohanKumar, Puliyur S. MohanKumar et al.
Cells 2022, 11(21), 3523;
Available online:

“Monoclonal Antibodies against Calcitonin Gene-Related Peptide for Migraine Prophylaxis: A Systematic Review of Real-World Data”
by Antun R. Pavelic, Christian Wöber, Franz Riederer and Karin Zebenholzer
Cells 2023, 12(1), 143;
Available online:

“What’s in a Gene? The Outstanding Diversity of MAPT
by Daniel Ruiz-Gabarre, Almudena Carnero-Espejo, Jesús Ávila and Vega García-Escudero
Cells 2022, 11(5), 840;
Available online:

“The Physiological Roles of the Exon Junction Complex in Development and Diseases”
by Shravan Asthana, Hannah Martin, Julian Rupkey, Shray Patel, Joy Yoon, Abiageal Keegan and Yingwei Mao
Cells 2022, 11(7), 1192;
Available online:

26 December 2023
Cells | Top Cited Papers in 2023 in the Section “Cell Signaling”

“Emerging Role of cAMP/AMPK Signaling”
by Muhammad Aslam andYury Ladilov
Cells 2022, 11(2), 308;
Available online:

“Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction”
by Harikrishnan Venugopal, Anis Hanna, Claudio Humeres and Nikolaos G. Frangogiannis
Cells 2022, 11(9), 1386;
Available online:

“Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart”
by Bartosz Walkowski, Marcin Kleibert, Miłosz Majka and Małgorzata Wojciechowska
Cells 2022, 11(9), 1553;
Available online:

“ISG15 and ISGylation in Human Diseases”
by Oygul Mirzalieva, Meredith Juncker, Joshua Schwartzenburg and Shyamal Desai
Cells 2022, 11(3), 538;
Available online:

“cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach”
by Muhammad Bilal Ahmed, Abdullah A. A. Alghamdi, Salman Ul Islam, Joon-Seok Lee and Young-Sup Lee
Cells 2022, 11(13), 2020;
Available online:

“New Insights into Hippo/YAP Signaling in Fibrotic Diseases”
by Masum M. Mia and Manvendra K. Singh
Cells 2022, 11(13), 2065;
Available online:

“Specific NLRP3 Inflammasome Assembling and Regulation in Neutrophils: Relevance in Inflammatory and Infectious Diseases”
by Christophe Paget, Emilie Doz-Deblauwe, Nathalie Winter and Benoit Briard
Cells 2022, 11(7), 1188;
Available online:

“Early Protective Role of Inflammation in Cardiac Remodeling and Heart Failure: Focus on TNFα and Resident Macrophages”
by Sophie Besse, Sophie Nadaud, Elise Balse and Catherine Pavoine
Cells 2022, 11(7), 1249;
Available online:

“Calcium Signals during SARS-CoV-2 Infection: Assessing the Potential of Emerging Therapies”
by Sascha Berlansky, Matthias Sallinger, Herwig Grabmayr, Christina Humer, Andreas Bernhard, Marc Fahrner and Irene Frischauf
Cells 2022, 11(2), 253;
Available online:

“Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer”
by Kamal Eltayeb, Silvia La Monica, Marcello Tiseo, Roberta Alfieri and Claudia Fumarola
Cells 2022, 11(3), 413;
Available online:

“KRAS as a Modulator of the Inflammatory Tumor Microenvironment: Therapeutic Implications”
by Flávia Pereira, Anabela Ferreira, Celso Albuquerque Reis, Maria João Sousa, Maria José Oliveira and Ana Preto
Cells 2022, 11(3), 398;
Available online:

“Comparative Efficacy and Safety of Tezepelumab and Other Biologics in Patients with Inadequately Controlled Asthma According to Thresholds of Type 2 Inflammatory Biomarkers: A Systematic Review and Network Meta-Analysis”
by Koichi Ando, Yosuke Fukuda, Akihiko Tanaka and Hironori Sagara
Cells 2022, 11(5), 819;
Available online:

“BMP Signaling Pathway in Dentin Development and Diseases”
by Mengmeng Liu, Graham Goldman, Mary MacDougall and Shuo Chen
Cells 2022, 11(14), 2216;
Available online:

“Bioenergetic Aspects of Mitochondrial Actions of Thyroid Hormones”
by Federica Cioffi, Antonia Giacco, Fernando Goglia and Elena Silvestri
Cells 2022, 11(6), 997;
Available online:

“Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro”
by Santosh V. Suryavanshi, Mariia Zaiachuk, Nazar Pryimak, Igor Kovalchuk and Olga Kovalchuk
Cells 2022, 11(9), 1391;
Available online:

“Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance”
by Sydney Diep, Mahita Maddukuri, Stephanie Yamauchi, Ganamee Geshow and Nikki A. Delk
Cells 2022, 11(10), 1673;
Available online:

“Therapeutic Targeting of NF-κB in Acute Lung Injury: A Double-Edged Sword”
by Michelle Warren Millar, Fabeha Fazal and Arshad Rahman
Cells 2022, 11(20), 3317;
Available online:

“Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer”
by Farhoud Faraji, Sydney I. Ramirez, Paola Y. Anguiano Quiroz, Amaya N. Mendez-Molina and J. Silvio Gutkind
Cells 2022, 11(8), 1370;
Available online:

“Single-Cell RNA-Sequencing: Astrocyte and Microglial Heterogeneity in Health and Disease”
by Michael S. Spurgat and Shao-Jun Tang
Cells 2022, 11(13), 2021;
Available online:

“Vitamin D Receptor Influences Intestinal Barriers in Health and Disease”
by Jun Sun and Yong-Guo Zhang
Cells 2022, 11(7), 1129;
Available online:

“C-C Chemokine Receptor 7 in Cancer”
by Colin A. Bill, Christopher M. Allen and Charlotte M. Vines
Cells 2022, 11(4), 656;
Available online:

“Ibrutinib in the Treatment of Solid Tumors: Current State of Knowledge and Future Directions”
by Katarzyna Szklener, Adam Michalski, Klaudia Żak, Michał Piwoński and Sławomir Mańdziuk
Cells 2022, 11(8), 1338;
Available online:

“Crucial Role of Oncogenic KRAS Mutations in Apoptosis and Autophagy Regulation: Therapeutic Implications”
by Anabela Ferreira, Flávia Pereira, Celso Reis, Maria José Oliveira, Maria João Sousa and Ana Preto
Cells 2022, 11(14), 2183;
Available online:

“Identification, Quantification, and Characterization of HIV-1 Reservoirs in the Human Brain”
by Maribel Donoso, Daniela D’Amico, Silvana Valdebenito, Cristian A. Hernandez, Brendan Prideaux and Eliseo A. Eugenin
Cells 2022, 11(15), 2379;
Available online:

“NLRP6 Inflammasome Modulates Disease Progression in a Chronic-Plus-Binge Mouse Model of Alcoholic Liver Disease”
by Rebecca Elena Mainz, Stefanie Albers, Madhuri Haque, Roland Sonntag, Nicole Simone Treichel, Thomas Clave, Eicke Latz, Kai Markus Schneider, Christian Trautwein and Tobias Otto
Cells 2022, 11(2), 182;
Available online:

“Hypoxia-Inducible Factor Signaling in Inflammatory Lung Injury and Repair”
by Colin E. Evans
Cells 2022, 11(2), 183;
Available online:

“Intestinal Epithelial AMPK Deficiency Causes Delayed Colonic Epithelial Repair in DSS-Induced Colitis”
by Séverine Olivier, Hanna Diounou, Camille Pochard, Lisa Frechin, Emilie Durieu, Marc Foretz, Michel Neunlist, Malvyne Rolli-Derkinderen and Benoit Viollet
Cells 2022, 11(4), 590;
Available online:

“Dissecting miRNA–Gene Networks to Map Clinical Utility Roads of Pharmacogenomics-Guided Therapeutic Decisions in Cardiovascular Precision Medicine”
by Fani Chatzopoulou, Konstantinos A. Kyritsis, Christos I. Papagiannopoulos, Eleftheria Galatou, Nikolaos Mittas, Nikoleta F. Theodoroula, Andreas S. Papazoglou, Efstratios Karagiannidis, Maria Chatzidimitriou, Anna Papa et al.
Cells 2022, 11(4), 607;
Available online:

“Microbial Metabolite Regulation of Epithelial Cell-Cell Interactions and Barrier Function”
by Alfredo Ornelas, Alexander S. Dowdell, J. Scott Lee and Sean P. Colgan
Cells 2022, 11(6), 944;
Available online:

“Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?”
by Jolanta Weresa, Anna Pędzińska-Betiuk, Krzysztof Mińczuk, Barbara Malinowska and Eberhard Schlicker
Cells 2022, 11(7), 1142;
Available online:

“Selectin-Mediated Signaling—Shedding Light on the Regulation of Integrin Activity in Neutrophils”
by Anika Cappenberg, Marina Kardell and Alexander Zarbock
Cells 2022, 11(8), 1310;
Available online:

“Lethal and Non-Lethal Functions of Caspases in the DNA Damage Response”
by Karla E. Lopez and Lisa Bouchier-Hayes
Cells 2022, 11(12), 1887;
Available online:

“The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy”
by Hiroyuki Takahashi, Gumpei Yoshimatsu and Denise Louise Faustman
Cells 2022, 11(12), 1952;
Available online:

“Dysregulated Ca2+ Homeostasis as a Central Theme in Neurodegeneration: Lessons from Alzheimer’s Disease and Wolfram Syndrome”
by Manon Callens, Jens Loncke and Geert Bultynck
Cells 2022, 11(12), 1963;
Available online:

“Signaling by LncRNAs: Structure, Cellular Homeostasis, and Disease Pathology”
by Revathy Nadhan, Ciro Isidoro, Yong Sang Song and Danny N. Dhanasekaran
Cells 2022, 11(16), 2517;
Available online:

“KRAS G12D Mutation Subtype in Pancreatic Ductal Adenocarcinoma: Does It Influence Prognosis or Stage of Disease at Presentation?”
by Henry Shen, Joanne Lundy, Andrew H. Strickland, Marion Harris, Michael Swan, Christopher Desmond, Brendan J. Jenkins and Daniel Croagh
Cells 2022, 11(19), 3175;
Available online:

“HMGB1-Mediated Activation of the Inflammatory-Reparative Response Following Myocardial Infarction”
by Eleonora Foglio, Laura Pellegrini, Matteo Antonio Russo and Federica Limana
Cells 2022, 11(2), 216;
Available online:

“Nuclear Receptor PXR in Drug-Induced Hypercholesterolemia”
by Mikko Karpale, Janne Hukkanen and Jukka Hakkola
Cells 2022, 11(3), 313;
Available online:

“Deubiquitinases in Neurodegeneration”
by Abudu I. Bello, Rituparna Goswami, Shelby L. Brown, Kara Costanzo, Taylor Shores, Shefaa Allan, Revan Odah and Ryan D. Mohan
Cells 2022, 11(3), 556;
Available online:

“Maintenance of NAD+ Homeostasis in Skeletal Muscle during Aging and Exercise”
by Li Li Ji and Dongwook Yeo
Cells 2022, 11(4), 710;
Available online:

“Normal and Neoplastic Growth Suppression by the Extended Myc Network”
by Edward V. Prochownik and Huabo Wang
Cells 2022, 11(4), 747;
Available online:

“To Detach, Migrate, Adhere, and Metastasize: CD97/ADGRE5 in Cancer”
by Gabriela Aust, Leyu Zheng and Marianne Quaas
Cells 2022, 11(9), 1538;
Available online:

“Global PIEZO1 Gain-of-Function Mutation Causes Cardiac Hypertrophy and Fibrosis in Mice”
by Fiona Bartoli, Elizabeth L. Evans, Nicola M. Blythe, Leander Stewart, Eulashini Chuntharpursat-Bon, Marjolaine Debant, Katie E. Musialowski, Laeticia Lichtenstein, Gregory Parsonage, T. Simon Futers et al.
Cells 2022, 11(7), 1199;
Available online:

“Distinct CholinomiR Blood Cell Signature as a Potential Modulator of the Cholinergic System in Women with Fibromyalgia Syndrome”
by Christoph Erbacher, Shani Vaknine, Gilli Moshitzky, Sebastian Lobentanzer, Lina Eisenberg, Dimitar Evdokimov, Claudia Sommer, David S. Greenberg, Hermona Soreq and Nurcan Üçeyler
Cells 2022, 11(8), 1276;
Available online:

“How Pyroptosis Contributes to Inflammation and Fibroblast-Macrophage Cross-Talk in Rheumatoid Arthritis”
by Benjamin Demarco, Sara Danielli, Fabian A. Fischer and Jelena S. Bezbradica
Cells 2022, 11(8), 1307;
Available online:

“p66Shc in Cardiovascular Pathology”
by Landon Haslem, Jennifer M. Hays and Franklin A. Hays
Cells 2022, 11(11), 1855;
Available online:

“Involvement of Nuclear Factor-κB in Inflammation and Neuronal Plasticity Associated with Post-Traumatic Stress Disorder”
by Sudhiranjan Gupta and Rakeshwar S. Guleria
Cells 2022, 11(13), 2034;
Available online:

26 December 2023
Cells | Top Cited Papers in 2022 in the Section “Tissues and Organs”

“Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF)”
by Confalonieri, Paola, Maria Concetta Volpe, Justin Jacob, Serena Maiocchi, Francesco Salton, Barbara Ruaro, Marco Confalonieri and Luca Braga
Cells 2022, 11(13), 2095;
Available online:

“The Role of Airway Epithelial Cell Alarmins in Asthma”
by Whetstone, Christiane E., Maral Ranjbar, Hafsa Omer, Ruth P. Cusack and Gail M. Gauvreau
Cells 2022, 11(7), 1105;
Available online:

“IL-17 Cytokines and Chronic Lung Diseases”
by Ritzmann, Felix, Lars Peter Lunding, Robert Bals, Michael Wegmann and Christoph Beisswenger
Cells 2022, 11(14), 2132;
Available online:

“Browning Epicardial Adipose Tissue: Friend or Foe?”
by Doukbi, Elisa, Astrid Soghomonian, Coralie Sengenès, Shaista Ahmed, Patricia Ancel, Anne Dutour and Bénédicte Gaborit
Cells 2022, 11(6), 991;
Available online:

“Morphological and Immunopathological Aspects of Lingual Tissues in COVID-19
by Henin, Dolaji, Gaia Pellegrini, Daniela Carmagnola, Giuseppe Carlo Lanza Attisano, Gianluca Lopez, Stefano Ferrero, Antonella Amendola, Danilo De Angelis, Elisabetta Tanzi and Claudia Dellavia
Cells 2022, 11(7), 1248;
Available online:

“Inhibition of Adipose Tissue Beiging by HIV Integrase Inhibitors, Dolutegravir and Bictegravir, Is Associated with Adipocyte Hypertrophy, Hypoxia, Elevated Fibrosis, and Insulin Resistance in Simian Adipose Tissue and Human Adipocytes”
by Ngono Ayissi, Kenza, Jennifer Gorwood, Laura Le Pelletier, Christine Bourgeois, Carine Beaupère, Martine Auclair, Roberta Foresti, Roberto Motterlini, Michael Atlan, Aurélie Barrail-Tran et al.
Cells 2022, 11(11), 1841;
Available online:

“Untangling the Extracellular Matrix of Idiopathic Epiretinal Membrane: A Path Winding among Structure, Interactomics and Translational Medicine”
by Bianchi, Laura, Annalisa Altera, Virginia Barone, Denise Bonente, Tommaso Bacci, Elena De Benedetto, Luca Bini, Gian Marco Tosi, Federico Galvagni and Eugenio Bertelli
Cells 2022, 11(16), 2531;
Available online:

“Importance of the Microenvironment and Mechanosensing in Adipose Tissue Biology”
by Lecoutre, Simon, Mélanie Lambert, Krzysztof Drygalski, Isabelle Dugail, Salwan Maqdasy, Mathieu Hautefeuille and Karine Clément
Cells 2022, 11(15), 2310;
Available online:

“Immunological Insights into Cigarette Smoking-Induced Cardiovascular Disease Risk”
by Dahdah, Albert, Robert M. Jaggers, Gopalkrishna Sreejit, Jillian Johnson, Babunageswararao Kanuri, Andrew J. Murphy and Prabhakara R. Nagareddy
Cells 2022, 11(20), 3190;
Available online:

“Nutraceuticals in Brown Adipose Tissue Activation”
by Armani, Andrea, Alessandra Feraco, Elisabetta Camajani, Stefania Gorini, Mauro Lombardo and Massimiliano Caprio
Cells 2022, 11(24), 3996;
Available online:

26 December 2023
Cells | Top Cited Papers in 2022 in the Section “Cell Microenvironment”

“Insight into Extracellular Vesicle-Cell Communication: From Cell Recognition to Intracellular Fate”
by Lana Ginini, Salem Billan, Eran Fridman and Ziv Gil
Cells 2022, 11(9), 1375;
Available online:

“Exosome as a Delivery Vehicle for Cancer Therapy”
by Bohyun Moon and Suhwan Chang
Cells 2022, 11(3), 316;
Available online:

“Immunogenic Cell Death: An Emerging Target in Gastrointestinal Cancers”
by Marta Chiaravalli, Alexia Spring, Antonio Agostini, Geny Piro, Carmine Carbone and Giampaolo Tortora
Cells 2022, 11(19), 3033;
Available online:

“Human Milk Extracellular Vesicles: A Biological System with Clinical Implications”
by Somchai Chutipongtanate, Ardythe L. Morrow and David S. Newburg
Cells 2022, 11(15), 2345;
Available online:

“Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns”
by Said A. Omar, Amal Abdul-Hafez, Sherif Ibrahim, Natasha Pillai, Mohammed Abdulmageed, Ranga Prasanth Thiruvenkataramani, Tarek Mohamed, Burra V. Madhukar and Bruce D. Uhal
Cells 2022, 11(8), 1275;
Available online:

“The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment”
by Eran S. Fridman, Lana Ginini and Ziv Gil
Cells 2022, 11(9), 1433;
Available online:

“Aquaporin-6 May Increase the Resistance to Oxidative Stress of Malignant Pleural Mesothelioma Cells”
by Giorgia Pellavio, Simona Martinotti, Mauro Patrone, Elia Ranzato and Umberto Laforenza
Cells 2022, 11(12), 1892;
Available online:

“Emergence of Edible Plant-Derived Nanovesicles as Functional Food Components and Nanocarriers for Therapeutics Delivery: Potentials in Human Health and Disease”
by Sora Q. Kim and Kee-Hong Kim
Cells 2022, 11(14), 2232;
Available online:

“Secretory Immunoglobulin A Immunity in Chronic Obstructive Respiratory Diseases”
by Charlotte de Fays, François M. Carlier, Sophie Gohy and Charles Pilette
Cells 2022, 11(8), 1324;
Available online:

“Angiogenesis, Lymphangiogenesis, and Inflammation in Chronic Obstructive Pulmonary Disease (COPD): Few Certainties and Many Outstanding Questions”
by Remo Poto, Stefania Loffredo, Francesco Palestra, Gianni Marone, Vincenzo Patella and Gilda Varricchi
Cells 2022, 11(10), 1720;
Available online:

“CAR T Cell Locomotion in Solid Tumor Microenvironment”
by Duy T. Nguyen, Elizabeth Ogando-Rivas, Ruixuan Liu, Theodore Wang, Jacob Rubin, Linchun Jin, Haipeng Tao, William W. Sawyer, Hector R. Mendez-Gomez, Matthew Cascio et al.
Cells 2022, 11(12), 1974;
Available online:

“Supraphysiological Oxygen Levels in Mammalian Cell Culture: Current State and Future Perspectives”
by Ricardo Alva, Georgina L. Gardner, Ping Liang and Jeffrey A. Stuart
Cells 2022, 11(19), 3123;
Available online:

“Current Progress in Vascular Engineering and Its Clinical Applications”
by Hatem Jouda, Luis Larrea Murillo and Tao Wang
Cells 2022, 11(3), 493;
Available online:

“Interleukin-6 at the Host-Tumor Interface: STAT3 in Biomolecular Condensates in Cancer Cells”
by Pravin B. Sehgal
Cells 2022, 11(7), 1164;
Available online:

“Tumor Immunogenic Cell Death as a Mediator of Intratumor CD8 T-Cell Recruitment”
by Nicolas Roussot, François Ghiringhelli and Cédric Rébé
Cells 2022, 11(22), 3672;
Available online:

“Freeze-Dried Curdlan/Whey Protein Isolate-Based Biomaterial as Promising Scaffold for Matrix-Associated Autologous Chondrocyte Transplantation—A Pilot In-Vitro Study”
by Katarzyna Klimek, Marta Tarczynska, Wieslaw Truszkiewicz, Krzysztof Gaweda, Timothy E. L. Douglas and Grazyna Ginalska
Cells 2022, 11(2), 282;
Available online:

Salvia miltiorrhiza Bunge as a Potential Natural Compound against COVID-19”
by Simon J. L. Petitjean, Marylène Lecocq, Camille Lelong, Robin Denis, Sylvie Defrère, Pierre-Antoine Mariage, David Alsteens and Charles Pilette
Cells 2022, 11(8), 1311;
Available online:

“Role of Respiratory Epithelial Cells in Allergic Diseases”
by Constanze A. Jakwerth, Jose Ordovas-Montanes, Simon Blank, Carsten B. Schmidt-Weber and Ulrich M. Zissler
Cells 2022, 11(9), 1387;
Available online:

“TGF-β Superfamily Signaling in the Eye: Implications for Ocular Pathologies”
by Soumaya Hachana and Bruno Larrivée
Cells 2022, 11(15), 2336;
Available online:

“The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology”
by Isaure Vanmeerbeek, Jannes Govaerts, Raquel S. Laureano, Jenny Sprooten, Stefan Naulaerts, Daniel M. Borras, Damya Laoui, Massimiliano Mazzone, Jo A. Van Ginderachter and Abhishek D. Garg
Cells 2022, 11(23), 3890;
Available online:

26 December 2023
Cells | Top Cited Papers in 2022 in the Section “Cellular Immunology”

“Regulation and Dysregulation of Endothelial Permeability during Systemic Inflammation”
by Katharina E. M. Hellenthal, Laura Brabenec and Nana-Maria Wagner
Cells 2022, 11(12), 1935;
Available online:

“The Good and the Bad: Monocytes’ and Macrophages’ Diverse Functions in Inflammation”
by Judith Austermann, Johannes Roth and Katarzyna Barczyk-Kahlert
Cells 2022, 11(12), 1979;
Available online:

“Plasmacytoid Dendritic Cells and Cancer Immunotherapy”
by Chunmei Fu, Li Zhou, Qing-Sheng Mi and Aimin Jiang
Cells 2022, 11(2), 222;
Available online:

“The Fatal Circle of NETs and NET-Associated DAMPs Contributing to Organ Dysfunction
by Helena Block, Jan Rossaint and Alexander Zarbock
Cells 2022, 11(12), 1919;
Available online:

“The Immune and Regenerative Response to Burn Injury”
by Matthew Burgess, Franklin Valdera, David Varon, Esko Kankuri and Kristo Nuutila
Cells 2022, 11(19), 3073;
Available online:

“Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants”
by Kyonghwan Choe, Hyun Young Park, Muhammad Ikram, Hyeon Jin Lee, Tae Ju Park, Rahat Ullah and Myeong Ok Kim
Cells 2022, 11(8), 1298;
Available online:

“Platelets at the Crossroads of Pro-Inflammatory and Resolution Pathways during Inflammation”
by Nadine Ludwig, Annika Hilger, Alexander Zarbock and Jan Rossaint
Cells 2022, 11(12), 1957;
Available online:

“Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells”
by Piper A. Robida, Clayton H. Rische, Netali Ben-Baruch Morgenstern, Rethavathi Janarthanam, Yun Cao, Rebecca A. Krier-Burris, Wouter Korver, Alan Xu, Thuy Luu, Julia Schanin et al.
Cells 2022, 11(7), 1138;
Available online:

“Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era”
by Laura Kalfeist, Loïck Galland, Fanny Ledys, François Ghiringhelli, Emeric Limagne and Sylvain Ladoire
Cells 2022, 11(5), 770;
Available online:

“Polyamine Immunometabolism: Central Regulators of Inflammation, Cancer and Autoimmunity”
by Tzu-yi Chia, Andrew Zolp and Jason Miska
Cells 2022, 11(5), 896;
Available online:

“Extracellular Vesicles as Drivers of Immunoinflammation in Atherothrombosis”
by Rosa Suades, Maria Francesca Greco, Teresa Padró and Lina Badimon
Cells 2022, 11(11), 1845;
Available online:

“Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes”
by Yasmin Abaza and Amer M. Zeidan
Cells 2022, 11(14), 2249;
Available online:

“The Role of Inflammatory Mediators in Colorectal Cancer Hepatic Metastasis”
by Lavanya Goodla and Xiang Xue
Cells 2022, 11(15), 2313;
Available online:

“Oxysterols in the Immune Response to Bacterial and Viral Infections”
by Cheng Xiang Foo, Stacey Bartlett and Katharina Ronacher
Cells 2022, 11(2), 201;
Available online:

“Functional Differences between Proteasome Subtypes”
by Joanna Abi Habib, Julie Lesenfants, Nathalie Vigneron, and Benoit J. Van den Eynde
Cells 2022, 11(3), 421;
Available online:

“Microbiota and Pain: Save Your Gut Feeling”
by Chiara Morreale, Ilia Bresesti, Annalisa Bosi, Andreina Baj, Cristina Giaroni, Massimo Agosti and Silvia Salvatore
Cells 2022, 11(6), 971;
Available online:

“Buffering Adaptive Immunity by Hydrogen Sulfide”
by Giulia Pozzi, Giuliana Gobbi, Elena Masselli, Cecilia Carubbi, Valentina Presta, Luca Ambrosini, Marco Vitale and Prisco Mirandola
Cells 2022, 11(3), 325;
Available online:

“Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer”
by Éilis Russell, Melissa J. Conroy and Martin P. Barr
Cells 2022, 11(4), 605;
Available online:

“Plasma Metabolomic Alterations Induced by COVID-19 Vaccination Reveal Putative Biomarkers Reflecting the Immune Response”
by Ioanna Dagla, Aikaterini Iliou, Dimitra Benaki, Evagelos Gikas, Emmanuel Mikro, Tina Bagratuni, Efstathios Kastritis, Meletios A. Dimopoulos, Evangelos Terpos and Anthony Tsarbopoulos
Cells 2022, 11(7), 1241;
Available online:

“Proteomics and Metabolomics Profiling of Platelets and Plasma Mediators of Thrombo-Inflammation in Gestational Hypertension and Preeclampsia”
by Luiz Gustavo N. de Almeida, Daniel Young, Lorraine Chow, Joshua Nicholas, Adrienne Lee, Man-Chiu Poon, Antoine Dufour and Ejaife O. Agbani
Cells 2022, 11(8), 1256;
Available online:

“Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis”
by Alexandra Linke, Gisa Tiegs and Katrin Neumann
Cells 2022, 11(10), 1625;
Available online:

“Fibrosis Is a Basement Membrane-Related Disease in the Cornea: Injury and Defective Regeneration of Basement Membranes May Underlie Fibrosis in Other Organs”
by Steven E. Wilson
Cells 2022, 11(2), 309;
Available online:

“Long-Term Subjective and Objective Assessment of Smell and Taste in COVID-19”
by Andrea Ciofalo, Carlo Cavaliere, Simonetta Masieri, Alessandra Di Chicco, Irene Fatuzzo, Federica Lo Re, Silvia Baroncelli, Elona Begvarfaj, Andrea Adduci, Ivano Mezzaroma et al.
Cells 2022, 11(5), 788;
Available online:

“Colonic Fluid and Electrolyte Transport 2022: An Update”
by Abel B. Negussie, Annika C. Dell, Bruce A. Davis and John P. Geibel
Cells 2022, 11(10), 1712;
Available online:

“T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies”
by Federica Pulvirenti, Stefano Di Cecca, Matilde Sinibaldi, Eva Piano Mortari, Sara Terreri, Christian Albano, Marika Guercio, Eleonora Sculco, Cinzia Milito, Simona Ferrari et al.
Cells 2022, 11(12), 1918;
Available online:

“Monocytes and Macrophages in Spondyloarthritis: Functional Roles and Effects of Current Therapies”
by Sara Martínez-Ramos, Carlos Rafael-Vidal, José M. Pego-Reigosa and Samuel García
Cells 2022, 11(3), 515;
Available online:

22 December 2023
Cells | Top Cited Papers in 2022 in the Section “Mitochondria”

“Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver”
by Julie Massart, Karima Begriche, Jessica H. Hartman and Bernard Fromenty
Cells 2022, 11(2), 288;
Available online:

“Role of Estrogens in Menstrual Migraine”
by Rossella E. Nappi, Lara Tiranini, Simona Sacco, Eleonora De Matteis, Roberto De Icco and Cristina Tassorelli
Cells 2022, 11(8), 1355;
Available online:

“NRF2 and Mitochondrial Function in Cancer and Cancer Stem Cells”
by Emiliano Panieri, Sónia A. Pinho, Gonçalo J. M. Afonso, Paulo J. Oliveira, Teresa Cunha-Oliveira, and Luciano Saso
Cells 202211(15), 2401;
Available online:

“Shaping of Hepatic Ischemia/Reperfusion Events: The Crucial Role of Mitochondria”
by João S. Teodoro, Rui T. Da Silva, Ivo F. Machado, Arnau Panisello-Roselló, Joan Roselló-Catafau, Anabela P. Rolo and Carlos M. Palmeira
Cells 202211(4), 688;
Available online:

“Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis”
by Sandra Torres, Paula Segalés, Carmen García-Ruiz and José C. Fernández-Checa
Cells 202211(9), 1475;
Available online:

“RIP3 Translocation into Mitochondria Promotes Mitofilin Degradation to Increase Inflammation and Kidney Injury after Renal Ischemia–Reperfusion”
by Yansheng Feng, Abdulhafiz Imam Aliagan, Nathalie Tombo, Derrick Draeger and Jean C. Bopassa
Cells 202211(12), 1894;
Available online:

“Biochemical Mechanisms of Sirtuin-Directed Protein Acylation in Hepatic Pathologies of Mitochondrial Dysfunction”
by Courtney D. McGinnis, Erin Q. Jennings, Peter S. Harris, James J. Galligan and Kristofer S. Fritz
Cells 202211(13), 2045;
Available online:

“Is Type 2 Diabetes a Primary Mitochondrial Disorder?”
by Sarah Weksler-Zangen
Cells 202211(10), 1617;
Available online:

“Organismal and Cellular Stress Responses upon Disruption of Mitochondrial Lonp1 Protease”
by Eirini Taouktsi, Eleni Kyriakou, Stefanos Smyrniotis, Fivos Borbolis, Labrina Bondi, Socratis Avgeris, Efstathios Trigazis, Stamatis Rigas, Gerassimos E. Voutsinas and Popi Syntichaki
Cells 202211(8), 1363;
Available online:

“Regulation of Oxidative Phosphorylation of Liver Mitochondria in Sepsis”
by Pierre Eyenga, Benjamin Rey, Lilia Eyenga and Shey-Shing Sheu
Cells 202211(10), 1598;
Available online:

22 December 2023
Cells | Top Cited Papers in 2022 in the Section “Intracellular and Plasma Membranes”

“Structure and Function of the ABCD1 Variant Database: 20 Years, 940 Pathogenic Variants, and 3400 Cases of Adrenoleukodystrophy”
by Eric J. Mallack, Kerry Gao, Marc Engelen and Stephan Kemp
Cells 2022, 11(2), 283;
Available online:

“High-Mobility Group Box 1: Biological Functions and Relevance in Oxidative Stress-Related Chronic Diseases”
by Simona Taverna, Alessandro Tonacci, Maria Ferraro, Giuseppe Cammarata, Giuseppina Cuttitta, Salvatore Bucchieri, Elisabetta Pace and Sebastiano Gangemi
Cells 2022, 11(5), 849;
Available online:

“Endomembrane-Based Signaling by GPCRs and G-Proteins”
by Federica Liccardo, Alberto Luini and Rosaria Di Martino
Cells 2022, 11(3), 528;
Available online:

“Mitoferrin, Cellular and Mitochondrial Iron Homeostasis”
by Md Yousuf Ali, Claudia R. Oliva, Susanne Flor and Corinne E. Griguer
Cells 2022, 11(21), 3464;
Available online:

“T Lymphocyte and CAR-T Cell-Derived Extracellular Vesicles and Their Applications in Cancer Therapy”
by Victor Calvo and Manuel Izquierdo
Cells 2022, 11(5), 790;
Available online:

“Functional Coordination among the Golgi Complex, the Centrosome and the Microtubule Cytoskeleton during the Cell Cycle”
by FabiolaMascanzoni, Roberta Iannitti and Antonino Colanzi
Cells 2022, 11(3), 354;
Available online:

“Cell-Type Selective Loss of Peroxisomal and Beta-Oxidation Impairs Bipolar Cell but Not Photoreceptor Survival in the Retina”
by Daniëlle Swinkels, Yannick Das, Sai Kocherlakota, Stefan Vinckier, Eric Wever, Antoine H. C. van Kampen, Frédéric M. Vaz and Myriam Baes
Cells 2022, 11(1), 161;
Available online:

“The Role of Matrix-Bound Extracellular Vesicles in the Regulation of Endochondral Bone Formation”
by Barbara D. Boyan, Niels C. Asmussen, Zhao Lin and Zvi Schwartz
Cells 2022, 11(10), 1619;
Available online:

“Golgi Metal Ion Homeostasis in Human Health and Diseases”
by Jie Li and Yanzhuang Wang
Cells 2022, 11(2), 289;
Available online:

“The Role of Non-Coding RNAs in the Human Placenta”
by Milena Žarković, Franziska Hufsky, Udo R. Markert and Manja Marz
Cells 2022, 11(9), 1588;
Available online:

“Endocrine Fibroblast Growth Factors in Relation to Stress Signaling”
by Makoto Shimizu and Ryuichiro Sato
Cells 2022, 11(3), 505;
Available online:

“Current Methods to Unravel the Functional Properties of Lysosomal Ion Channels and Transporters”
by Margherita Festa, Velia Minicozzi, Anna Boccaccio, Laura Lagostena, Antonella Gradogna, Tianwen Qi, Alex Costa, Nina Larisch, Shin Hamamoto, Emanuela Pedrazzini et al.
Cells 2022, 11(6), 921;
Available online:

“Exosome-Mediated Therapeutic Strategies for Management of Solid and Hematological Malignancies”
by Alessandro Allegra, Claudia Petrarca, Mario Di Gioacchino, Marco Casciaro, Caterina Musolino and Sebastiano Gangemi
Cells 2022, 11(7), 1128;
Available online:

“Exosome-Associated circRNAs as Key Regulators of EMT in Cancer”
by Laura Amicone, Alessandra Marchetti and Carla Cicchini
Cells 2022, 11(10), 1716;
Available online:

“Golgi Apparatus Regulates Plasma Membrane Composition and Function”
by Ilenia Agliarulo and Seetharaman Parashuraman
Cells 2022, 11(3), 368;
Available online:

“Mechanisms of Regulation in Intraflagellar Transport”
by Wouter Mul, Aniruddha Mitra and Erwin J. G. Peterman
Cells 2022, 11(17), 2737;
Available online:

“The Emerging Role of Pericyte-Derived Extracellular Vesicles in Vascular and Neurological Health”
by Kushal Sharma, Yunpei Zhang, Keshav Raj Paudel, Allan Kachelmeier, Philip M. Hansbro and Xiaorui Shi
Cells 2022, 11(19), 3108;
Available online:

“TFEB Regulates ATP7B Expression to Promote Platinum Chemoresistance in Human Ovarian Cancer Cells”
by Raffaella Petruzzelli, Marta Mariniello, Rossella De Cegli, Federico Catalano, Floriana Guida, Elia Di Schiavi and Roman S. Polishchuk
Cells 2022, 11(2), 219;
Available online:

“Essential Roles of Efferent Duct Multicilia in Male Fertility”
by Mohammed Hoque, Eunice N. Kim, Danny Chen, Feng-Qian Li and Ken-Ichi Takemaru
Cells 2022, 11(3), 341;
Available online:

22 December 2023
Cells | Top Cited Papers in 2022 in the Section “Cellular Biophysics”

“Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan–Kynurenine Metabolic System”
by Masaru Tanaka, Ágnes Szabó, Eleonóra Spekker, Helga Polyák, Fanni Tóth and László Vécsei
Cells 2022, 11(16), 2607;
Available online:

“Label-Free Digital Holographic Microscopy for In Vitro Cytotoxic Effect Quantification of Organic Nanoparticles”
by Kai Moritz Eder, Anne Marzi, Álvaro Barroso, Steffi Ketelhut, Björn Kemper and Jürgen Schnekenburger
Cells 2022, 11(4), 644;
Available online:

“Boron Vehiculating Nanosystems for Neutron Capture Therapy in Cancer Treatment”
by Giorgia Ailuno, Alice Balboni, Gabriele Caviglioli, Francesco Lai, Federica Barbieri, Irene Dellacasagrande, Tullio Florio and Sara Baldassari
Cells 2022, 11(24), 4029;
Available online:

“Cryopreservation by Directional Freezing and Vitrification Focusing on Large Tissues and Organs”
by Amir Arav
Cells 2022, 11(7), 1072;
Available online:

“Digital Holographic Microscopy for Label-Free Detection of Leukocyte Alternations Associated with Perioperative Inflammation after Cardiac Surgery”
by David Rene Steike, Michael Hessler, Eberhard Korsching, Florian Lehmann, Christina Schmidt, Christian Ertmer, Jürgen Schnekenburger, Hans Theodor Eich, Björn Kemper and Burkhard Greve
Cells 2022, 11(4), 755;
Available online:

“The Role of KH-Type Splicing Regulatory Protein (KSRP) for Immune Functions and Tumorigenesis”
by Kim-Alicia Palzer, Vanessa Bolduan, Rudolf Käfer, Hartmut Kleinert, Matthias Bros and Andrea Pautz
Cells 2022, 11(9), 1482;
Available online:

“A Human In Vitro Model to Study Adenoviral Receptors and Virus Cell Interactions”
by Raphael L. Tsoukas, Wolfram Volkwein, Jian Gao, Maren Schiwon, Nora Bahlmann, Thomas Dittmar, Claudia Hagedorn, Eric Ehrke-Schulz, Wenli Zhang, Armin Baiker et al.
Cells 2022, 11(5), 841;
Available online:

“Monitoring SARS-CoV-2 Surrogate TGEV Individual Virions Structure Survival under Harsh Physicochemical Environments”
by Miguel Cantero, Diego Carlero, Francisco Javier Chichón, Jaime Martín-Benito and Pedro José De Pablo
Cells 2022, 11(11), 1759;
Available online:

“Enhanced Delivery of Rose Bengal by Amino Acids Starvation and Exosomes Inhibition in Human Astrocytoma Cells to Potentiate Anticancer Photodynamic Therapy Effects”
by Bianca Slivinschi, Federico Manai, Carolina Martinelli, Francesca Carriero, Camilla D’Amato, Martina Massarotti, Giorgia Bresciani, Claudio Casali, Gloria Milanesi, Laura Artal et al.
Cells 2022, 11(16), 2502;
Available online:

“The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer’s Disease”
by Micha M. M. Wilhelmus, Elisa Tonoli, Clare Coveney, David J. Boocock, Cornelis A. M. Jongenelen, John J. P. Brevé, Elisabetta A. M. Verderio and Benjamin Drukarch
Cells 2022, 11(3), 389;
Available online:

22 December 2023
Cells | Top Cited Papers in 2022 in the Section “Cell Methods”

“STAT3 Is the Master Regulator for the Forming of 3D Spheroids of 3T3-L1 Preadipocytes”
by Hiroshi Ohguro, Yosuke Ida, Fumihito Hikage, Araya Umetsu, Hanae Ichioka, Megumi Watanabe and Masato Furuhashi
Cells 2022, 11(2), 300;
Available online:

“Scaffold-Mediated Immunoengineering as Innovative Strategy for Tendon Regeneration”
by Valentina Russo, Mohammad El Khatib, Giuseppe Prencipe, Adrián Cerveró-Varona, Maria Rita Citeroni, Annunziata Mauro, Paolo Berardinelli, Melisa Faydaver, Arlette A. Haidar-Montes, Maura Turriani et al.
Cells 2022, 11(2), 266;
Available online:

“Spatial Proteomic Analysis of Isogenic Metastatic Colorectal Cancer Cells Reveals Key Dysregulated Proteins Associated with Lymph Node, Liver, and Lung Metastasis”
by Guillermo Solís-Fernández, Ana Montero-Calle, Javier Martínez-Useros, Álvaro López-Janeiro, Vivian de los Ríos, Rodrigo Sanz, Jana Dziakova, Elena Milagrosa, María Jesús Fernández-Aceñero, Alberto Peláez-García et al.
Cells 2022, 11(3), 447;
Available online:

“Electrospun Membrane Surface Modification by Sonocoating with HA and ZnO:Ag Nanoparticles—Characterization and Evaluation of Osteoblasts and Bacterial Cell Behavior In Vitro”
by Julia Higuchi, Katarzyna Klimek, Jacek Wojnarowicz, Agnieszka Opalińska, Agnieszka Chodara, Urszula Szałaj, Sylwia Dąbrowska, Damian Fudala and Grazyna Ginalska
Cells 2022, 11(9), 1582;
Available online:

“Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications”
by Rita Azevedo, Chloé Jacquemin, Nicolas Villain, François Fenaille, Foudil Lamari and François Becher
Cells 2022, 11(8), 1279;
Available online:

“MALDI Mass Spectrometry Imaging: A Potential Game-Changer in a Modern Microbiology”
by Maureen Feucherolles and Gilles Frache
Cells 2022, 11(23), 3900;
Available online:

“An Optimized Workflow for the Analysis of Metabolic Fluxes in Cancer Spheroids Using Seahorse Technology”
by Gloria Campioni, Valentina Pasquale, Stefano Busti, Giacomo Ducci, Elena Sacco and Marco Vanoni
Cells 2022, 11(5), 866;
Available online:

“Multi-Omics Approach Reveals Dysregulation of Protein Phosphorylation Correlated with Lipid Metabolism in Mouse Non-Alcoholic Fatty Liver”
by Sora Q. Kim, Rodrigo Mohallem, Jackeline Franco, Kimberly K. Buhman, Kee-Hong Kim and Uma K. Aryal
Cells 2022, 11(7), 1172;
Available online:

“Human Enzyme PADI4 Binds to the Nuclear Carrier Importin α3”
by José L. Neira, Bruno Rizzuti, Olga Abián, Salomé Araujo-Abad, Adrián Velázquez-Campoy and Camino de Juan Romero
Cells 2022, 11(14), 2166;
Available online:

“Influence of ROCK Pathway Manipulation on the Actin Cytoskeleton Height”
by Carolin Grandy, Fabian Port, Jonas Pfeil and Kay-Eberhard Gottschalk
Cells 2022, 11(3), 430;
Available online: 

“Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease”
by Paula Germino-Watnick, Malikiya Hinds, Anh Le, Rebecca Chu, Xiong Liu and Naoya Uchida
Cells 2022, 11(11), 1843;
Available online:

“Corneal Regeneration Using Adipose-Derived Mesenchymal Stem Cells”
by Jorge L. Alió del Barrio, Ana De la Mata, María P. De Miguel, Francisco Arnalich-Montiel, Teresa Nieto-Miguel, Mona El Zarif, Marta Cadenas-Martín, Marina López-Paniagua, Sara Galindo, Margarita Calonge et al.
Cells 2022, 11(16), 2549;
Available online:

22 December 2023
Cells | Top Cited Papers in 2022 in the Section “Cell and Gene Therapy”

“Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements
by Salima Akter, Md. Ataur Rahman, Mohammad Nazmul Hasan, Hajara Akhter, Priya Noor, Rokibul Islam, Yoonhwa Shin, MD. Hasanur Rahman, Md. Shamim Gazi, Md Nazmul Huda et al.
Cells 2022, 11(4), 650;
Available online:

“Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI)
by Clémence David and Marie-Louise Frémond
Cells 2022, 11(3), 318;
Available online:

“Pathological Role of HDAC8: Cancer and Beyond
by Ji Yoon Kim, Hayoung Cho, Jung Yoo, Go Woon Kim, Yu Hyun Jeon, Sang Wu Lee and So Hee Kwon
Cells 2022, 11(19), 3161;
Available online:

“Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering
by Xiaoqiang Huang, Dongshan Yang, Jifeng Zhang, Jie Xu and Y. Eugene Chen
Cells 2022, 11(14), 2186;
Available online:

“Role of MicroRNAs and Long Non-Coding RNAs in Sarcopenia
by Jihui Lee and Hara Kang
Cells 2022, 11(2), 187;
Available online:

“Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process
by Marine Melixetian, Pier Giuseppe Pelicci and Luisa Lanfrancone
Cells 2022, 11(3), 577;
Available online:

“MicroRNA Roles in Cell Reprogramming Mechanisms
by Emilia Pascale, Carmen Caiazza, Martina Paladino, Silvia Parisi, Fabiana Passaro and Massimiliano Caiazzo
Cells 2022, 11(6), 940;
Available online:

“Histone Mono-Ubiquitination in Transcriptional Regulation and Its Mark on Life: Emerging Roles in Tissue Development and Disease
by Liat Oss-Ronen, Tzlil Sarusi and Idan Cohen
Cells 2022, 11(15), 2404;
Available online:

“An Altered Skin and Gut Microbiota Are Involved in the Modulation of Itch in Atopic Dermatitis
by Catharina Sagita Moniaga, Mitsutoshi Tominaga and Kenji Takamori
Cells 2022, 11(23), 3930;
Available online:

“The Role of MeCP2 in Regulating Synaptic Plasticity in the Context of Stress and Depression
by Carla L. Sánchez-Lafuente, Lisa E. Kalynchuk, Hector J. Caruncho and Juan Ausió
Cells 2022, 11(4), 748;
Available online:

“DEAD/H-Box Helicases in Immunity, Inflammation, Cell Differentiation, and Cell Death and Disease
by Parimal Samir and Thirumala-Devi Kanneganti
Cells 2022, 11(10), 1608;
Available online:

22 December 2023
Cells | Top Cited Papers in 2022 in the Section “Cell Proliferation and Division”

“Estimating Biomass and Vitality of Microalgae for Monitoring Cultures: A Roadmap for Reliable Measurements”
by Michael Schagerl, Rainer Siedler, Eliška Konopáčová and Sameh Samir Ali
Cells 2022, 11(15), 2455;
Available online:

“Advances in the Current Understanding of How Low-Dose Radiation Affects the Cell Cycle”
by Md Gulam Musawwir Khan and Yi Wang
Cells 2022, 11(3), 356;
Available online:

“The Effect of Variable Light Source and Light Intensity on the Growth of Three Algal Species”
by Vitali Bialevich, Vilém Zachleder and Kateřina Bišová
Cells 2022, 11(8), 1293;
Available online:

“A Journey through Time on the Discovery of Cell Cycle Regulation”
by Rustem Uzbekov and Claude Prigent
Cells 2022, 11(4), 704;
Available online:

“Enhanced Photodynamic Therapy: A Review of Combined Energy Sources”
by José A. Rodrigues and José H. Correia
Cells 2022, 11(24), 3995;
Available online:

“NGLY1 Deficiency, a Congenital Disorder of Deglycosylation: From Disease Gene Function to Pathophysiology”
by Ashutosh Pandey, Joshua M. Adams, Seung Yeop Han and Hamed Jafar-Nejad
Cells 2022, 11(7), 1155;
Available online:

“Cyclin-Dependent Kinases and CTD Phosphatases in Cell Cycle Transcriptional Control: Conservation across Eukaryotic Kingdoms and Uniqueness to Plants”
by Zhi-Liang Zheng
Cells 2022, 11(2), 279;
Available online:

“Modulation of Cell-Cycle Progression by Hydrogen Peroxide-Mediated Cross-Linking and Degradation of Cell-Adhesive Hydrogels”
by Wildan Mubarok, Kelum Chamara Manoj Lakmal Elvitigala, Masaki Nakahata, Masaru Kojima and Shinji Sakai
Cells 2022, 11(5), 881;
Available online:

“Cell Cycle Regulation by Heat Shock Transcription Factors”
by Yasuko Tokunaga, Ken-Ichiro Otsuyama and Naoki Hayashida
Cells 2022, 11(2), 203;
Available online:

“An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs”
by Debora Bencivenga, Emanuela Stampone, Angela Vastante, Myassar Barahmeh, Fulvio Della Ragione and Adriana Borriello
Cells 2022, 11(8), 1346;
Available online:

21 December 2023
Cells | Top Cited Papers in 2022 in the Section “Cellular Aging”

“Interconnections between Inflammageing and Immunosenescence during Ageing”
by Thibault Teissier, Eric Boulanger and Lynne S. Cox
Cells 2022, 11(3), 359;
Available online:

“Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions”
by Ashley Brauning, Michael Rae, Gina Zhu, Elena Fulton, Tesfahun Dessale Admasu, Alexandra Stolzing and Amit Sharma
Cells 2022, 11(6), 1017;
Available online:

GBA Variants and Parkinson Disease: Mechanisms and Treatments”
by Laura Smith and Anthony H. V. Schapira
Cells 2022, 11(8), 1261;
Available online:

“Epigenetic Regulation of Cellular Senescence”
by Jack Crouch, Maria Shvedova, Rex Jeya Rajkumar Samdavid Thanapaul, Vladimir Botchkarev and Daniel Roh
Cells 2022, 11(4), 672;
Available online:

“RhoA Signaling in Neurodegenerative Diseases”
by Sissel Ida Schmidt, Morten Blaabjerg, Kristine Freude and Morten Meyer
Cells 2022, 11(9), 1520;
Available online:

“Overview of Polyamines as Nutrients for Human Healthy Long Life and Effect of Increased Polyamine Intake on DNA Methylation”
by Kuniyasu Soda
Cells 2022, 11(1), 164;
Available online:

“Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview”
by Angelica Varesi, Adelaide Carrara, Vitor Gomes Pires, Valentina Floris, Elisa Pierella, Gabriele Savioli, Sakshi Prasad, Ciro Esposito, Giovanni Ricevuti, Salvatore Chirumbolo et al.
Cells 2022, 11(8), 1367;
Available online:

“The Senescence Markers p16INK4A, p14ARF/p19ARF and p21 in Organ Development and Homeostasis”
by Kay-Dietrich Wagner and Nicole Wagner
Cells 2022, 11(12), 1966;
Available online:

“Effects of Air Pollution on Cellular Senescence and Skin Aging”
by Ines Martic, Pidder Jansen-Dürr and Maria Cavinato
Cells 2022, 11(14), 2220;
Available online:

“Yeast Chronological Lifespan: Longevity Regulatory Genes and Mechanisms”
by Mario G. Mirisola and Valter D. Longo
Cells 2022, 11(10), 1714;
Available online:

“NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson’s Disease”
by William M. Curtis, William A. Seeds, Mark P. Mattson and Patrick C. Bradshaw
Cells 2022, 11(15), 2416;
Available online:

IGF2: Development, Genetic and Epigenetic Abnormalities”
by Céline Sélénou, Frédéric Brioude, Eloïse Giabicani, Marie-Laure Sobrier and Irène Netchine
Cells 2022, 11(12), 1886;
Available online:

“Skin-Aging Pigmentation: Who Is the Real Enemy?”
by Jin Cheol Kim, Tae Jun Park and Hee Young Kang
Cells 2022, 11(16), 2541;
Available online:

“Maintenance of Chronological Aging Features in Culture of Normal Human Dermal Fibroblasts from Old Donors”
by Julie Rorteau, Fabien P. Chevalier, Sébastien Bonnet, Théo Barthélemy, Amandine Lopez-Gaydon, Lisa S. Martin, Nicolas Bechetoille and Jérôme Lamartine
Cells 2022, 11(5), 858;
Available online:

“Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy”
by Berkiye Sonustun, Melek Firat Altay, Catherine Strand, Kirsten Ebanks, Geshanthi Hondhamuni, Thomas T. Warner, Hilal A. Lashuel and Rina Bandopadhyay
Cells 2022, 11(5), 906;
Available online:

“Central Auditory Functions of Alzheimer’s Disease and Its Preclinical Stages: A Systematic Review and Meta-Analysis”
by Hadeel Y. Tarawneh, Holly K. Menegola, Andrew Peou, Hanadi Tarawneh and Dona M. P. Jayakody
Cells 2022, 11(6), 1007;
Available online:

“Cellular Senescence in Aging Lungs and Diseases”
by Arbi Aghali, Maunick Lefin Koloko Ngassie, Christina M. Pabelick and Y. S. Prakash
Cells 2022, 11(11), 1781;
Available online:

“GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight”
by Giulia Monti, Diana Gomes Moreira, Mette Richner, Henricus Antonius Maria Mutsaers, Nelson Ferreira and Asad Jan
Cells 2022, 11(13), 2023;
Available online:

“Epigenetic Mechanisms of Senescence in Plants”
by Matin Miryeganeh
Cells 2022, 11(2), 251;
Available online:

“Metabolic Alterations in a Drosophila Model of Parkinson’s Disease Based on DJ-1 Deficiency”
by Cristina Solana-Manrique, Francisco José Sanz, Isabel Torregrosa, Martina Palomino-Schätzlein, Carolina Hernández-Oliver, Antonio Pineda-Lucena and Nuria Paricio
Cells 2022, 11(3), 331;
Available online:

21 December 2023
Cells | Top Cited Papers in 2022

“Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs”

by Aleksandra Twarda-Clapa, Aleksandra Twarda-Clapa, Aneta M. Białkowska and Maria Koziołkiewicz

Cells 2022, 11(8), 1312;

Available online:

“Multifactorial Mechanism of Sarcopenia and Sarcopenic Obesity. Role of Physical Exercise, Microbiota and Myokines”

by Jan Bilski, Piotr Pierzchalski, Marian Szczepanik, Joanna Bonior and Jerzy A. Zoladz

Cells 2022, 11(1), 160;

Available online:

“Innate Immune Cell Death in Neuroinflammation and Alzheimer’s Disease”

by Yetirajam Rajesh and Thirumala-Devi Kanneganti

Cells 2022, 11(12), 1885;

Available online:

Protective Effects of Curcumin in Cardiovascular Diseases—Impact on Oxidative Stress and Mitochondria

by Fiona Frederike Cox, Angelina Misiou, Annika Vierkant, Niloofar Ale-Agha, Maria Grandoch, Judith Haendeler and Joachim Altschmied

Cells 2022, 11(3), 342;

Available online:

Causes of and Molecular Targets for the Treatment of Intervertebral Disc Degeneration: A Review

by Takashi Ohnishi, Norimasa Iwasaki and Hideki Sudo

Cells 2022, 11(3), 394;

Available online:

Into the Tissues: Extracellular Matrix and Its Artificial Substitutes: Cell Signalling Mechanisms

by Aleksandra Bandzerewicz and Agnieszka Gadomska-Gajadhur

Cells 2022, 11(5), 914;

Available online:

The Role of the Immune System in the Development of Endometriosis

by Monika Abramiuk, Ewelina Grywalska, Paulina Małkowska, Olga Sierawska, Rafał Hrynkiewicz and Niedźwiedzka-Rystwej

Cells 2022, 11(13), 2028;

Available online:

Stem Cells and Angiogenesis: Implications and Limitations in Enhancing Chronic Diabetic Foot Ulcer Healing

by Vikrant Rai, Rebecca Moellmer and Devendra K. Agrawal

Cells 2022, 11(15), 2287;

Available online:

Cardiovascular Inflammaging: Mechanisms and Translational Aspects

by Maria Luisa Barcena, Muhammad Aslam, Sofya Pozdniakova, Kristina Norman and Yury Ladilov

Cells 2022, 11(6), 1010;

Available online:

One-Carbon Metabolism: Pulling the Strings behind Aging and Neurodegeneration

by Eirini Lionaki, Christina Ploumi and Nektarios Tavernarakis

Cells 2022, 11(2), 214;

Available online:

Tendon Immune Regeneration: Insights on the Synergetic Role of Stem and Immune Cells during Tendon Regeneration

by Valentina Russo, Mohammad El Khatib, Giuseppe Prencipe, Maria Rita Citeroni, Melisa Faydaver, Annunziata Mauro, Paolo Berardinelli, Adrián Cerveró-Varona, Arlette A. Haidar-Montes, Maura Turriani et al.

Cells 2022, 11(3), 434;

Available online:

Necroptosis and Prostate Cancer: Molecular Mechanisms and Therapeutic Potential

by Giovanni Luca Beretta and Nadia Zaffaroni

Cells 2022, 11(7), 1221;

Available online:

Extracellular Release of Mitochondrial DNA: Triggered by Cigarette Smoke and Detected in COPD

by Luca Giordano, Alyssa D. Gregory, Mireia Pérez Verdaguer, Sarah A. Ware, Hayley Harvey, Evan DeVallance, Tomasz Brzoska, Prithu Sundd, Yingze Zhang, Frank C. Sciurba et al.

Cells 2022, 11(3), 369;

Available online:

“Glucose Regulates m6A Methylation of RNA in Pancreatic Islets”

by Florine Bornaque, Clément Philippe Delannoy, Emilie Courty, Nabil Rabhi, Charlène Carney, Laure Rolland, Maeva Moreno, Xavier Gromada, Cyril Bourouh, Pauline Petit et al.

Cells 2022, 11(2), 291;

Available online:

“High-Fat Diet-Induced Dysregulation of Immune Cells Correlates with Macrophage Phenotypes and Chronic Inflammation in Adipose Tissue”

by Sonia Kiran, Ahmed Rakib, Sunitha Kodidela, Santosh Kumar and Udai P. Singh

Cells 2022, 11(8), 1327;

Available online:

“Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications”

by Marco Heestermans, Géraldine Poenou, Hind Hamzeh-Cognasse, Fabrice Cognasse and Laurent Bertoletti

Cells 2022, 11(20), 3214;

Available online:

“Probiotics in the Prevention of the Calcium Oxalate Urolithiasis”

by Paulina Wigner, Michał Bijak and Joanna Saluk-Bijak

Cells 2022, 11(2), 284;

Available online:

“The Future of the COVID-19 Pandemic: How Good (or Bad) Can the SARS-CoV2 Spike Protein Get?”

by Matthew A. Nugent

Cells 2022, 11(5), 855;

Available online:

“Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis”

by Rakhee Bajaj, Amanda N. Warner, Jared F. Fradette and Don L. Gibbons

Cells 2022, 11(9), 1484;

Available online:

Endothelial Progenitor Cells as Biomarkers of Cardiovascular Pathologies: A Narrative Review”

by Paul Philipp Heinisch, Corina Bello, Maximilian Y. Emmert, Thierry Carrel, Martina Dreßen, Jürgen Hörer, Bernhard Winkler and Markus M. Luedi

Cells 2022, 11(10), 1678;

Available online:

“Transient Exposure of Endothelial Cells to Doxorubicin Leads to Long-Lasting Vascular Endothelial Growth Factor Receptor 2 Downregulation”

by Silvia Graziani, Luca Scorrano and Giovanna Pontarin

Cells 2022, 11(2), 210;

Available online:

Mesenchymal Stromal/Stem Cells and Their Products as a Therapeutic Tool to Advance Lung Transplantation”

by Vitale Miceli and Alessandro Bertani

Cells 2022, 11(5), 826;

Available online:

Pyroptosis and Its Role in SARS-CoV-2 Infection”

by Zsofia Agnes Bittner, Markus Schrader, Shilpa Elizabeth George and Ralf Amann

Cells 2022, 11(10), 1717;

Available online:

The H+ Transporter SLC4A11: Roles in Metabolism, Oxidative Stress and Mitochondrial Uncoupling”

by Joseph A. Bonanno, Raji Shyam, Moonjung Choi and Diego G. Ogando

Cells 2022, 11(2), 197;

Available online:

“Molecular Mechanisms of Exercise and Healthspan”

by Yuntian Guan and Zhen Yan

Cells 2022, 11(5), 872;

Available online:

“Modulating the Ubiquitin–Proteasome System: A Therapeutic Strategy for Autoimmune Diseases”

by Dhananjay Yadav, Ji Yeon Lee, Nidhi Puranik, Pallavi S. Chauhan, Vishal Chavda, Jun-O. Jin and Peter C. W. Lee

Cells 2022, 11(7), 1093;

Available online:

Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma”

by Ahmad Najem, Laura Soumoy, Malak Sabbah, Mohammad Krayem, Ahmad Awada, Fabrice Journe and Ghanem E. Ghanem

Cells 2022, 11(7), 1157;

Available online:

Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway”

by Yang Li, Shuting Yang and Shuying Yang

Cells 2022, 11(8), 1361;

Available online:

Role of Intestinal Dysbiosis and Nutrition in Rheumatoid Arthritis”

by Malavikalakshmi Attur, Jose U Scher, Steven B. Abramson and Mukundan Attur

Cells 2022, 11(15), 2436;

Available online:

Apple Derived Exosomes Improve Collagen Type I Production and Decrease MMPs during Aging of the Skin through Downregulation of the NF-κB Pathway as Mode of Action”

by Martina Trentini, Ilaria Zanolla, Federica Zanotti, Elena Tiengo, Danilo Licastro, Simeone Dal Monego, Luca Lovatti and Barbara Zavan

Cells 2022, 11(24), 3950;

Available online:

“Regulation of Mitochondrial Hydrogen Peroxide Availability by Protein S-glutathionylation”

by Ryan J. Mailloux, Cathryn Grayson and Olivia Koufos

Cells 2023, 12(1), 107;

Available online:

“Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma”

by Philipp Licht and Volker Mailander

Cells 2022, 11(3), 328;

Available online:

Cytochrome c Oxidase Inhibition by ATP Decreases Mitochondrial ROS Production”

by Rabia Ramzan, Amalia M. Dolga, Susanne Michels, Petra Weber, Carsten Culmsee, Ardawan J. Rastan and Sebastian Vogt

Cells 2022, 11(6), 992;

Available online:

The Protective Action of Metformin against Pro-Inflammatory Cytokine-Induced Human Islet Cell Damage and the Mechanisms Involved”

by Laura Giusti, Marta Tesi, Federica Ciregia, Lorella Marselli, Lorenzo Zallocco, Mara Suleiman, Carmela De Luca, Silvia Del Guerra, Mariachiara Zuccarini, Marco Trerotola et al.

Cells 2022, 11(15), 2465;

Available online:

“Neurodegenerative Disease-Associated TDP-43 Fragments Are Extracellularly Secreted with CASA Complex Proteins”

Elena Casarotto, Daisy Sproviero, Eleonora Corridori, Maria Cristina Gagliani, Marta Cozzi, Marta Chierichetti, Riccardo Cristofani, Veronica Ferrari, Mariarita Galbiati, Francesco Mina et al.

Cells 2022, 11(3), 516;

Available online:

The Cell Membrane of a Novel Rhizobium phaseoli Strain Is the Crucial Target for Aluminium Toxicity and Tolerance”

by Clabe Wekesa, John O. Muoma, Michael Reichelt, George O. Asudi, Alexandra C. U. Furch and Ralf Oelmüller

Cells 2022, 11(5), 873;

Available online:

Senescence-Associated Cell Transition and Interaction (SACTAI): A Proposed Mechanism for Tissue Aging, Repair, and Degeneration”

by Yajun Liu, Jonah Schwam and Qian Chen

Cells 2022, 11(7), 1089;

Available online:

Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Neonatal Lung Disease: Tiny Particles, Major Promise, Rigorous Requirements for Clinical Translation”

by Flore Lesage and Bernard Thébaud

Cells 2022, 11(7), 1176;

Available online:

The Cytoskeleton Effectors Rho-Kinase (ROCK) and Mammalian Diaphanous-Related (mDia) Formin Have Dynamic Roles in Tumor Microtube Formation in Invasive Glioblastoma Cells”

by Kathryn N. Becker, Krista M. Pettee, Amanda Sugrue, Kevin A. Reinard, Jason L. Schroeder and Kathryn M. Eisenmann

Cells 2022, 11(9), 1559;

Available online:

“Reactive Oxygen Species in Regulating Lymphangiogenesis and Lymphatic Function”

by Bhupesh Singla, Ravi Varma Aithabathula, Sonia Kiran, Shweta Kapil, Santosh Kumar and Udai P. Singh

Cells 2022, 11(11), 1750;

Available online:

“Mitochondrial Damage-Associated Molecular Patterns Content in Extracellular Vesicles Promotes Early Inflammation in Neurodegenerative Disorders”

by Cláudia M. Deus, Henrique Tavares, Margarida Beatriz, Sandra Mota and Carla Lopes

Cells 2022, 11(15), 2364;

Available online:

Akkermansia muciniphila Reduces Peritonitis and Improves Intestinal Tissue Wound Healing after a Colonic Transmural Defect by a MyD88-Dependent Mechanism”

by Radu Bachmann, Matthias Van Hul, Pamela Baldin, Daniel Léonard, Nathalie M. Delzenne, Clara Belzer, Janneke P. Ouwerkerk, Dirk Repsilber, Ignacio Rangel and Alex Kartheuser

Cells 2022, 11(17), 2666;

Available online:

STAT3 and Its Pathways’ Dysregulation—Underestimated Role in Urological Tumors“

by Maciej Golus, Piotr Bugajski, Joanna Chorbińska, Wojciech Krajewski, Artur Lemiński, Jolanta Saczko, Julita Kulbacka, Tomasz Szydełko and Bartosz Małkiewicz

Cells 2022, 11(19), 3024;

Available online:

Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Promote Corneal Wound Repair by Regulating Inflammation and Angiogenesis”

by Gabriele Saccu, Valeria Menchise, Chiara Gai, Marina Bertolin, Stefano Ferrari, Cristina Giordano, Marta Manco, Walter Dastrù, Emanuela Tolosano and Benedetta Bussolati

Cells 2022, 11(23), 3892;

Available online:

Enhancing In Vitro Production of the Tree Fern Cyathea delgadii and Modifying Secondary Metabolite Profiles by LED Lighting”

by Wojciech Tomaszewicz, Monika Cioć, Katarzyna Dos Santos Szewczyk, Małgorzata Grzyb, Wioleta Pietrzak, Bożena Pawłowska and Anna Mikuła

Cells 2022, 11(3), 486;

Available online:

C53 Interacting with UFM1-Protein Ligase 1 Regulates Microtubule Nucleation in Response to ER Stress”

by Anastasiya Klebanovych, Stanislav Vinopal, Eduarda Dráberová, Vladimíra Sládková, Tetyana Sulimenko, Vadym Sulimenko, Věra Vosecká, Libor Macůrek, Agustin Legido and Pavel Dráber

Cells 2022, 11(3), 555;

Available online:

“Targeting Protein O-GlcNAcylation, a Link between Type 2 Diabetes Mellitus and Inflammatory Disease”

by Israel Olapeju Bolanle and Timothy M. Palmer

Cells 2022, 11(4), 705;

Available online:

How Cargo Identity Alters the Uptake of Cell-Penetrating Peptide (CPP)/Cargo Complexes: A Study on the Effect of Net Cargo Charge and Length”

By Hannah C. Hymel, Alireza Rahnama, Olivia M. Sanchez, Dong Liu, Ted J. Gauthier and Adam T. Melvin

Cells 2022, 11(7), 1195;

Available online:

Human Platelet-Rich Plasma Facilitates Angiogenesis to Restore Impaired Uterine Environments with Asherman’s Syndrome for Embryo Implantation and Following Pregnancy in Mice”

by Min Kyoung Kim, Jung Ah Yoon, Sook Young Yoon, Mira Park, Woo Sik Lee, Sang Woo Lyu and Haengseok Song

Cells 2022, 11(9), 1549;

Available online:

“Targeting Acid Ceramidase Inhibits Glioblastoma Cell Migration through Decreased AKT Signaling”

by Cyntanna C. Hawkins, Amber B. Jones, Emily R. Gordon, Sarah E. Williford, Yuvika Harsh, Julia K. Ziebro, Catherine J. Landis, Sajina Gc, David K. Crossman and Sara J. Cooper

Cells 2022, 11(12), 1873;

Available online:

21 December 2023
Cells | Top Cited Papers in 2022 in Section “Cell Nuclei: Function, Transport and Receptors”

“Progesterone Actions and Resistance in Gynecological Disorders”
by James A. MacLean II and Kanako Hayashi
Cells 2022, 11(4), 647,
Available online:

“MicroRNA as a Potential Therapeutic Molecule in Cancer”
by Joanna Szczepanek, Monika Skorupa and Andrzej Tretyn
Cells 2022, 11(6), 1008,
Available online:

“Membrane Progesterone Receptors (mPRs, PAQRs): Review of Structural and Signaling Characteristics”
by Peter Thomas
Cells 2022, 11(11), 1785,
Available online:

“The Nuclear Pore Complex: Birth, Life, and Death of a Cellular Behemoth”
by Elisa Dultz, Matthias Wojtynek, Ohad Medalia and Evgeny Onischenko
Cells 2022, 11(9), 1456,
Available online:

“The Regulatory Functions and the Mechanisms of Long Non-Coding RNAs in Cervical Cancer”
by Qiwei Yang and Ayman Al-Hendy
Cells 2022, 11(7), 1149,
Available online:

“From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer”
by Jiho Rhim, Woosun Baek, Yoona Seo and Jong Heon Kim
Cells 2022, 11(18), 2791,
Available online:

“Constitutive Heterochromatin in Eukaryotic Genomes: A Mine of Transposable Elements”
by René Massimiliano Marsano and Patrizio Dimitri
Cells 2022, 11(5), 761,
Available online:

“Current Methods and Pipelines for Image-Based Quantitation of Nuclear Shape and Nuclear Envelope Abnormalities”
by Anne F. J. Janssen, Sophia Y. Breusegem and Delphine Larrieu
Cells 2022, 11(3), 347,
Available online:

“Generating Membrane Curvature at the Nuclear Pore: A Lipid Point of View”
by Bas W. A. Peeters, Alexandra C. A. Piët and Maarten Fornerod
Cells 2022, 11(3), 469,
Available online:

“SWI/SNF Antagonism of PRC2 Mediates Estrogen-Induced Progesterone Receptor Expression”
by Mike R. Wilson, Jake J. Reske, Julie Koeman, Marie Adams, Niraj R. Joshi, Asgerally T. Fazleabas and Ronald L. Chandler
Cells 2022, 11(6), 1000,
Available online:

“Progesterone Signaling in Endometrial Epithelial Organoids”
by Sylvia C. Hewitt, San-pin Wu, Tianyuan Wang, Steven L. Young, Thomas E. Spencer and Francesco J. DeMayo
Cells 2022, 11(11), 1760,
Available online:

“Genotype-Phenotype Correlations in Human Diseases Caused by Mutations of LINC Complex-Associated Genes: A Systematic Review and Meta-Summary”
by Emily C. Storey and Heidi R. Fuller
Cells 2022, 11(24), 4065,
Available online:

“miRNA-Dependent Regulation of AKT1 Phosphorylation”
by Mallory I. Frederick, Tarana Siddika, Pengcheng Zhang, Nileeka Balasuriya, Matthew A. Turk, Patrick O’Donoghue and Ilka U. Heinemann
Cells 2022, 11(5), 821,
Available online:

“The Chemopreventive Effects of Polyphenols and Coffee, Based upon a DMBA Mouse Model with microRNA and mTOR Gene Expression Biomarkers”
by Richard Molnar, Laszlo Szabo, Andras Tomesz, Arpad Deutsch, Richard Darago, Bence L. Raposa, Nowrasteh Ghodratollah, Timea Varjas, Balazs Nemeth, Zsuzsanna Orsos et al.
Cells 2022, 11(8), 1300,
Available online:

“Nuclear Lipid Droplet Birth during Replicative Stress”
by Sylvain Kumanski, Romain Forey, Chantal Cazevieille and María Moriel-Carretero
Cells 2022, 11(9), 1390,
Available online:

“Progesterone Signaling and Mammalian Ovarian Follicle Growth Mediated by Progesterone Receptor Membrane Component Family Members”
by John J. Peluso
Cells 2022, 11(10), 1632,
Available online:

“MicroRNAs as Potential Tools for Predicting Cancer Patients’ Susceptibility to SARS-CoV-2 Infection and Vaccination Response”
by Tânia R. Dias, Francisca Dias, Ana Luísa Teixeira, Hugo Sousa, Júlio Oliveira and Rui Medeiros
Cells 2022, 11(15), 2279,
Available online:

“miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma”
by Patricia de la Cruz-Ojeda, Tobias Schmid, Loreto Boix, Manuela Moreno, Víctor Sapena, Juan M. Praena-Fernández, Francisco J. Castell, Juan Manuel Falcón-Pérez, María Reig, Bernhard Brüne et al.
Cells 2022, 11(17), 2673,
Available online:

“Partial Disassembly of the Nuclear Pore Complex Proteins during Semi-Closed Mitosis in Dictyostelium discoideum
by Kristina Mitic, Marianne Grafe, Petros Batsios and Irene Meyer
Cells 2022, 11(3), 407,
Available online:

“Altered RBP1 Gene Expression Impacts Epithelial Cell Retinoic Acid, Proliferation, and Microenvironment”
by Jianshi Yu, Mariarita Perri, Jace W. Jones, Keely Pierzchalski, Natalia Ceaicovscaia, Erika Cione and Maureen A. Kane
Cells 2022, 11(5), 792,
Available online:

21 December 2023
Cells | Top Cited Papers in 2022 in the Section “Cellular Metabolism”

“Role of Dietary Supplements and Probiotics in Modulating Microbiota and Bone Health: The Gut-Bone Axis”
by Alessandro de Sire, Roberto de Sire, Claudio Curci, Fabiana Castiglione and Walter Wahli
Cells 2022, 11(4), 743;
Available online:

“Amino Acid Metabolism in Cancer Drug Resistance”
by Hee-Chan Yoo and Jung-Min Han
Cells 2022, 11(1), 140;
Available online:

“Versatile Triad Alliance: Bile Acid, Taurine and Microbiota”
by Kalina Duszka
Cells 2022, 11(15), 2337;
Available online:

“Targeting Epigenetic Modifiers of Tumor Plasticity and Cancer Stem Cell Behavior”
by Vigneshwari Easwar Kumar, Roshni Nambiar, Cristabelle De Souza, Audrey Nguyen, Jeremy Chien and Kit S. Lam
Cells 2022, 11(9), 1403;
Available online:

“Role of Mitochondrial Stress Response in Cancer Progression”
by Yu Geon Lee, Do Hong Park and Young Chan Chae
Cells 2022, 11(5), 771;
Available online:

“Tumor Cell Glycolysis—At the Crossroad of Epithelial–Mesenchymal Transition and Autophagy”
by Fabrizio Marcucci and Cristiano Rumio
Cells 2022, 11(6), 1041;
Available online:

“The Clinical Chameleon of Autoinflammatory Diseases in Children”
by Eugenio Sangiorgi and Donato Rigante
Cells 2022, 11(14), 2231;
Available online:

“Pregnant Women and Endocrine Disruptors: Role of P2X7 Receptor and Mitochondrial Alterations in Placental Cell Disorders”
by Sophie Fouyet, Elodie Olivier, Pascale Leproux, Mélody Dutot and Patrice Rat
Cells 2022, 11(3), 495;
Available online:

“Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?”
by Nicolas Lanthier and Nathalie Delzenne
Cells 2022, 11(17), 2718;
Available online:

“Obesity: The Fat Tissue Disease Version of Cancer”
by Besma Boubertakh, Cristoforo Silvestri and Vincenzo Di Marzo
Cells 2022, 11(12), 1872;
Available online:

“Roles of Palmitoleic Acid and Its Positional Isomers, Hypogeic and Sapienic Acids, in Inflammation, Metabolic Diseases and Cancer”
by Miguel A. Bermúdez, Laura Pereira, Cristina Fraile, Laura Valerio, María A. Balboa and Jesús Balsinde
Cells 2022, 11(14), 2146;
Available online:

“A Multi-Strain Probiotic Formulation Improves Intestinal Barrier Function by the Modulation of Tight and Adherent Junction Proteins”
by Raffaella di Vito, Carmela Conte and Giovanna Traina
Cells 2022, 11(16), 2617;
Available online:

“Targeting PGM3 as a Novel Therapeutic Strategy in KRAS/LKB1 Co-Mutant Lung Cancer”
by Hyunmin Lee, Feng Cai, Neil Kelekar, Nipun K. Velupally and Jiyeon Kim
Cells 2022, 11(1), 176;
Available online:

“Intestinal Microbiota Remodeling Protects Mice from Western Diet-Induced Brain Inflammation and Cognitive Decline”
by Prasant Kumar Jena, Tahereh Setayesh, Lili Sheng, Jacopo Di Lucente, Lee Way Jin and Yu-Jui Yvonne Wan
Cells 2022, 11(3), 504;
Available online:

“Prevention of L-Dopa-Induced Dyskinesias by MPEP Blockade of Metabotropic Glutamate Receptor 5 Is Associated with Reduced Inflammation in the Brain of Parkinsonian Monkeys”
by Marc Morissette, Mélanie Bourque, Marie-Ève Tremblay and Thérèse Di Paolo
Cells 2022, 11(4), 691;
Available online:

“Obesity-Associated Cancers: Evidence from Studies in Mouse Models”
by Ho Lee
Cells 2022, 11(9), 1472;
Available online:

“Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression”
by Kevinn Eddy, Mohamad Naser Eddin, Anna Fateeva, Stefano Vito Boccadamo Pompili, Raj Shah, Saurav Doshi and Suzie Chen
Cells 2022, 11(18), 2857;
Available online:

20 December 2023
Cells | Top 10 Cited Papers in 2022 in the Section “Cell Motility and Adhesion”

The 2022 top 10 papers from the Section “Cell Motility and Adhesion”, published in Cells (ISSN: 2073-4409), are as follows:

“Current Understanding of Asthma Pathogenesis and Biomarkers”
by Nazia Habib, Muhammad Asghar Pasha and Dale D. Tang
Cells 2022, 11(17), 2764;
Available online:

“Breast Cancer Bone Metastasis: A Narrative Review of Emerging Targeted Drug Delivery Systems”
by Huimin Shao and Pegah Varamini
Cells 2022, 11(3), 388;
Available online:

“Control of Synapse Structure and Function by Actin and Its Regulators”
by Juliana E. Gentile, Melissa G. Carrizales and Anthony J. Koleske
Cells 2022, 11(4), 603;
Available online:

“Cell Cycle Regulation by Integrin-Mediated Adhesion”
by Siamak A. Kamranvar, Bhavna Rani and Staffan Johansson
Cells 2022, 11(16), 2521;
Available online:

“Comparative Analysis of Gene Expression in Fibroblastic Foci in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis”
by Jan C. Kamp, Lavinia Neubert, Helge Stark, Jan B. Hinrichs, Caja Boekhoff, Allison D. Seidel, Fabio Ius, Axel Haverich, Jens Gottlieb, Tobias Welte et al.
Cells 2022, 11(4), 664;
Available online:

“Subacromial Bursa: A Neglected Tissue Is Gaining More and More Attention in Clinical and Experimental Research”
by Franka Klatte-Schulz, Kathi Thiele, Markus Scheibel, Georg N. Duda and Britt Wildemann
Cells 2022, 11(4), 663;
Available online:

“Links of Cytoskeletal Integrity with Disease and Aging”
by Yu Jin Kim, Min Jeong Cho, Won Dong Yu, Myung Joo Kim, Sally Yunsun Kim and Jae Ho Lee
Cells 2022, 11(18), 2896;
Available online:

“CRISPR/Cas9 Mediated Knockout of Cyclooxygenase-2 Gene Inhibits Invasiveness in A2058 Melanoma Cells”
by Cathleen Haase-Kohn, Markus Laube, Cornelius K. Donat, Birgit Belter and Jens Pietzsch
Cells 2022, 11(4), 749;
Available online:

“Sex Steroids Effects on Asthma: A Network Perspective of Immune and Airway Cells”
by Niyati A. Borkar, Colin Kelly Combs and Venkatachalem Sathish
Cells 2022, 11(14), 2238;
Available online:

“Pathologic Proteolytic Processing of N-Cadherin as a Marker of Human Fibrotic Disease”
by Paul Durham Ferrell, Kristianne Michelle Oristian, Everett Cockrell and Salvatore Vincent Pizzo
Cells 2022, 11(1), 156;
Available online:

20 December 2023
Meet the Editors | Interview with Dr. Alexander E. Kalyuzhny—Editor-in-Chief of Cells

Prof. Dr. Swee Hin Teoh











Dr. Alexander E. Kalyuzhny is a research assistant professor and is affiliated with the Department of Neuroscience at the University of Minnesota, USA. We had the pleasure of meeting him at the Neuroscience 2023 conference and had a discussion in which we learned more about his background, views, and interests.

The following is a brief Q&A with Dr. Alexander E. Kalyuzhny:

1. You are an internationally recognized neurologist—could you share your current research focus with us and what is exciting about it?
To be more precise, I am a neuroscientist rather than a neurologist. My major interest remains in the area of opioids, focussing on the cellular mechanisms underlying antinociception. What recently excited me was the discovery of novel nonaddictive analgesics and precision analgesia that can be delivered at the level of the individual patient.

2. What made you decide to lead this journal?
Dr. Shu-Kun Lin invited me to join and lead Cells, and I accepted his invitation because I wanted to help young scientists advance to the forefront of science. I am glad to be part of Cells and to see you develop so much over the years. I am very motivated to support our journal and to make science accessible to everyone.

3. What suggestions do you have for our journal’s development?
I think Cells is on the right track, but we need to expand the network of experienced reviewers covering the entire landscape of cell biology, and, of course, keep sponsoring different scientific meetings and conferences.

4. What made you move from your home country and pursue research in the USA?
I was invited in 1992 by the Department of Pharmacology, University of Minnesota, to work on a project to study the function of opioid receptors. Back then, I thought it was a temporary endeavor, but as an old saying goes, “Nothing is more permanent than a temporary solution”. I am very passionate about my research and happy to have the opportunity to work with outstanding scientists.

19 December 2023
Cells | Top Cited Papers in 2022 in the Section “Autophagy”

“Chaperone-Mediated Autophagy in Neurodegenerative Diseases and Acute Neurological Insults in the Central Nervous System”
by Haruo Kanno, Kyoichi Handa, Taishi Murakami, Toshimi Aizawa and Hiroshi Ozawa
Cells 2022, 11(7), 1205;
Available online:

“Mitophagy Regulation Following Myocardial Infarction”
by Annie Turkieh, Yara El Masri, Florence Pinet and Emilie Dubois-Deruy
Cells 2022, 11(2), 199;
Available online:

“Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors”
by Gabriela Reyes-Castellanos, Nadine Abdel Hadi and Alice Carrier
Cells 2022, 11(3), 426;
Available online: 

“Modulating Chaperone-Mediated Autophagy and Its Clinical Applications in Cancer”
by Virginie Hubert, Sebastian Weiss, Andrew Jackson Rees and Renate Kain
Cells 2022, 11(16), 2562;
Available online: 

“Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription”
by Catherine DeMarino, Maria Cowen, Pooja Khatkar, Bianca Cotto, Heather Branscome, Yuriy Kim, Sarah Al Sharif, Emmanuel T. Agbottah, Weidong Zhou, Cecilia T. Costiniuk et al.
Cells 2022, 11(4), 723;
Available online: 

“Morphology of Phagophore Precursors by Correlative Light-Electron Microscopy”
by Sigurdur Runar Gudmundsson, Katri A. Kallio, Helena Vihinen, Eija Jokitalo, Nicholas Ktistakis and Eeva-Liisa Eskelinen
Cells 2022, 11(19), 3080;
Available online: 

“Autophagy and Lysosomal Functionality in CMT2B Fibroblasts Carrying the RAB7K126R Mutation”
by Roberta Romano, Victoria Stefania Del Fiore, Paola Saveri, Ilaria Elena Palamà, Chiara Pisciotta, Davide Pareyson, Cecilia Bucci and Flora Guerra
Cells 2022, 11(3), 496;
Available online: 

“PINK1 Protects against Staurosporine-Induced Apoptosis by Interacting with Beclin1 and Impairing Its Pro-Apoptotic Cleavage”
by Francesco Brunelli, Liliana Torosantucci, Vania Gelmetti, Davide Franzone, Anne Grünewald, Rejko Krüger, Giuseppe Arena and Enza Maria Valente
Cells 2022, 11(4), 678;
Available online: 

“Diving into the Evolutionary History of HSC70-Linked Selective Autophagy Pathways: Endosomal Microautophagy and Chaperone-Mediated Autophagy”
by Simon Schnebert, Maxime Goguet, Emilio J. Vélez, Alexandra Depincé, Florian Beaumatin, Amaury Herpin and Iban Seiliez
Cells 2022, 11(12), 1945;
Available online: 

“In Vitro Anticancer Screening and Preliminary Mechanistic Study of A-Ring Substituted Anthraquinone Derivatives”
by Ibrahim Morgan, Ludger A. Wessjohann and Goran N. Kaluđerović
Cells 2022, 11(1), 168;
Available online:

30 November 2023
MDPI Insights: The CEO’s Letter #6 - MDPI Spain Summit and ResearchGate

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.

Opening Thoughts

MDPI Spain Summit

Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.

On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.

With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.

The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.

The main objective of this Summit was to bring together Editors representing MDPI journals across various disciplines within Spanish universities and research centers, primarily from the Barcelona area. The aim was to facilitate an open and fruitful discussion regarding the development of their journals, the future of OA in Spain, and to provide meaningful interactions and networking opportunities.

Connecting with Editorial Board Members

Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."

Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.

From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.

As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.

Open Access in Spain

In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.

For further details of Spain's OA policy and the history of government mandates, click here.

Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus. 

A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!

MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.

I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.

Impactful Research

769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023

Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.

Click here to view the full list of 769 Editorial Board Members.

Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.

Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!

Inside MDPI

Corporate Marketing and Communications Strategy Session

Members of MDPI’s Corporate Marketing & Communications team.

For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.

This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.

We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.

The strategy session also serves as a team-building activity, during which the team voted on bowling!

Strategy Session

In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.

To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.

I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.

Coming Together for Science

ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home

Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.

When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.

In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.

While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.

The press release below provides further details.

Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023

ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.  

This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.

Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.

Closing Thoughts

November is Men’s Health Awareness Month

Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.

November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.

I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.

Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.

Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.

Healthy men help build healthy families and a healthy society

Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.

From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.


Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:

Stefan Tochev
Chief Executive Officer

21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023

We extend our sincere congratulations to the 769 Editorial Board Members of our journals – from 40 different countries/territories – who have been recognized as Highly Cited Researchers for the year 2023 by Clarivate. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields, as indicated by Web of Science data.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade who stand out for their significant and broad influence in various scientific and social science domains. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 21 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. They represent a small fraction of the researcher population whose contributions disproportionately push the boundaries of knowledge, enhancing global well-being, sustainability, and security.

Congratulations to the scholars for their noteworthy achievement – we are honored to have them on board with our journals!

Abate, Antonio
Aguilera, Ruth V.
Ahmed, Warish
Ahn, Myung-Ju
An, Qiaoshi
Anasori, Babak
Andersson, Dan I.
Angeletti, Silvia
Annabi, Nasim
Antinori, Spinello
Ariga, Katsuhiko
Asa, Sylvia L.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Balsamo, Gianpaolo
Bandodkar, Amay J.
Banks, William A.
Bao, Yan-Ping
Barba, Francisco J.
Barnes, Peter J.
Barnholtz-Sloan, Jill S.
Barrow, Colin J.
Bashir, Ali Kashif
Basit, Abdul W.
Bassetti, Matteo
Batley, Jacqueline
Battino, Maurizio
Behnood, Ali
Benediktsson, Jon Atli
Biondi, Antonio
Bjarnsholt, Thomas
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boczkaj, Grzegorz
Bogers, Marcel
Bonomo, Robert A.
Boyd, Robert W.
Boyer, Cyrille
Braeckmans, Kevin
Bragazzi, Nicola Luigi
Bu, Wenbo
Bursać Kovačević, Danijela
Bush, Ashley I.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cambria, Erik
Cao, Guozhong
Cao, Xingzhong
Capasso, Raffaele
Carvalho, Andre F.
Casper, Jonathan
Castellanos-Gomez, Andres
Cavalli, Giacomo
Chai, Siang-Piao
Chan, Jasper Fuk-Woo
Chan, Timothy A.
Chang, Chih-Hao
Chang, Guoqing
Chao, Dongliang
Chen, Bo
Chen, Chaoji
Chen, Fahu
Chen, Gang
Chen, Jianmin
Chen, Jun
Chen, Jun
Chen, Jun
Chen, Lidong
Chen, Lingxin
Chen, Min
Chen, Mou
Chen, Peng
Chen, Qian
Chen, Qianwang
Chen, Shaowei
Chen, Shuangming
Chen, Wei
Chen, Xiaobo
Chen, Yimin
Chen, Yu
Chen, Yulin
Chen, Zhong
Chen, Zonghai
Cheng, Gong
Cheng, Huanyu
Cheng, Laifei
Cheng, Qiang
Chew, Kit Wayne
Chiclana, Francisco
Choi, Wonyong
Choi, Young Hae
Chowdhary, Anuradha
Cichocki, Andrzej
Clevers, Hans
Coops, Nicholas C.
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Creutzig, Felix
Crommie, Michael F.
Cuadrado, Antonio
Cui, Haiying
Cui, Yi
Curigliano, Giuseppe
Dai, Sheng
Dai, Shifeng
Daiber, Andreas
Davies, Michael J.
Davis, Thomas P.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Delord, Jean-Pierre
Demaria, Marco
Deng, Xiangzheng
Desneux, Nicolas
Dikic, Ivan
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Ding, Jianxun
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Chung-Li
Dou, Shi Xue
Dragicevic, Tomislav
Du, Bo
Du, Qian
Du, Yonghua
Duan, Xidong
Dufresne, Alain
Dummer, Reinhard
Edwards, David
Elaissari, Abdelhamid
ElMasry, Gamal
Enjuanes, Luis
Fabbro, Doriano
Facchetti, Antonio
Fan, Junliang
Fan, Kelong
Fan, Xiulin
Fan, Zhanxi
Fang, Baizeng
Fang, Chuanglin
Fang, Yongjin
Fasano, Alessio
Feng, Liangzhu
Feng, Xuning
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Filippi, Massimo
Flavian, Carlos
Fortino, Giancarlo
Fowler, Michael
Franceschi, Claudio
Frattini, Federico
Friston, Karl J.
Fu, Gengtao
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gao, Feng
Gao, Huijun
Gao, Huile
Gao, Peng
Gao, Wei
Garbe, Claus
Garg, Abhishek D.
Gasbarrini, Antonio
Gastaldelli, Amalia
Gautier, Emmanuel L.
Genevet, Patrice
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghaffari, Roozbeh
Ghamisi, Pedram
Giacobbe, Daniele Roberto
Giampieri, Francesca
Gillies, Robert J.
Godos, Justyna
Gogotsi, Yury
Golding, Nick
Gong, Jinlong
Gong, Peng
Gong, Yongji
Govindan, Kannan
Gozal, David
Grancini, Giulia
Grant, William B.
Graus, Francesc
Green, Douglas R.
Grosso, Giuseppe
Gu, Meng
Gu, Zhanjun
Guan, Cao
Gueimonde, Miguel
Gui, Guan
Guigo, Roderic
Guo, Hengyu
Guo, Jianping
Guo, Lin
Guo, Song
Guo, Yan
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Hagger, Martin S.
Hall, C. Michael
Han, Fudong
Han, Heesup
Hanes, Justin
Hartung, Hans-Peter
He, Bao-Jie  
He, Debiao
He, Hongwen
He, Jiaqing
He, Jie
He, Jr-Hau
He, Qiong
He, Xiangming
He, Xijun
He, Zhili
Heneka, Michael T.
Herrera, Francisco
Herrera-Estrella, Luis
Herrera-Viedma, Enrique
Hetz, Claudio
Holick, Michael F.
Hong, Danfeng
Hong, Xuechuan
Hsueh, Po-Ren
Hu, Bin
Hu, Enyuan
Hu, Jin-Song
Hu, Weida
Hu, Wenbin
Hu, Xiaosong
Huang, Baibiao
Huang, Hongwei
Huang, Jianliang
Huang, Jianping
Huang, Peng
Huang, Xin
Hubacek, Klaus
Hussain, Saddam
Italiano, Antoine
Iwata, Hiroji
Jaeschke, Hartmut
Jain, Atul

Jaiswal, Amit K.
Jankovic, Joseph
Janssens, Ivan A.
Jelezko, Fedor
Jeon, Byong-Hun
Ji, Guangbin
Ji, Qiang
Ji, Wei
Ji, Xiaobo
Ji, Xiaoyuan
Jiang, Bin
Jiang, Hong
Jiang, Junjun
Jiang, Lianzhou
Jiang, Qing
Jiang, Shibo
Jiang, Yuyan
Jiang, Zhongyi
Jiao, Licheng
Jin, Shi
Jin, Zhong
Kalantar-zadeh, Kourosh
Kamal, Mohammad Amjad
Kaner, Richard B.
Kaneti, Yusuf Valentino
Kang, Zhenhui
Karagiannidis, George K.
Karniadakis, George Em
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Kepp, Oliver
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kildishev, Alexander V.
Kim, Haegyeom
Kim, Jeonghun
Kim, Jin-Hoi
Kim, Jong Seung
Kim, Ki-Hyun
Kirkwood, John M.
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Kong, Baohua
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kroemer, Guido
Kuang, Dai-Bin
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Prashant
Kumar, Sudhir
Kurths, Juergen
Kurzrock, Razelle
Kuzyakov, Yakov
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lan, Ke
Lancellotti, Patrizio
Landi, Francesco
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Chengkuo
Lee, Jechan
Lee, Jin-Wook
Lee, Pooi See
Lee, Sang Soo
Lehmann, Johannes
Lei, Yaguo
Li, Bin
Li, Chunzhong
Li, Dongsheng
Li, Feng
Li, Hai
Li, Heng
Li, Hongyi
Li, Hui
Li, Jinghong
Li, Jun
Li, Li
Li, Linlin
Li, Neng
Li, Ning
Li, Shuai
Li, Shutao
Li, Wei
Li, Wentao
Li, Xiang
Li, Xuecao
Li, Xuelong
Li, Yat
Li, Yurui
Li, Zhijun
Liang, Chao
Liang, Shuquan
Liaw, Peter K.
Lin, Jun
Lin, Yuehe
Lippi, Giuseppe
Lister, Ryan
Liu, Chengmei
Liu, Gang
Liu, Hong
Liu, Hui
Liu, Jian
Liu, Jinyan
Liu, Jun
Liu, Meilin
Liu, Pan
Liu, Wei
Liu, Xianhu
Liu, Xiaoping
Liu, Xuejun
Liu, Yang
Liu, Yu
Liu, Yuan
Lonardo, Amedeo
Long, Hualou
Long, Ying
Lu, Bingan
Lu, Junling
Lu, Lu
Lu, Nanshu
Lu, Rongxing
Lucey, Brian
Lucieer, Arko
Lugato, Emanuele
Lund, Henrik
Luo, Yangchao
Luo, Yi
Luo, Zisheng
Lv, Wei
Lyons, Timothy W.
Ma, Haile
Ma, Jianmin
Ma, Jun
Ma, Tianyi
Ma, Wei
Ma, Yanming
Madabhushi, Anant
Mahmoudi, Morteza
Mai, Liqiang
Mai, Wenjie
Makridakis, Spyros
Mandala, Mario
Mantovani, Alberto
Mao, Jianfeng
Mao, Like
Mardani, Abbas
Mathivanan, Suresh
Matyjaszewski, Krzysztof
McCabe, Matthew F.
McCauley, Darren
McClements, David Julian
Mei, Lin
Melenhorst, Jan Joseph
Melero, Ignacio
Meyerholz, David K.
Van Mierlo, Joeri
Miroshnichenko, Andrey E.
Mittler, Ron
Mu, Shichun
Mubarak, Mohammad S.
Mueller, Lukas A.
Muhammad, Khan
Mumtaz, Shahid
Munekata, Paulo Eduardo Sichetti
Nakagawa, Shinichi
Nauen, Ralf
Newman, David J.
Niaura, Raymond S.
Nidheesh, P. V.
Niu, Ben
Nussinov, Ruth
O'Connor, David
Odintsov, Sergei D.
Omri, Anis
Orsini, Nicola
Ostrikov, Kostya (Ken)
Oswald, Isabelle P.
Oudard, Stephane
Ouyang, Minggao
Ozcan, Aydogan
Pan, Anlian
Pan, Anqiang
Pan, Caofeng
Pan, Genxing
Pan, Likun
Pan, Quan-Ke
Pan, Xiaoqing
Pandolfi, Pier Paolo
Parati, Gianfranco
Pateiro, Mirian
Peng, Qiang
Peng, Qing
Peng, Shushi
Perc, Matjaz
Perlin, David S.
Perlman, Stanley
Petruzzelli, Antonio Messeni
Pitt, Bertram
Pöhlmann, Stefan
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Potenza, Marc N.
Preat, Veronique
Prinsep, Michele R.
Pu, Kanyi
Putnik, Predrag
Qin, Yuanwei
Qiu, Jieshan
Qu, Xiaogang
Ragauskas, Arthur J.
Ramakrishna, Seeram
Ramkissoon, Haywantee
Ran, Jingrun
Rao, Zhonghao
Recio, Isidra
Ren, Jinsong
Rengel, Zed
Rho, Junsuk
Riahi, Keywan
Ribeiro-Soriano, Domingo
Richardson, Paul G.
Robert, Caroline
Rocca, Maria A.
Rodriguez-Manas, Leocadio
Rojas, Orlando J.
Rojo, Teofilo
Roubaud, David
Saad, Fred
Saad, Walid
Sadorsky, Perry
Saliba, Michael
Sander, Chris
Sangaiah, Arun Kumar
Santamouris, Mattheos
Santoro, Gabriele
Scaldaferri, Franco
Schatzberg, Alan F.
Schwab, Matthias
Schweizer, Frank
Scolyer, Richard A.
Scott, Daniel
Serruys, Patrick W.
Setzer, William N.
Shahzad, Babar
Shao, Shuai
Shao, Zongping
Shen, Guozhen
Shen, Liyin

Shen, Zexiang
Shi, Peng
Shi, Yi
Siano, Pierluigi
Simões, Manuel
Sing, Swee Leong
Singh, Vijay P.
Smagghe, Guy
Smith, Lee
Soffietti, Riccardo
Song, Houbing
Song, Jibin
Song, Yu
Sood, Anil K.
Souto, Eliana B.
Stadler, Marc
Stanley, H. Eugene
Stephanopoulos, Gregory
Sternberg, Cora N.
Stoumpos, Constantinos C.
Stunnenberg, Hendrik G.
Su, Shiliang
Sun, Baoguo
Sun, Cuixia
Sun, Fengchun
Sun, Hongqi
Sun, Jie
Sun, Lijun
Sun, Litao
Sun, Runcang
Sun, Yanjuan
Sun, Zaicheng
Sun, Zhipei
Sureda, Antoni
Svenning, Jens-Christian
Tan, Chaoliang
Tan, Weihong
Tang, Chuan-He
Tang, Chuyang
Tang, Dianping
Tang, Yongbing
Tanzi, Rudolph E.
Terpos, Evangelos
Teschendorff, Andrew E.
Tian, He
Timsit, Jean-Francois
Tiwari, Aviral Kumar
Tohge, Takayuki
Tousoulis, Dimitris
Tran, Lam-Son Phan
Tress, Wolfgang
Trivedi, Pankaj
Tsao, Rong
Tully, Mark A.
Tung, Chen-Ho
Van der Bruggen, Bart
Vandenbroucke, Roosmarijn E.
Vangronsveld, Jaco
Varsani, Arvind
Vatanen, Tommi
Verbeke, Kristin
Vermote, Eric
Verpoorte, Robert
Vieta, Eduard
Vincent, Jean-Louis
Vita, Antonio
Wan, Jiafu
Wan, Shaohua
Wanek, Wolfgang
Wang, Bin
Wang, Bo
Wang, Chao
Wang, Chuanyi
Wang, Chunsheng
Wang, Dan
Wang, Feng
Wang, Gongming
Wang, Guoxiu
Wang, Haihui
Wang, Hao
Wang, Huanqing
Wang, Huanting
Wang, Hui
Wang, Jian
Wang, Jie
Wang, Jing
Wang, John
Wang, Joseph
Wang, Lianzhou
Wang, Lihui
Wang, Meng
Wang, Peng
Wang, Pengfei
Wang, Qi
Wang, Qi
Wang, Qiang
Wang, Qilin
Wang, Qin
Wang, Qing
Wang, Shaojian
Wang, Sibo
Wang, Tao
Wang, Ying
Wang, Yong
Wang, Zhen
Wang, Zhong Lin
Wang, Zhongrui
Wang, Zifa
Wang, Zuankai
Wei, Haotong
Wei, Leyi
Wei, Zhixiang
Wei, Zhongbao
Weissleder, Ralph
Weitschies, Werner
Wen, Guanghui
Wesemael, Bas van
Willerslev, Eske
Witlox, Frank
Wu, Haijun
Wu, Hao Bin
Wu, Hui
Wu, Jun
Wu, Qinglin
Wu, Shuilin
Wu, Xiaojun
Wu, Yongzhen
Wu, Yuping
Wu, Zheng-Guang
Wu, Zhong-Shuai
Xia, Jianguo (Jeff)
Xia, Meimei
Xia, Xinhui
Xia, Yongyao
Xia, Zhiguo
Xiang, Quanjun
Xiao, Fuyuan
Xiao, Jie
Xin, Sen
Xing, Baoshan
Xing, Wei
Xiong, Rui
Xu, Hui
Xu, Li Da
Xu, Ping
Xu, Yi-Jun
Xu, Zhenjiang Zech
Yan, Chong
Yan, He
Yan, Huaicheng
Yan, Kai
Yan, Ruqiang
Yang, Bing
Yang, Chenguang
Yang, Hongshun
Yang, Hui
Yang, Jian
Yang, Jianping
Yang, Jie
Yang, Jun
Yang, Kai
Yang, Shihe
Yang, Xiaofeng
Yang, Xinsong
Yang, Yun-Gui
Yao, Yonggang
Yigitcanlar, Tan
Yin, Shen
Yin, Shou-Wei
Yin, Yulong
Yin, Zongyou
Yokoya, Naoto
Young, Allan H.
Yu, Guihua
Yu, Jun
Yu, Le
Yu, Minghao
Yu, Shu-Hong
Yu, Wei
Yu, Wenwu
Yuan, Qiangqiang
Yuan, Yifei
Yuan, Yuan
Yuen, Chau
Zeadally, Sherali
Zhai, Tianyou
Zhang, Bing
Zhang, Dengsong
Zhang, Fan
Zhang, Fusuo
Zhang, Guangyu
Zhang, Guowen
Zhang, Hengjie
Zhang, Hongjie
Zhang, Hui
Zhang, Lai-Chang
Zhang, Lefei
Zhang, Lei
Zhang, Liangpei
Zhang, Lijun
Zhang, Min
Zhang, Peng
Zhang, Qiang
Zhang, Qiaobao
Zhang, Qichun
Zhang, Shicheng
Zhang, Shujun
Zhang, Tierui
Zhang, Wei
Zhang, Weili
Zhang, Xian-Ming
Zhang, Xiaodong
Zhang, Xiaogang
Zhang, Xiaoling
Zhang, Yang
Zhang, Yaobin
Zhang, Yi
Zhang, Yi-Zhou
Zhang, Yong
Zhang, Yu Shrike
Zhang, Yue-Jun
Zhang, Yuelin
Zhang, Zheng
Zhang, Zhicheng
Zhang, Zhien
Zhao, Guochun
Zhao, Jie
Zhao, Li-Dong
Zhao, Qing
Zhao, Yi
Zheng, Hao
Zheng, Weitao
Zheng, Yufeng
Zhong, Cheng
Zhou, Jie
Zhou, Jizhong
Zhou, Kun
Zhou, Liang
Zhou, Peng
Zhou, Qi
Zhou, Wei
Zhou, Weiqi
Zhu, Chengzhou
Zhu, Hongwei
Zhu, Junfa
Zhu, Jun-Jie
Zhu, Lei
Zhu, Mingshan
Zhu, Quanxin
Zhu, Yi
Zhu, Yongfa
Zhu, Zhe
Zhuang, Xiaodong
Zou, Quan
Zou, Ruqiang
Zuo, Chao

1 November 2023
MDPI Insights: The CEO’s Letter #5 - OA Week, UK, and Strategy

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.

Opening Thoughts

Open Access Week 2023 – the Global Drive to Open Continues

As the world's largest open-access (OA) publisher, we believe that unrestricted access to research findings is the cornerstone of transparency, efficiency, and quality control across scientific disciplines. At MDPI, we provide free, immediate access to scientific papers, empowering scientists to examine, validate, replicate, and build upon existing results. This minimizes redundancy, optimizes resources, and fosters innovative approaches.

International OA Week, held from 23 to 29 October 2023, provided a unique opportunity to link the global movement toward open sharing and open science with the progress of policy changes at the local level. Our mission, during OA Week and all the year round, is to offer educational resources highlighting the benefits of open-access publishing. The MDPI Blog is a valuable resource for information on open access and open science.

Core principles of OA publishing

Accessibility, transparency, and collaboration are core principles of OA publishing. OA aims to break down barriers that have traditionally restricted research access, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Our commitment to diverse pathways for OA publishing worldwide includes discounts for researchers. You can learn more about how MDPI supports scientific communities here.

One of the key strengths of OA publishing is its ability to facilitate interdisciplinary research. By removing paywalls and promoting knowledge-sharing across disciplines, OA encourages collaboration and innovation. Researchers from various fields can access and build upon each others’ work, fostering a holistic approach to addressing complex global challenges.

OA holds the potential to democratize knowledge, advance science, and drive positive societal change.

Policy driving change

Governments, institutions, and funding agencies have recognized the transformative potential of OA and have implemented policies to promote it. These policies often require publicly funded research to be made openly accessible, accelerating the growth of OA repositories and journals. Check out our spotlights on OA policies in the USEU and China

OA publishing is continuously evolving, with community-driven models and technologies shaping its future. Initiatives such as “Plan S” and “cOAlition S” promote OA publishing from the perspective of national funders, requiring grantees to publish their research openly. A new policy announced by the US administration last year mandates that, with effect from January 2026, all US federally funded research should be freely and immediately available after publication.

Additionally, preprint servers such as MDPI's, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.

For more than two decades, OA publishing has been revolutionizing academic publishing by promoting accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As OA continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.

MDPI is proud to lead the transition to open access.

Read more:

Impactful Research

Spotlight on Smart Cities

Smart cities will serve as a cornerstone for future human development. Their implementation will help us tackle many of the significant challenges we are facing – climate change, ageing populations, waste management, public safety, travel, and so on. Recognising the importance of this multifaceted field, MDPI launched the inaugural issue of Smart Cities in 2018 to provide an advanced forum for research into smart technology and society. Here we take a look at how this journal has developed, and its impact in this exciting field.

As at 30 October, 2023, Smart Cities has published 421 papers and has an Impact Factor of 6.4. It also has a CiteScore of 8.5, and more than one quarter of its published papers – 124 – have been cited 10 times or more.

Highly cited papers in Smart Cities

Below are several highly cited papers recently published in Smart Cities. Citation metrics are current as at 31 October 2023.

1. “Introducing the “15-Minute City”: Sustainability, Resilience and Place Identity in Future Post-Pandemic Cities
Authors: Carlos Moreno, Zaheer Allam, Didier Chabaud, Catherine Gall and Florent Pratlong
Smart Cities 2021, 4(1), 93-111;
Citations: Crossref (338), Scopus (366), Web of Science (270), Google Scholar (710)
The paper discusses the socio-economic impacts of the COVID-19 on cities, including increasing inequalities and rising unemployment. It introduces the concept of the "15-Minute City," a form of "chrono-urbanism," as a response to the challenges posed by the pandemic.

2. “A Review on Electric Vehicles: Technologies and Challenges
Authors: Julio A. Sanguesa, Vicente Torres-Sanz, Piedad Garrido, Francisco J. Martinez and Johann M. Marquez-Barja
Smart Cities 2021, 4(1), 372-404;
Citations: Crossref (359), Scopus (363), Web of Science (268), Google Scholar (558)
This paper provides an overview of the progress in Electric Vehicles (EVs), focusing on battery technology, charging methods, and emerging research challenges. It also analyzes the global EV market and its future outlook.

3. “IoT in Smart Cities: A Survey of Technologies, Practices and Challenges
Authors: Abbas Shah Syed, Daniel Sierra-Sosa, Anup Kumar and Adel Elmaghraby
Smart Cities 2021, 4(2), 429-475;
Citations: Crossref (121), Scopus (151), Web of Science (91), Google Scholar (215)
This paper gives an overview of the Internet of Things (IoT) in the context of Smart Cities, discussing the fundamental components, technologies, architectures, networking technologies, and artificial algorithms that underpin IoT-based Smart City systems.

4. “Artificial Intelligence Techniques in Smart Grid: A Survey
Authors: Olufemi A. Omitaomu and Haoran Niu
Smart Cities 2021, 4(2), 548-568;
Citations: Crossref (76), Scopus (94), Web of Science (57), Google Scholar (120)
This survey paper reviews the utilization of artificial intelligence (AI) techniques in the context of the smart grid. It covers various applications of AI in load forecasting, power grid stability assessment, fault detection, and security issues in the smart grid and power systems.

5. “The Metaverse as a Virtual Form of Smart Cities: Opportunities and Challenges for Environmental, Economic, and Social Sustainability in Urban Futures
Authors: Zaheer Allam, Ayyoob Sharifi, Simon Elias Bibri, David Sydney Jones and John Krogstie
Smart Cities 2022, 5(3), 771-801;
Citations: Crossref (72), Scopus (75), Web of Science (43), Google Scholar (176)
This paper discusses the concept of the Metaverse, a virtual world introduced by Meta (formerly Facebook), and its potential impact on urban life. It explores how emerging technologies such as AI, Big Data, IoT, and Digital Twins could reshape urban design and services in the context of the Metaverse.


“It was indeed a great and pleasant experience with MDPI regarding our recent publication. The submission process was very straightforward and less time-consuming than the norm. The review process was very fast compared to many other open access journals, which is praiseworthy. The support from the Editorial Office during the revision process was highly useful as well. We look forward to publishing with MDPI in the future, and I will most definitely recommend MDPI to my colleagues and collaborators. – Dr. Luís Rosa, University of Minho

Article in Smart Cities: Mobile Networks and Internet of Things Infrastructures to Characterize Smart Human Mobility

Inside MDPI

MDPI Manchester office, UK Visit

Allie Shi (Editorial Director, MDPI), Stefan Tochev (CEO, MDPI), Jamie Anderson (Manchester Office Manager, MDPI), Michael O’Sullivan (Senior Scientific Officer, MDPI), Hushneara Akhtar, and Becky Castellon (IOAP Team Lead, MDPI), dining out in Manchester, UK.

In October, I visited MDPI’s new office in Manchester. During the visit, I connected with our English Editing (EE) managers, Scientific Officer, members of the Editorial team, the Marketing team, and IOAP Team Lead.

Our Manchester office focuses primarily on EE services and provides local support for the UK market. Additionally, we regularly visit Editorial Board members and participate in local conferences.

I would like to thank Jamie Anderson, Manchester Office Manager, and her team, for their deep commitment to our Manchester staff and to MDPI’s impact on the UK market.

The UK by numbers

The UK is a hub for the world’s top universities, making it a key market for MDPI and the publishing world in general. It is home to two of the top-five-ranked universities globally, 11 in the top 100, and 15 in the top 200.

As a result, the UK plays a key role in MDPI’s global market. As at October 2023, it ranks as the seventh-largest contributor to the total number of papers published by MDPI. We have 3,500 Editorial Board members affiliated with UK institutions, including 34 serving as Editors-in-Chief (EiCs). Our commitment to collaboration with institutions is evident in the UK, where we have successfully established some 60 Institutional Open Access Program (IOAP) agreements with esteemed institutions, such as the University of Oxford, the University of Cambridge, Imperial College London, the University of Edinburgh, and more.

According to InCites Dataset + ESCI for the period 2018–2022, as at October 2023, nearly 65% of UK papers are now published as OA. Just over 10% of total OA publications are by UK authors. UK papers are known for their high quality, with an average of 11 citations per paper. Furthermore, 2.16% of UK papers are in the top 1% of cited papers, and 14.61% are in the top 10% of cited papers, showcasing their impact.

We are currently hiring EEs in various locations worldwide.

English Editing at MDPI

Our English Editing (EE) department consists of two main branches, Quality Control and Learning and Development, reflecting our priorities. We are continuously enhancing the quality of our English Editing services and have raised the relevant standards, which now extend to company-wide communications. English editors participate in international interviews, conduct English assessments, and provide colleagues with presentations on ways to improve their use of written and spoken English.

While expanding, the EE department has proactively refocused its efforts on the quality of our work and how the English Editing department can benefit the company more broadly. We currently have approximately 140 full-time English Editors based across five offices worldwide, supplemented by over 700 freelance English editors.

Our Manchester office serves as the hub for the EE Department, with EE Managers situated there, except for Kurtis Jackson, who serves as the Head of EE and is located in our Basel office. Manchester EEs play a critical role in establishing and developing EE teams in our other offices, overseeing management and recruitment. The EE department plays a vital role in MDPI’s operations, as it is the department that touches every published paper. If this work interests you, I encourage you to explore our available EE positions, whether you are seeking full-time or freelance opportunities.


“MDPI provides an excellent service compared to any other previously used services. It delivers fast and high-quality results but at an affordable price.” – Ardha Apriyanto, University of Potsdam

“In my role as a professor, I consider that MDPI Author Services offer an excellent quality in the editing of Western academic writing while maintaining the required standards of clarity, precision and rigor. Additionally, delivery times are fast compared to other available services.” – Jesus Insuasti, University of Nariño

Read more:

Coming Together for Science

STM and Frankfurt Book Fair

Attending STM

MDPI has been a proud sponsor of the STM Conference for several years. The STM Conference is a dynamic event featuring interactive sessions, expert panellists, idea-sharing, and ample networking opportunities. On 16 October, the event kicked off with arrival drinks, sponsored by MDPI, followed by a welcoming dinner, providing a great chance to connect and network with industry professionals. The following day was filled with speakers, sessions, and further opportunities to connect. STM exemplifies the collaborative spirit of the scientific community, with session topics including achieving open, visible, and impactful research at scale; maintaining research integrity in a rapidly changing world; and exploring the impact of ever-evolving technology in the scholarly community.

Meeting with Web of Science

On a personal note, one of the highlights of STM was a candid and productive conversation with Nandita Quaderi, Editor-in-Chief and SVP at Web of Science. During our discussion, we talked about MDPI, Web of Science, the IJERPH delisting, and ways of moving forward. This open conversation aimed at fostering better collaboration for the future.

“We discussed ways to improve our communication and collaboration.”

I appreciated our frank discussion and felt that Nandita wholeheartedly supports open access. She also expressed her appreciation for the monthly CEO Letter, which she sees as a way to add personality to the MDPI brand and provide insight into the great work we do at MDPI. While we highlighted the positives, we also discussed ways to improve our communication and collaboration moving forward. This meeting alone made the trip worthwhile, and I hope Nandita doesn’t mind my sharing that she found our chat to be “the most honest and constructive discussion” she’s had with someone from MDPI in recent years.

75th Frankfurt Book Fair

Jelena Milojevic (Book Editor, MDPI), Jovana Dubajic (Book Editor, MDPI), Evan Escamilla (Project Manager, MDPI), Laura Wagner (Head of Books, MDPI), and Jenny Knowles (Commissioning Editor, MDPI), at the Frankfurt Book Fair in Frankfurt am Main, Germany.

For the 75th time, the Frankfurter Buchmesse opened its doors in October to celebrate exciting stories and their authors. If you haven’t yet had the chance to visit the Frankfurt Book Fair, I highly recommend it. It’s the largest book fair in the world, attracting thousands of visitors from around the globe. This is the place to gain valuable industry insights from top-class publishing professionals, connect with publishers directly, and learn about the latest trends in publishing.

MDPI Books

Our Books team was also present at the Frankfurt Book Fair, networking and learning from various panels. Did you know that our MDPI Books department publishes OA Books?

The book publishing program includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.

If you have a book proposal you would like to discuss, please feel free to contact our Books team to understand the benefits and methods of publishing your next book with the OA model.

Closing Thoughts

MDPI Strategy Meeting

As the newly appointed CEO, this is my first year leading the MDPI Senior Management Strategy session. I saw it as an opportunity to explore what MDPI has the potential to become in the next five years. Guided by the vision of its founder and President, Dr. Shu-kun Lin, the company has accomplished remarkable feats over the past 27 years and currently holds the position as the world’s third-largest academic publisher, following Springer Nature and Elsevier.

Our primary objective is to build upon the milestones of the past decades and consolidate MDPI’s position as well-established publishing brand. The two-day meeting emphasized the importance of communicating MDPI’s values more actively via its brand and adopting a straightforward yet impactful approach to managing MDPI as a mature academic publisher.

“Our primary objective is to consolidate MDPI’s position as well-established publishing brand”

As the world’s number one open-access publisher, MDPI has long been a game-changer in the scholarly community, serving millions of authors. The challenge in being a trailblazer is the need to continuously improve and at the same time explore the next blue-ocean strategy, while also maintaining the smooth operation of the business. Our collection model, featuring guest-curated thematic topics in the form of Special Issues, has disrupted the industry. Other publishers closely study us and attempt to replicate our models. The future of this collection model is something we are actively addressing – while, of course, looking ahead to what comes next!

Stefan Tochev
Chief Executive Officer

19 October 2023
Open Access Week 2023 – the Global Drive to Open Continues

MDPI has been a strong proponent of the open access publishing model right from the beginning. As one of the pioneering fully open access publishers, we firmly believe that unrestricted access to research findings forms the foundation for better transparency, efficiency, and quality control across all scientific disciplines.

In December 2022, we reached a significant milestone by surpassing one million articles published. That is one million articles freely available to all, to circulate and build upon!

Offering free and immediate access to scientific papers empowers scientists to examine, validate, replicate, and expand upon existing results. This not only helps prevent redundancy and optimizes how resources are used but also paves the way for innovative new approaches.

The International Open Access Week takes place from 23 to 29 October 2023, providing a unique opportunity to connect the global movement towards open sharing and open science with the progress of policy transformations at the local level.

Our goal, during Open Access Week as well as throughout the year, is to offer resources for educating people about the benefits of open access publishing. The MDPI Blog offers a wealth of information around open access and open science.

Promoting the values of accessibility, transparency, and collaboration

Open access publishing embodies the fundamental values of democratizing knowledge and fostering global accessibility. It aims to break down barriers that have traditionally limited access to scholarly work, ensuring that knowledge is available to all, regardless of their financial or institutional affiliations. 

Discounts are part of our commitment to ensuring there are diverse pathways to Open Access publishing for researchers worldwide. MDPI supports scientific communities in several different ways. 

One of the key strengths of open access publishing lies in its ability to facilitate interdisciplinary research. By removing paywalls and promoting the sharing of knowledge across disciplines, OA encourages collaboration and innovation. Researchers from diverse fields can access and build upon each other's work, fostering a holistic approach to addressing complex global challenges. 

Funders' policies are getting aligned with open science

Governments, institutions, and funding agencies have recognized the transformative potential of open access and have implemented policies to promote it. These policies often mandate that publicly funded research should be made openly accessible. Such initiatives have accelerated the growth of open access repositories and journals, reinforcing the commitment to open access principles. Check our spotlights on OA policies in the USEU and China

Open access publishing is continually evolving, with innovative and community-driven models and technologies shaping its future. Initiatives like "Plan S" and "cOAlition S" promote the adoption of OA publishing from the national funders’ perspective by requiring grantees to publish their research openly. A new policy announced by the US administration last year requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. 

Additionally, preprint servers such as MDPI's, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing. 

For more than twenty years, open access scholarly publishing has been revolutionizing academia by promoting the values of accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As open access continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change. 

MDPI is proud to be a leader in the transition to open access.

18 October 2023
Meet Us at Neuroscience 2023, 11–15 November 2023, Washington, DC, USA

Neuroscience 2023 will be held from 11 to 15 November 2023 in Washington, DC, USA. The conference is organized by the Society for Neuroscience.

The conference will gather scientists, clinicians, and decision makers from around the world, creating a platform for the communication of knowledge and the sharing of groundbreaking research on the brain as well as nervous system. As stated in the introduction to the conference, you can “Present new research. Exchange ideas. Expand collaborations. Strengthen your career.”

As one of the exhibitors of Neuroscience 2022 last year, MDPI will be a part of Neuroscience 2023 this year, and looks forward to meeting our scholars as well as new friends, hoping to impress you with our open access publishing model face-to-face.

The following MDPI journals will be represented:

  • Brain Sciences.
  • JCM.
  • Cells.
  • NeuroSci.
  • J. Intell.
  • Neuroglia.
  • JPM.
  • Biomedicines.
  • Clinics and Practice.
  • Diagnostics.
  • Neurology International.
  • Pathophysiology.
  • Psych.

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following link:

2 October 2023
MDPI Insights: The CEO’s Letter #4 - MDPI Presence in China

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.

Opening Thoughts

Open Access in China

It is Saturday, 23 September, and I have just returned from an unforgettable 12-day trip to China, visiting our main offices in Beijing and Wuhan. In the wake of a packed and very enjoyable agenda of internal and external meetings, I would like to use this edition of the CEO Letter to showcase how MDPI supports the scholarly community in China.

Coincidentally, Jack McKenna, Communications Associate from MDPI’s corporate content team, has just released a blog article discussing China’s open access (OA) policy. It is a timely read, providing a concise overview of the development of the OA movement in China and reflecting on its future. I shall draw some content from Jack’s piece and use this edition of the CEO Letter to highlight the various ways in which MDPI is involved in this market. And it would be remiss of me not to include some pictures and highlights from my travels!

Open Access Policy in China

As per Jack’s post, in 2020, China became the world’s leading producer of research articles. Today, China is experiencing a “substantial growth rate in OA [Open Access] publication”. This growth is supported by the State’s commitment to research & development and its policy “requiring the promotion of open science”.

Over the past two decades, there have been gradual developments in China’s OA framework, with repositories and platforms being developed in a consistent manner. Currently, key institutions across China – including the National Science Library, the National Science and Technology Library, and the Natural Science Foundation of China – support OA. The State aims to establish consistent policies across government agencies – a framework for a more encompassing embrace of OA across institutions.

In China, the number of subscription-only articles decreased by nearly 30% over the 10-year period of 2011–2021, while gold OA increased by 22%. Between 2017 and 2020 alone, China published 800,921 academic papers in an OA format.

In 2023, as the leading publisher of academic research, China is pursuing “self-reliance”. Therefore, the State will be establishing consistent policies across government agencies, including those related to OA. Additionally, it will want to ensure that Chinese people can access the research that is supported by Chinese funding and produced by Chinese academics. For this reason, “Open Access is a matter of priority in China”.

MDPI Offices in China

 While the history of MDPI begins in Basel, Switzerland, the story of MDPI’s founder is very much rooted in China. Dr. Shu-kun Lin, Founder and President of MDPI, graduated with a BSc from Wuhan University in 1982. He also studied physical chemistry at the Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (1982–1986; MSc in 1985), and at the University of Louisville, USA (1987–1989). Dr. Lin completed his doctorate in organic chemistry at the Swiss Federal Institute of Technology (ETH-Zürich) in 1992.

Stefan Tochev (CEO, MDPI) at MDPI’s Wuhan office.

In 2002, MDPI’s Basel headquarters moved to Matthäusstrasse 11, 4052 Basel, and Dr. Lin opened an editorial office in Qingdao, China, which launched the journal Marine Drugs in the following year. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:

  • 2008: Beijing (Tongzhou, Haidian)
  • 2013: Wuhan (Hankou, Guanggu)
  • 2019: Tianjin
  • 2021: Dalian
  • 2021: Nanjing

Our Strength is in Our People

With over 6,000 MDPI staff, across 20 offices in 11 countries, MDPI is able to offer authors responsive and efficient round-the-clock support, enabling a rapid publication process.

In my experience, stakeholders are genuinely surprised when they realize the extent of our global operations. My response is to reiterate that our people are our strength. This is why we have fast and efficient processes and top-notch responsiveness. Our global presence ensures that your manuscript is constantly attended to, rather than sitting on someone’s desk. We prioritize our authors’ needs and act quickly to move things through the various stages of publication. MDPI is built on speed, convenience, and competence, which I believe are core pillars for success in any industry. We continually strive to improve our systems and processes on the basis of these core strengths. We literally have over 6,000 staff worldwide dedicated to serving your needs. It’s not magic: it’s people; it’s real.

Impactful Research

MDPI Awards

To support the academic community, and especially young researchers, and also to enhance communication among scientists, MDPI journals offer various awards in specific fields. We serve the scientific community by funding research to facilitate the development of sustainable global solutions through our annual World Sustainability Award and Emerging Sustainability Leader Award.

In 2022, MDPI made awards totalling over US$1 million in recognition and support of researchers worldwide.

Across our journal catalogue, we have granted over 2,000 awards to recognize and support researchers from all disciplines. Since 2016, these awards have served as a source of recognition, acknowledging the impact of research by heightening the influence of talented individuals. The award types mainly include the Young Investigator Award, the Best PhD Thesis Award, the Best Paper Award, and the Outstanding Reviewer Award.

To learn more about MDPI Awards and to find out which are currently available, please click here.

MDPI Awards to Scholars from China

Since 2021, there have been 23 Best Paper Awards granted to authors affiliated with Chinese institutions, identifying their papers as having high-quality scientific impact. A total of 45 Chinese scholars have received awards such as the Young Investigator Award, the Best PhD Thesis Award, the Outstanding Reviewer Award, and the Tu Youyou Award, among others. Prizes for these awards include MDPI grants for paid publications, totalling over CHF 70,000 for scholars affiliated with Chinese institutions.

MDPI’s Tu Youyou Award

Prof. Tu Youyou (left), Dr. Shu-Kun Lin (President, MDPI).

In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine “for her discoveries concerning a novel therapy against Malaria.” In order to commemorate Professor Tu’s contributions to human health and to promote the passion and spirit conveyed by her experiences, MDPI in 2016 established the ‘Tu Youyou Award’, which runs biennially to recognize outstanding scholars dedicated to the research of natural products and medicinal chemistry.

The 2022 Tu Youyou Award was granted to Prof. Dr. Xiaoguang Lei of Peking University. Click here to access the interview with the winner.

2015 Nobel Prize for Medicine Awarded to Professor Youyou Tu

Professor Tu’s work was celebrated in a Special Issue from Molecules on the occasion of her 80th birthday. The Special Issue: 'Artemisinin (Qinghaosu): Commemorative Issue in Honor of Professor Youyou Tu on the Occasion of her 80th Anniversary” was created five years before she won the Nobel Prize, highlighting the visibility MDPI provides researchers and their work.

Highly Cited Articles by Chinese Scholars Published in MDPI

Click here to access the most cited MDPI papers published by scholars affiliated with Chinese institutions. This list presents the most influential research from the more than 287,000 MDPI papers published by Chinese scholars. With over 9 million total citations, I encourage you to maximize your visibility and impact by publishing with MDPI, the number one most cited open access publisher.

Read more:

Inside MDPI

Stefan Tochev (CEO, MDPI) with the Beijing Marketing team.

Marketing Department in China

During my visit to our offices in Beijing and Wuhan, I had the opportunity to meet with, and to present to, our local marketing teams. These teams are responsible for various journal-related and corporate promotional activities, including newsletters, conferences, seminars, author training, journal awards, content creation, digital marketing, and social media.

I was pleased by the ambition and curiosity of our marketing colleagues. They showed a strong desire to collaborate and acquire knowledge and tactics to effectively market and promote MDPI-journal-related activities. I presented some of the principles and objectives that we apply in the Corporate Marketing and Communications department, and used the opportunity to strengthen our collaborative communications across offices.

Stefan Tochev (CEO, MDPI) with the Wuhan Marketing team.

Coming Together for Science

Collaborations, Scholarships and Meetings

MDPI maintains partnerships with nearly 190 learned societies and over 800 institutions and consortia, helping to facilitate the transition to OA publishing. Our commitment to working with institutions is evident in China, where we have successfully established over 35 Institutional Open Access Programs (IOAP) with esteemed institutions such as the Tsinghua University, Huazhong University of Science and Technology, and Shanghai Jiao Tong University.

Our institutional partnerships, waiver programs, and article processing cost discounts create diverse pathways to OA publishing for researchers worldwide.

Scholarships in China

Since 2021, several MDPI journals (Sensors, Photonics, Coatings, Materials, Energies, and Journal of Fungi) have funded full scholarships for four Master’s and five Ph.D. projects in China. These scholarships align with Tianjin University, Wuhan University of Technology, Central South University, the Chinese Academy of Sciences, and the China University of Petroleum (Beijing).

Meeting with the Society of Chinese University Journals (CUJS)

Prof. Tieming Zhang (President of CUJS, centre) and MDPI colleagues at CUJS office.

I am pleased to have participated in some highly productive meetings during my visit to China, including one with the Society of Chinese University Journals (CUJS). The meeting involved Prof. Tieming Zhang (President of CUJS), Assoc. Prof. Xin Zhang (Vice President and Secretary General), and Dr. Fei Gao (Executive Member of CUJS). Alongside my colleagues Dr. Guoshi Liu, Dr. Giulia Stefenelli, and Anita Sun, I represented MDPI and held an open discussion to address any questions regarding OA and MDPI.

We discussed several methods for collaboration, including a workshop on the future of peer review, MDPI sponsoring a funding grant for early-career researchers, and transitioning journals from diamond to gold OA. I am thankful for the opportunity to have met our colleagues at CUJS in person and feel very confident about our future collaborations in support of OA publishing in China.

MDPI hosts free academic seminars, author training sessions, and academic conferences as part of its commitment to enrich and support the scholarly community. CUJS often stages academic events (e.g., conferences, editor training, and editor competitions), and I believe there are great opportunities for CUJS and MDPI to collaborate accordingly.

Meeting with National Science Library, Chinese Academy of Sciences (NSLC)

Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Officers, MDPI), Anita Sun (PR Manager, MDPI) and Dr. Guoshi Liu (Managing Director, MDPI) at the National Science Library, Chinese Academy of Sciences.

We also visited the NSLC Director, Xiwen Liu, and colleagues Ying Jin, Zhesi Shen, and Sichao Tong. Following our introductions, we gave a presentation on the history and editorial process at MDPI, discussing specific details related to MDPI’s business and data. We highlighted the status of our  IOAP collaborations in China and the makeup of our author base, specifically in China, and drew attention to the fact that MDPI has published research by authors from every country in the world. We then discussed the design indicators, calculation methods and implementation purposes of the ‘Early Warning Journal List’ and how we can have open communication to provide any data regarding MDPI journals. I am pleased to report that we reached a consensus on future communications, and am grateful to NSLC for hosting us in their offices.

In-person meetings with stakeholders provide an invaluable opportunity to communicate what MDPI is about and the various ways in which we serve the scholarly community. While digital marketing and online communication are essential, they are no replacement for the understanding and trust that come about through in-person interactions.

The Numbers

As at September 2023, China holds the largest position in MDPI’s global market, ranking as the largest contributor to the total number of papers published by MDPI.

At this point in time, there were more than 847,000 China mainland scholars who have published with MDPI, 51 of whom are Section-Editors-in-Chief (SEiC) of MDPI journals, with seven serving as Editors-in-Chief (EiCs) for journals such as Air, Big Data and Cognitive Computing, Blockchains, Future, Nanoenergy Advances, and Targets.

Our growth and presence in China are a true testament to the service we provide to the scholarly community, and to the relationships we foster through collaborative activities. We look forward to continuing to support the growth of the scholarly community in China, providing a valuable and trusted experience with MDPI.

Closing Thoughts

Final Reflections on our MDPI Offices in Beijing and Wuhan

Stefan Tochev (CEO, MDPI), Dr. Constanze Schelhorn (Indexing Manager, MDPI), Jiale Shang (Admin, Tongzhou, MDPI) at Beijing Capital International Airport, Beijing.

I spent approximately two weeks visiting some of our offices in China, and the first word that comes to mind when describing my experience is ‘hospitality.’ My colleagues and I were met with enthusiasm and delight at the airport by the Tongzhou Admin team (thank you, Jiale Shang, and thank you, Eric Wang, for keeping us organized on this trip!) and were taken care of with great attention. From hotels to transportation, dinners, and meetings, our stay was catered for perfectly.

Perhaps this is where MDPI’s focus on customers and service originates. At our core, we are a service company that provides a publishing platform for its authors. It’s therefore no surprise that authors consistently rate their experience with MDPI very highly.

95% of submitting authors rate their overall experience with the MDPI publication process as Excellent or Good (Springer Nature report 90%).

91% of submitting authors rate their overall experience with the MDPI peer review process as Excellent or Good.

Speed/Efficiency and Editorial Relationship are two key reasons underlying this high satisfaction score. ‘Editorial Relationship’ can be further explored, but in the past month, the most commonly noted aspects were the professionalism, kindness, availability, communicativeness, and personalized assistance provided by our editorial staff throughout the process. These attributes are at the core of our work across all our offices and continents.

Hospitality and Service

Just as our Chinese colleagues strove to keep us engaged by showing us the city sights (thank you, Thea Pan, and Jason Wu from the Wuhan Marketing team!) and sharing a variety of wonderful meals, our editorial staff are committed to serving our authors throughout their publishing journey. Our aim is to place the author at the centre of everything we do, eager to welcome our ‘guests’ and provide them with a pleasant publishing experience.

I asked my colleague Francis Wu (Senior Publisher, Wuhan office) where this hospitality originates. He responded that it is part of Chinese culture. I reflected long and deep on this answer. China is a vast country, and when visitors arrive, hosts want to ensure they feel welcomed and taken care of in order to maximize their time and visit. I can’t think of a better analogy for how I would want our authors to feel when they visit MDPI for their publishing needs. A company culture that prioritizes service, something that goes beyond products and productivity, and focuses on the overall experience. Over 6,000 people, across all MDPI offices, are ready, willing and able to go the extra mile for their colleagues and their customers. This is something I am truly proud of.

Stefan Tochev
Chief Executive Officer

19 September 2023
Meet Us at the 13th Member Congress of the Chinese Society of Biochemistry and Molecular Biology and 2023 National Academic Congress, 19–22 October 2023, Hefei, China

MDPI will attend the 13th Member Congress of the Chinese Society of Biochemistry and Molecular Biology and 2023 National Academic Congress. This event will be held from 19 to 22 October 2023 in Hefei, China, and is hosted by the Chinese Society of Biochemistry and Molecular Biology.

This event includes invited reports of the conference, branch (special topic) reports, and posters. The theme of this conference is gene expression and regulation; RNA function and regulation; protein modification and function; metabolic homeostasis and networks; frontier technology and application, etc.

The following MDPI journals will be represented:

  • Biomolecules (leading);
  • Genes (leading);
  • IJMS (leading);
  • Cancers;
  • Cells;
  • Pharmaceutics;
  • CIMB;
  • Biology;
  • Symmetry.

If you plan on attending this conference, please feel free to stop by our booth (#C07) and chat with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit

6 September 2023
Recap of Awards Granted to Scholars in 2022

MDPI is committed to supporting the academic community, nurturing talent and advancing science. Awards are an important part of the research landscape and play a vital role in helping academics gain recognition, especially young researchers as they embark on new research avenues.

In 2022, our journals presented a total number of 394 Awards, including Travel Awards, Young Investigator Awards, Best PhD Thesis Awards, Best Paper Awards, and Outstanding Reviewer Awards, with several winners announced for some of the awards. The total prize sum amounted to just under 580,000 Swiss francs (CHF), or approximately 650,000 US dollars. Overall, more than 720 scholars were awarded.

The majority of the awards were dedicated to young researchers in relatively early stages of their careers. This encompassed 66 of the afore-mentioned Travel Awards, 60 Young Investigator Awards, supporting research projects and conference attendance, as well as 51 Best PhD Thesis Awards. Additionally, 113 Best Paper Awards were given by our journals. The selection committees were entrusted with identifying the most impactful and novel research and review articles published in their journal within a given year.

MDPI will continue its support and recognition for the academic community moving forward, sponsoring new awards across disciplines. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:

To explore more MDPI awards, please click here.

30 August 2023
MDPI Insights: The CEO’s Letter #3 - Sustainability and Co-opetition

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.

Opening Thoughts

Our Commitment to Sustainability

As a pioneer in academic open access publishing since 1996, MDPI has always been dedicated to facilitating scientific exchange across all disciplines. Our approach to open science is guided by principles such as Open Access (OA), Timeliness and Efficiency, Simplicity, High-Quality Service, Flexibility, and a commitment to Sustainability. This commitment involves preserving published papers for the long term and supporting the future of science through partnerships, sponsorships, and awards.

In this edition of the CEO Letter, I will delve into MDPI’s various sustainability initiatives. As a leader in OA publishing, we are able to provide the public with a significant amount of environment-related content at no cost.

MDPI and the Sustainable Development Goals (SDGs)

In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs. We also support authors from underrepresented communities by waiving publication charges for selected SDG-related papers. Detailed sustainability practices and supported publications are available in the report under each Goal page.

“More than 80% of MDPI articles and reviews published in 2022 relate to the Sustainable Development Goals.” [source: InCites, Accessed on 21.08.2023]

As at August 2023, MDPI boasts 14 journals dedicated to sustainability-related topics. Our first journal in this area, Sustainability, has published over 29,000 articles on the SDGs, accumulating over 240,000 citations (source: InCites, as at 1 January 2023). These journals serve as vital platforms for researchers to share insights and address environmental challenges. In addition:

MDPI journals specializing in sustainability-related topics:

  • 2009: Sustainability
  • 2012: Resources
  • 2013: Climate
  • 2014: Environments
  • 2016: Recycling
  • 2019: Clean Technologies
  • 2020: Sustainable Chemistry
  • 2021: Wind, Biomass, Conservation, Pollutants, Solar
  • 2022: Waste, Microplastics

Read more:

Impactful Research

Highly Cited Articles in Sustainability

In 2022, content published in Sustainability and indexed in Journal Citation Reports (JCR) received nearly 190,000 citations. This highlights the fact that Sustainability publishes highly cited research articles related to environmental sciences and SDG-related topics such as climate action.

We are pleased to share that Sustainability received a 2022 CiteScore of 5.8, marking a 16% increase from the 2021 metric. Specifically, the CiteScore positions Sustainability as follows: Q1 (27 out of 163) in the “Environmental Science (miscellaneous)” category, and Q1 (101 out of 779) in the “Geography Planning and Development” category. For additional journal statistics, please visit here.

“Sustainability received a 2022 CiteScore of 5.8”

While MDPI journals such as Climate and Atmosphere have a distinct focus on atmosphere pollution and its impact on climate processes, journals like Sustainability, Environments, Water, Remote Sensing, and IJERPH publish content related to climate change. These journals have published over 32,300 articles related to SDG 13: Climate Action.

Highly Cited Papers in Sustainability

Below are several highly cited papers published in Sustainability over the past three years. Citation metrics are current as at 15 August 2023.

1. “A Global Assessment: Can Renewable Energy Replace Fossil Fuels by 2050?
Authors: Jerry L. Holechek, Hatim M. E. Geli, Mohammed N. Sawalhah, and Raul Valdez
Sustainability 2022, 14(8), 4792;
Citations: Crossref (97), Scopus (91), Web of Science (82), Google Scholar (125)

This paper addresses one of the most significant challenges of climate change – achieving Net Zero Carbon by 2050. The meta-analysis suggests that while difficult, this transition is possible through the concerted application of pathways, lifestyle changes, and global cooperation.

2. “Anxiety and the Ecological Crisis: An Analysis of Eco-Anxiety and Climate Anxiety
Author: Panu Pihkala
Sustainability 2020, 12(19), 7836;
Citations: Crossref (144), Scopus (121), Web of Science (159), Google Scholar (382)

This paper has received substantial media attention, including coverage by The Guardian, BBC, Vice, and CNBC. An interview with Dr. Panu Pihkala, a leading interdisciplinary researcher on the topic, can be found on MDPI’s podcast: Insight Faster, Episode 1.

3. “Impact of Climate Change on Agriculture and Its Mitigation Strategies: A Review
Authors: Gurdeep Singh Malhi, Manpreet Kaur, and Prashant Kaushik
Sustainability 2021, 13(3), 1318;
Citations: Crossref (207), Scopus (221), Web of Science (186), Google Scholar (355)

This paper reviews literature on climate change, addressing its causes, future projections, impact on agriculture, including plant physiology, growth, productivity, pest infestation, and the economic implications of mitigation strategies.

4. Impacts of Plastic Pollution on Ecosystem Services, Sustainable Development Goals, and Need to Focus on Circular Economy and Policy Interventions
Authors: Rakesh Kumar, Anurag Verma, Arkajyoti Shome, Rama Sinha, Srishti Sinha, Prakash Kumar Jha, Ritesh Kumar, Pawan Kumar, Shubham, Shreyas Das, Prabhakar Sharma, and P. V. Vara Prasad
Sustainability 2021, 13(17), 9963;
Citations: Crossref (134), Scopus (136), Web of Science (113), Google Scholar (184)

This review aims to assess the adverse effects of plastic pollution on ecosystems, link the management of plastic with the SDGs, and propose policy measures using transdisciplinary approaches. Empowering communities to reduce plastic use is crucial. Addressing global plastic pollution is a priority.

Sustainability is an international, cross-disciplinary, open access journal that explores environmental, cultural, economic, and social sustainability of human beings. It provides a forward-looking platform for research on sustainability and sustainable development, and is published semi-monthly online by MDPI. Sustainability is affiliated with The Canadian Urban Transit Research & Innovation Consortium (CUTRIC) and The International Council for Research and Innovation in Building and Construction (CIB).

Read more:

Inside MDPI

President of Ireland Authors Editorial in MDPI Journal Sustainability

It’s a very special occasion when the president of a country takes the initiative to write an editorial for a journal. Michael D. Higgins, President of the Republic of Ireland, has contributed his insights to a forthcoming Special Issue in Sustainability:

This Special Issue, focusing on “making sustainable development happen” at grassroots levels, allows for perspectives from, and on, the major world faiths, exploring how challenges have been conceptualised and addressed, in addition to case studies of faith-based sustainability initiatives in practice.

The experience of faith institutions and communities in translating theological and moral commitments to sustainable development into action is now a topic we must examine with urgency; one on which I am so glad this Special Issue focuses.

As President of Ireland, I very much support this Special Issue of Sustainability. It is my great hope that the contents of the papers contained herein will assist in making sustainable development happen at grassroots levels across the world so that we can cooperate together, people of faith and of none, to ensure a just, inclusive and sustainable future for all on our fragile planet.

Read the completed editorial here:

Special Issue “Faith and Sustainable Development: Exploring Practice, Progress and Challenges among Faith Communities and Institutions”: Foreword by the President of Ireland
Author: Michael D. Higgins
Sustainability 2023, 15(12), 9683;

Coming Together for Science

The World Sustainability Forum 2023

The World Sustainability Forum (WSF) is a biennial MDPI event focused on sustainability. WSF 2023 marks the tenth anniversary of the conference series, taking place on 14 September. For the first time, the event will be hosted as a 24-hour conference across three locations – Singapore, Basel in Switzerland, and Toronto in Canada – alongside virtual streaming.

This unique format allows us to span three time zones, providing live coverage of critical sustainability-related topics throughout the day:

  • The Singapore Hub, chaired by Professor Horn Mun Cheah and Associate Professor Renee Tan, will explore “Sustainability for Social and Community Impact”.
  • The Basel Hub, chaired by Prof. Dr. Anet Režek Jambrak and Dr. Lela Mélon, will delve into “Sustainability in the industry, and at university and corporate settings”.
  • The Toronto Hub, led by Dr. Umberto Berardi, will discuss “The Sustainable Built Environment”.

MDPI Sustainability Foundation: Recognizing Excellence in Sustainability Research

The MDPI Sustainability Foundation supports researchers through two sustainability-focused awards:

  1. The World Sustainability Award, amounting to USD 100,000, is given to senior researchers.
  2. The Emerging Sustainability Leader Award, valued at USD 20,000, sponsored by the journal Sustainability, is presented to early-career researchers.

The winners of the Sustainability Foundation will be formally awarded during the WSF2023 on 14 September. Interviews with the award winners and finalists are available below.

2023 World Sustainability Award Winners

  1. Professor Michael R. Templeton
  2. Professor Tom Lyon
  3. Dr Krithi K. Karanth

Interviews with 2023 Emerging Sustainability Leader Award Finalists

  • Dr. Bahareh Kamranzad
  • Dr. Youjin Kim
  • Dr. Julia Lohmann

As a hybrid event, WSF23 provides scholars with the option to attend in person at one of the conference sites or, for a more sustainable approach, virtually. All sessions will be recorded and archived for future access. Registration is open until 3 September 2023, with in-person and virtual tickets available here.

Read more:

Closing Thoughts

“Co-opetition”: Collaboration Plus Healthy Competition – A Visit to Elsevier

I firmly believe in fostering collaboration and at the same time promoting healthy competition within the academic publishing industry. The market offers ample room for publishers and related companies to provide valuable services and products that enrich the academic community. While MDPI is recognized for its efficient and streamlined processes –thanks to our over 6,000 colleagues, in-house tools, and initiatives that support the author journey – our ethos has always involved learning from and collaborating with other organizations.

MDPI’s Interaction with Elsevier

In January 2023, I had a brief conversation with Judy Verses, President of Global Academic and Government Markets at Elsevier, following her participation in a panel discussion at the Academic Publishers Europe event in Berlin. One of the highlights for me was Judy’s insight into the impact of research, particularly her emphasis on the role of collaboration, including policy and showing the impact of research to influence on funding decisions.

“Such collaborations drive forward-looking strategies to elevate our support for the scholarly community”

Judy and I resumed our discussion in August, when I visited Elsevier's office to review current projects, such as our recent agreement with Science Direct and the continued indexing of MDPI journals in Scopus (indexing database owned by Elsevier). We also explored possible opportunities for the future, including a potential collaboration to expand MDPI’s Scilit data infrastructure. This endeavour aims to aggregate and provide access to scholarly metadata encompassing journal articles, conference papers, books, preprints, and more. While these discussions are ongoing, the underlying principle remains that such collaborations drive forward-looking strategies to elevate our services and support for the scholarly community.

It was great that Judy and I acknowledged the merits of 'co-opetition,' a concept based of the belief that fostering cooperation alongside healthy competition can lead to shared advancements for both individual companies and the industry at large.

‘Fully OA’ Organizations Dedicated to Open Access

MDPI proudly aligns with the ‘Fully OA’ group, a collaborative initiative comprising nine organizations dedicated to Open Access. Our monthly meetings, including an OASPA representative, serve as platforms to share non-confidential information, resources, and projects. These gatherings also facilitate discussions on topics relevant to fully OA organizations. Occasionally, joint actions spring from these interactions, such as collaborative blog posts on pertinent subjects and joint statements, such as a recent response to the House Appropriations Committee.

This display of cooperation among competing entities forms a strategic alliance focused on nurturing the best interests of the OA publishing model.

As I wrap up this third edition of the CEO Letter, I encourage you to seize opportunities for collaboration and contribute to advancing our shared academic culture. As the African proverb has it, “If you want to go fast, go alone; if you want to go far, go together.”

Stefan Tochev
Chief Executive Officer

14 August 2023
MDPI’s 2022 Young Investigator Awards in Biology and Life Sciences—Winners Announced

MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2022 in biology and life sciences. The winners were selected by the journals’ Award Evaluation Committee.

We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.


  • Thomas Hartinger, University of Veterinary Medicine Vienna, Austria


  • Leontina Lipan, Universidad Miguel Hernández, Spain


  • Daniel Stec, Polish Academy of Sciences, Poland

Brain Sciences:

  • Dibyadeep Datta, Yale Medical School, USA
  • Giacomo Valle, ETH Zurich, Switzerland
  • Morgan H. James, Rutgers University, USA


  • Xiaonan Lu, McGill University, Canada


  • Alfredo Iacoangeli, King's College London, UK
  • Elisa De Franco, University of Exeter, UK
  • Riccardo Pecori, German Cancer Research Center, Germany
  • Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal


  • Massimiliano Renna, University of Bari Aldo Moro at Bari, Italy


  • Adam G. Dolezal, University of Illinois Urbana-Champaign, United States


  • Carla Rodrigues, Institut Pasteur, France
  • Lorena Rodriguez-Rubio, University of Barcelona, Spain
  • Kevin Solomon, University of Delaware, USA


  • Colleen Deane, University of Southampton, UK


  • Paz Otero Fuertes, University of Vigo, Spain


  • Marta Giovanetti, National Reference Laboratory of Flavivirus in the Oswaldo Cruz Foundation, Brazil
  • Carrie M. Long, National Institute of Allergy and Infectious Diseases (NIAID), USA


  • Carina Joe, University of Oxford, UK

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s 2022 Travel Awards in Biology and Life Sciences—Winners Announced

We are proud to recognize the winners of MDPI’s 2022 Travel Awards in biology and life sciences for their outstanding presentations.

MDPI journals regularly offer travel awards to encourage junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the winners of the 2022 Travel Awards and wish them the greatest success in their future research endeavors. MDPI will continue to enhance communication among scientists.

Brain Sciences:

  • Liloia Donato, University of Turin, Italy
  • Roberta Bettoni, University of Milano Bicocca, Italy


  • Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal


  • Carlo Matera, University of Milan, Italy
  • Elisabetta Coppi, University of Florence, Italy
  • Ilaria Tonazzini, Nanoscience Institute—National Research Council (CNR) @ NEST in Pisa, Italy


  • Pere Catala, University Eye Clinic Maastricht, Maastricht University Medical Center, the Netherlands


  • Angela Blasimann, University of Antwerp, Belgium
  • Angelo Sabag, Western Sydney University, Australia

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s 2022 Outstanding Reviewer Awards in Biology and Life Sciences—Winners Announced

In order to acknowledge our reviewers, who demonstrate diligence, professionalism, and timeliness when generously dedicating their time to reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer review process.

We are proud to recognize the winners for the year 2022 in biology and life sciences for their outstanding contributions, among extensive competition, by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievements. MDPI will continue to provide support and recognition to the academic community.


  • Ewa Ropelewska, The National Institute of Horticultural Research, Poland
  • Marek Rašovský, Slovak University of Agriculture in Nitra, Slovakia
  • Prakash Jha, Kansas State University, USA
  • Vasileios Greveniotis, Institute of Industrial and Forage Crops, Greece


  • Alberto Collareta, University of Pisa, Italy
  • Francisco Curate, University of Coimbra, Portugal
  • Gianpiero Greco, University of Study of Bari, Italy
  • Luca Poli, University of Study of Bari, Italy
  • Shaohua Chen, South China Agricultural University, China

Brain Sciences:

  • Chong Chen, Yamaguchi University Graduate School of Medicine, Japan


  • Marco Sapienza, University of Catania, Italy
  • Sabina Barrios-Fernández, University of Extremadura, Spain


  • Corrado Battisti, Torre Flavia LTER (Long Term Ecological Research) Station, Italy
  • Daniel Stec, Institute of Systematics and Evolution of Animals of the Polish Academy of Sciences, Poland
  • Emilia Grzędzicka, Institute of Systematics and Evolution of Animals of the Polish Academy of Sciences, Poland
  • Igor Zelnik, University of Ljubljana, Slovenia


  • Eva S. Liu, 1Harvard Medical School, USA 2Brigham and Women’s Hospital, USA


  • Aleksandra Szydlowska, Warsaw University of Life Sciences (WULS), Poland
  • Mohamed Ali Abdel-Rahman, Al-Azhar University, Egypt


  • Andrew G. Jeffs, University of Auckland, New Zealand
  • Mohamed Samy-Kamal, Universitat d'Alacant, Spain


  • Baskaran Stephen Inbaraj, Fu Jen Catholic University, Taiwan
  • Marzena Włodarczyk-Stasiak, University of Life Sciences in Lublin, Poland
  • Minaxi Sharma, Haute Ecole Provinciale de Hainaut-Condorcet, Belgium
  • Viviani Ruffo de Oliveira, Federal University of Rio Grande do Sul (UFRGS), Brazil


  • Federico Manuel Giorgi, University of Bologna, Italy
  • Jan Bocianowski, Poznań University of Life Sciences, Poland
  • Magdalena Mroczek, Center for Cardiovascular Genetics and Gene Diagnostics, Switzerland


  • Keigi Fujiwara, University of Texas MD Anderson Cancer Center, USA
  • Tomasz W. Kaminski, University of Pittsburgh, USA
  • Takujiro Homma, Yamagata University, Japan
  • William Bryan Terzaghi, Wilkes University, United States
  • Zong-jie Cui, Beijing Normal University, China


  • Abraão Almeida Santos, University of Florida, USA
  • Agata Kaczmarek, Polish Academy of Sciences, Poland
  • Miguel A. García-Martínez, Universidad Veracruzana, Mexico


  • Andrei S. Rodin, Diabetes and Metabolism Research Institute, USA
  • Kazuhiko Kotani, Jichi Medical University, Japan


  • Jianing Mi, King Abdullah University of Science and Technology, Saudi Arabia
  • Nguyen Phuoc Long, Inje University College of Medicine, Republic of Korea
  • Xian Luo, University of Alberta, Canada


  • Guillaume Fiches, Ohio State University, USA
  • Jianxuan Wu, Gilead Sciences, USA
  • Tomasz M. Karpiński, Poznań University of Medical Sciences, Poland


  • Alicia Ayerdi Gotor, Institut Polytechnique UniLaSalle, France
  • Andrea Mastinu, University of Brescia, Italy
  • Edyta Paczos-Grzeda, University of Life Sciences in Lublin, Poland
  • Narayan Bhusal, Seoul National University, Republic of Korea
  • Mohsen Hesami, University of Guelph, Canada


  • Christian Müller, University of Greifswald, Germany
  • Margarita Fernández-Tejedor, IRTA, Spain


  • Christian Napoli, “Sapienza” University of Rome, Italy
  • Federico Marchesi, University of Parma, Italy
  • Roger E. Thomas, University of Calgary, Canada

Veterinary Sciences:

  • Fun-In Wang, National Taiwan University, Taiwan
  • Valeria Grieco, University of Milan, Italy

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s 2022 Best PhD Thesis Awards in Biology and Life Sciences—Winners Announced

MDPI’s Best PhD Thesis Awards are presented to recognize the young scholars who are judged to have completed the most outstanding PhD thesis in their field of research and to encourage them to continue their outstanding work and further contributions to their field.

We would like to warmly congratulate the winners of the 2022 Best PhD Thesis Awards and wish them success in their future research endeavors. MDPI will continue to enhance communication among scientists.

Brain Sciences:

  • “CYP2D in the Brain Alters Response to Drugs and Neurotoxins”
    by Marlaina R. Stocco, University of California, USA
  • “Neural Encoding of Prior Experience in Sensorimotor Behavior”
    by Nicolas Meirhaeghe, Institut de Neurosciences de la Timone, France
  • “Perinatal Stem Cell: Epigenetic, Biological and Differentiative Characteristics”
    by Giulia Gaggi, University "G.D'Annunzio" of Chieti-Pescara, Italy


  • “Uncovering the Genetic Variation Involved in Asthma Exacerbations through Multiple Genomic Approaches”
    by Esther Herrera Luis, Universidad de La Laguna, Spain

Veterinary Sciences:

  • “Development of Novel Tools for Monitoring Antimicrobial Resistance in Complex Microbial Communities and Their Application to Improving Our Stewardship of Antimicrobials in Livestock”
    by Ashenafi Feyisa Beyi, Iowa State University, United States

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s Best Paper Awards in Biology and Life Sciences—Winners Announced in 2022

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as scientific merit, overall impact, and the quality of presentation.

We are honored to present the winners for the year 2022 in biology and life sciences, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.



Brain Sciences:












Veterinary Sciences:

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

27 July 2023
MDPI Insights: The CEO’s Letter #2 - Open Peer-Review and IJERPH

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.

Opening Thoughts

Open Peer Review Reports

Continuing the topic of openness from my inaugural monthly CEO letter, in these Opening Thoughts, I highlight the growth and importance of open peer-review reports at MDPI. Open peer reports align with the principles of open science, making the publishing process more transparent and facilitating rigorous peer review.

MDPI journals operate an open peer-review option by default, allowing authors to publish review reports and author responses (often referred to as open reports) together with the published paper. Publishing the reviewer reports and author responses together with the article provides greater transparency and trust for readers, as this allows them to track the editorial decision-making process. Open peer-review also encourages reviewers and editors to provide high-quality comments, as these will be made public if the article is accepted for publication.

Start and Growth of Open Peer Review at MDPI

The MDPI journal Life was a pioneer in offering this opportunity to its authors in 2014. The first MDPI article with peer-review reports openly published was a review by the Nobel Laureate Werner Arber, in which the review reports were published as supplementary material. By 2018, open peer-review was available across all MDPI journals. As such, MDPI authors have embraced the open peer-review model, providing a steady increase in the number of MDPI articles. As of 2023, approximately one-third (34.0%) of MDPI articles were published with open review reports.

As at July 2023, the percentage of MDPI articles published with open peer review has increased to 36.2% of the total papers published in 2023 so far, indicating ongoing growth in adoption.

Open peer review continues to play a critical role in the assessment of the peer-review process in Life. For further insights, please see the recent editorial by Dr. Pabulo Henrique Rampelotto, the former Editor-in-Chief of Life, who spearheaded the implementation of the open peer-review process.

Benefits of Open Peer Review

The benefits of open peer review include increased transparency, trust and constructive feedback. To promote open communication further and increase the robustness of the peer-review process, we encourage reviewers to sign their reports so that their name appears on the review report (this process is referred to as open identity). The default option is for reviewers to remain anonymous; however, by signing the reports, reviewers receive direct credit for their contribution to the peer-review process and show their commitment towards open science.

As the leading open access publisher, MDPI remains committed to promoting open peer-review and encourages authors to choose this approach. Our goal is to provide a rigorous and transparent peer-review process that benefits the scientific community, and we believe that open peer-review is a vital step in fostering openness and collaboration in scientific communication.

Impactful Research

MDPI Papers Cited in the News – IJERPH edition

Every month, our corporate marketing team compiles data from Altmetrics to create a list of MDPI papers that have been cited in the news. This list continues to grow as renowned news outlets regularly reference research published by MDPI in their articles.

During 2022, a total of 111,965 MDPI research papers were mentioned in prominent news outlets such as National Geographic, The Washington Post, Forbes, The Guardian, the BBC, CNN, Time, and Harvard Business Review.

Highly Cited Journal Publications

IJERPH, known for publishing impactful research, received the most news mentions among all MDPI journals in 2022, based on Altmetrics data:

  • International Journal of Environmental Research and Public Health: 3509 mentions
  • Nutrients: 2698 mentions
  • International Journal of Molecular Sciences: 1701 mentions
  • Journal of Clinical Medicine: 1131 mentions
  • Viruses: 1111 mentions

These numbers show the recognition and impact of the articles published in IJERPH. For a more detailed view of the journal’s most cited and viewed papers, you can visit here. In total, IJERPH has garnered over 28,000 mentions in prominent news outlets, and as at July 2023, an impressive count of over 17,000 papers cited 10 times or more. These figures highlight the impactful contribution of IJERPH publications to the scientific community.

Example of Recent Mentions

During May and June 2023, a noteworthy selection of articles from IJERPH was cited in news articles, including:

The Washington Post: “Bringing nature inside can improve your health. Here’s how to do it.”
IJERPH paper:Physiological Benefits of Viewing Nature: A Systematic Review of Indoor Experiments

Harvard Business Review: “How to Take Better Breaks at Work, According to Research
IJERPH paper:Canine-Assisted Therapy Improves Well-Being in Nurses

National Geographic: “Lyme disease is spreading fast—but a vaccine may be on the way
IJERPH paper:Range Expansion of Tick Disease Vectors in North America: Implications for Spread of Tick-Borne Disease

Inside MDPI

MDPI Develops an Artificial Intelligence Tool to Enhance the Peer-Review Process

At MDPI, we believe that rigorous peer-review is the corner-stone of high-quality academic publishing. We are grateful to the scholars who generously dedicate their time to peer-review articles submitted to MDPI journals. Their contributions are invaluable to the advancement of science.

Peer-review is a critical part of the publication process, ensuring that MDPI upholds the highest quality standards for the papers we publish. Every manuscript submitted to our journals undergoes a comprehensive peer-review process conducted by subject-matter experts.

To further enhance our peer-review process, our Data Analytics team has developed an Artificial Intelligence (AI) tool designed to support the selection of reviewers. This proprietary tool utilizes Natural Language Processing (NLP), a specially designed AI language model, to extract information from the title and abstract of submitted papers. It then searches our database for similar manuscripts and suggests potential reviewers based on this analysis. Integrated with MDPI's submission system (SuSy), the AI tool cross-references the suggested candidates with our reviewer database to verify their invitation status and availability.

The goal of this tool is to provide better targeted peer-review invitations, reducing the number of emails sent for each paper and increasing the efficiency of our editorial staff.

In the near future, our Data Analytics team plans to deploy similar AI projects to improve other critical aspects of our services, offering an enhanced experience to our authors and readers.

Click here to learn about MDPI’s review process, including procedures, responsibilities, and benefits.

Read more:

Coming Together for Science

The Future of IJERPH

On 5 July 2023, Prof. Dr. Paul B. Tchounwou, the founding Editor-in-Chief of IJERPH, along with five Section Editors in Chief (Prof. Dr. Germán Vicente-Rodríguez, Prof. Dr. Karl Goodkin, Prof. Dr. William A. Toscano, Prof. Dr. Jimmy T. Efird, and Prof. Dr. William Douglas Evans), gathered in Basel to discuss the future of the journal. The meeting provided an opportunity to address the recent decision by The Web of Science to delist IJERPH due to the journal failing the Content Relevance criterion, and propose best strategies that will ensure high scientific rigor as well as a clear scope and aim of IJERPH, going forward.

While the delisting is disappointing for IJERPH, as well as for our authors, academic editors, and the entire scientific community supporting our journal, we see it as an opportunity to reflect and prepare for the future direction of the journal.

Since its launch in 2004, IJERPH’s vision and mission have evolved to be more complete and comprehensive in engaging scientific communities. In light of this, we will refresh the journal’s aims and scope, ensuring they align with the organic expansion of IJERPH. Additionally, we will restructure the journal sections into broader categories, encouraging collaborative research and transdisciplinary approaches for authors. This is designed to foster collaboration and knowledge exchange among diverse fields, contributing to a holistic understanding of health promotion and disease prevention. We are confident that these next steps will enhance the scientific strength and societal impact of our journal.

Journal Achievements

In addition to the productive discussions, we took the time to celebrate some of the remarkable achievements of IJERPH, which I highlight below:

  • Founded by Prof. Dr. Paul B. Tchounwou in 2004
  • Indexed in PubMed in 2008
  • Received its first Impact Factor in 2012
  • Published its 5000th paper in 2017
  • Over 60,000 papers published as at June 30, 2023
  • 131,628,173 paper views in 2018–2022
  • Over 28,000 mentions in prominent news outlets
  • 17,000 papers cited 10 times or more as at June 30, 2023
  • No.1 journal in the 2022 Google Scholar Metrics in the category of Public Health
  • Awarded several editions of Young Investigator Awards, Travel Awards, and Outstanding Reviewer Awards since 2018.

These achievements showcase the journal’s significant contributions to the field and its impact on global health. We are proud of the exceptional work accomplished by the IJERPH team and look forward to building upon this success in the years to come.

Closing Thoughts

MDPI’s Impact in Spain

During the past month, I had the opportunity to visit our new office building in Barcelona, where I met with our local colleagues to discuss the ways we serve the scholarly community, particularly in Spain. The multi-functional office plays a vital role in supporting various business needs, including editorial, design, conference management, data analytics, journal relationship management, publishing partnerships, and collaborations with societies.

Spain holds a significant position in MDPI’s global market, ranking as the fourth-largest contributor to the total number of papers published by MDPI as at July 2023, ranking next to Italy, the USA, and China, with Germany completing the top five.

The Numbers

Out of the 1,680,000 total MDPI articles published as at 25 July, almost 80,000 articles are contributed by Spanish authors, representing nearly 40,000 unique authors affiliated with Spanish institutions. Remarkably, over 6,300 of these authors hold editorial board member (EBM) positions within MDPI journals, with 30 of them serving as Editors-in-Chief (EiCs).

Our commitment to working with institutions is very evident in Spain, where we have successfully established over 40 Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Barcelona, the Autonomous University of Barcelona, Pompeu Fabra University, the University of Navarre, and Complutense University of Madrid.

Over the past five years, we have successfully organized eight in-person conferences in Barcelona, attracting over 1,150 registrations, with two forthcoming events scheduled for 2024. Barcelona's excellent connectivity to international airports makes it easily accessible to participants from around the world. Its welcoming atmosphere provides us with the perfect environment for knowledge-sharing, networking, and contributing to the local economy.

Our growth and presence in Spain are a true testament to the incredible service we provide to the scholarly community and the relationships we foster through responsive and collaborative communication. We look forward to continuing to support Spanish scholars, providing them a valuable and trusted experience with MDPI, the leader in open access publishing.


I close this letter as I did in the first edition, by sharing testimonials from our stakeholders. Here are a few IJERPH testimonials from a Spanish guest editor and an author:

Guest Editor
“I want to thank the kindness, attention and professionalism of the MDPI team throughout the editorial process of the Special Issue. I believe that it is a very professional and quality editorial process.”
- Professor Víctor Arufe-Giráldez, University of A Coruña
Special Issue in International Journal of Environmental Research and Public Health: Physical Activity in Childhood and Adolescence
Special Issue in International Journal of Environmental Research and Public Health: Physical Education: Present and Future
“I want to thank the rigor of the revisions made to the manuscripts to improve their quality, the support to the authors for the editor assignment system they have and the follow-up they carry out, for the speed in answering and in carrying out the entire process of the revision, and for doing all this at an affordable price.”
- Dr. María Paz García-Caro, University of Granada
Article in International Journal of Environmental Research and Public Health: Factors Associated with Suicide Attempts and Suicides in the General Population of Andalusia (Spain)

Stefan Tochev
Chief Executive Officer

26 July 2023
Meet Us at the 45th Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM 2023), 5–8 September 2023, Zaragoza, Spain

The 45th Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM 2023)
Date: 5–8 September 2023
Place: University of Zaragoza Faculty of Medicine, Zaragoza, Spain
Booth: #30

MDPI journals will be attending the 45th Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM 2023) as an exhibitor. This meeting will be held in Zaragoza, Spain, from 5 to 8 September 2023.

SEBBM contributed significantly to the creation of the Federation of European Biochemical Societies (FEBS) in 1964, represents Spain in the International Union of Biochemistry and Molecular Biology (IUBMB), is one of the founding members of the Confederation of Spanish Scientific Societies (COSCE) and belongs to the Spanish Association of Biocompanies (ASEBIO), which develops activities in the field of biotechnology in Spain.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website:

20 July 2023
Meet Us at the 2023 National Plant Biology Congress, 2–6 August 2023, Lanzhou, China

MDPI will be attending the 2023 National Plant Biology Congress as an exhibitor. This meeting will be held in Lanzhou, China, from 2 to 6 August 2023.

The conference is jointly organized by the Chinese Society of Genetics, Chinese Society of Cell Biology, China Crop Society, Chinese Society of Botany, and Chinese Society of Plant Physiology and Molecular Biology. The conference is scheduled to be held in Lanzhou, Gansu, China. Domestic experts, scholars, and outstanding young scientists who have made outstanding achievements in related fields of plant biology will be invited to give academic reports. The conference aims to promote exchanges and cooperation among plant scientists, promote the transformation and application of plant scientific research achievements in agricultural production practice, and help the revitalization of the seed industry.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference and our booth, please visit the following link:

19 July 2023
Meet Us at the 50th Annual Meeting of Japanese Society for Neonatal Screening, 25–26 August 2023, Niigata, Japan

MDPI will attend the 50th annual meeting of the Japanese Society of Neonatal Screening as an exhibitor. This meeting will be held in Niigata, Japan, from 25 to 26 August 2023.

The Japan Mass Screening Society started as a metabolic disorder screening study group established in 1973. At the national level, the world's top-level newborn screening is being carried out for more than 20 diseases. The society is made up of enthusiastic researchers and engineers from a wide range of fields, including obstetricians and gynecologists, pediatricians, basic medical researchers, and laboratory engineers. It has developed into an academic organization that has great significance in society.

The following MDPI journals will be represented:

  • International Journal of Neonatal Screening (IJNS);
  • Children;
  • Cells;
  • Healthcare.

If you are attending this conference, please feel free to start a conversation with us at our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit

11 July 2023
MDPI’s Newly Launched Journals in June 2023

With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.

The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal topics (selected)
Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue growth and development;
diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article
Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article
Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article
Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article
Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee ([email protected]) if you would like to create more new journals.

7 July 2023
Cells Webinar | Actin–Myosin Cytoskeleton Regulation and Function, Held on 19 July 2023

On 19 July 2023, MDPI and the journal Cells (ISSN: 2073-4409) organized the webinar entitled Actin–Myosin Cytoskeleton Regulation and Function.

This webinar, hosted by Prof. Dr. Michael F. Olson from Toronto Metropolitan University (Toronto, Canada), focused on the fascinating world of the actin–myosin cytoskeleton and the role of its key regulators, the Rho GTPases. Within the intricate and dynamic network of the cell, this system plays a crucial role in a myriad of cellular processes, ranging from cell division and migration to muscle contraction and intracellular transport. Dr. Mélanie Laurin described how her laboratory at Université Laval (Québec City, Canada) uses ultrasound-guided in utero lentiviral injection to investigate the contribution of Rho GTPase network components during skin morphogenesis. Dr. Valentin Jaumouillé from Simon Fraser University (Burnaby, Canada) showed that phagocytosis mediated by β2 integrins involves their mechanical coupling to the actin cytoskeleton by a mechanosensitive molecular clutch, which enables the discrimination of phagocytic targets based on their mechanical properties. Dr. Michael Samuel from the Centre for Cancer Biology (Adelaide, Australia) discussed novel molecular mechanisms regulated by mechanotransduction, including signaling molecules such as CRELD2, whose secretion is regulated by Rho-ROCK signaling, that could be targeted to suppress cancer metastasis.

Please note that this webinar is associated with a Special Issue in the Cells journal, “Actin-Myosin Cytoskeleton Regulation and Function Series 2”. The deadline is 15 September 2023. We also invite you to read the excellent papers in the first of the Special Issue series, “Actin-Myosin Cytoskeleton Regulation and Function”.

You can watch the recorded webinar at the following link:

Webinar Chair and Keynote Speakers:

  • Prof. Dr. Michael F. Olson, Department of Chemistry and Biology, Toronto Metropolitan University, Toronto, Ontario, Canada;
  • Dr. Mélanie Laurin, Department of Molecular Biology, Medical Biochemistry and Pathology, Université Laval, Canada;
  • Dr. Valentin Jaumouillé, Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada;
  • Dr. Michael Samuel, Centre for Cancer Biology, Adelaide, Australia.

3 July 2023
MDPI Insights: The CEO's Letter #1 - Open Access and Impactful Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.

Opening Thoughts

The Future is Open, and MDPI is Leading the Way

I strongly believe in a future that embraces openness, where open source, open information, and open access (OA) take center stage. This belief that led me to join MDPI in 2020, and I am honored to have recently been appointed as Chief Executive Officer (CEO). In this capacity, and operating in close liaison with Dr. Lin and MDPI’s senior management, I shall work to build on Dr. Lin’s achievements of the past quarter-century. In this role, I will focus on communication initiatives to promote MDPI's remarkable work and continue to build our company as a trusted leader in OA publishing. For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment and vision for an open future.

1 Million Published Articles

2023 began with a remarkable achievement for MDPI, as we became the first OA publisher to reach the milestone of 1 million published articles. This represents 2.7 million unique authors who have trusted us with their work, or about a third of all researchers worldwide. As the world's most cited OA publisher, we are proud in sharing these significant milestones.

Our mission remains unchanged: to make science open and accessible to all. We understand the importance of knowledge access, empowering researchers to stay at the forefront of a rapidly changing world. Our diverse range of journals covers a wide spectrum of disciplines, offering cutting-edge insights, trusted tools, and crucial knowledge to address global challenges.

Liberating Science

As the world’s leading OA publisher, MDPI is actively liberating science. We are committed to eliminating the frustrations researchers and the general public face when accessing information, ensuring it is not locked behind paywalls. We firmly believe that everyone has a right to information, and our commitment to open access publishing drives our work.

In this inaugural edition of Insights: The CEO's Letter, I draw inspiration from the upcoming 20th anniversary of the Berlin Declaration on Open Access. Its stated mission reminds us that true impact is achieved when knowledge is widely and readily available to society:

"Our mission of disseminating knowledge is only half complete if the information is not made widely and readily available to society”

Impactful Research

MDPI Publishes Impactful Research: Recognized by Leading Indexing Databases

MDPI journals are indexed in every single top database in the world.

As of June 2023, we have 214 journals indexed within Web of Science, 223 indexed within Scopus, 87 indexed within PubMed and PMC, and 17 indexed within MEDLINE, and these numbers increase every month. We constantly strive to expand the coverage of our journals within leading multi-disciplinary and scope-specific databases, resulting in an incredibly broad range of journals that are indexed within a variety of databases. MDPI has active relationships with approximately 65 well-known databases around the world, and we continue to expand our portfolio every year so that your work can be found, cited, and referenced with ease.

Continued Growth of MDPI Journals

The 2022 Scopus and Web of Science journal citation metrics were officially released in June, and I am pleased to report that 31 MDPI journals received their first CiteScore, taking the total number of journals with a CiteScore to 216. The number of MDPI journals receiving an Impact Factor (IF) also continues to grow with 111 receiving their first, by being covered in the ESCI, bringing our total number of journals with an IF to 208 of which 41 journals received an IF above 4.0. Looking at 2022 CiteScores in the Scopus database, 80% of MDPI journals have a score that ranks them in Q1 or Q2 in at least one subject category.

Publishing impactful science would not be possible without all of our authors, editors and reviewers. Thank you for your contribution and continued support! Together we share the latest scientific insights faster and ensure that your work is accessible to all.

Read more

Interview with Indexing Manager—Constanze Shelhorn

Inside MDPI Clarivate adds the Preprint Citation Index to the Web of Science

At MDPI, we are dedicated to driving the advancement of science. Through our initiative,, researchers can publish their work and gain valuable feedback from the broader research community, ensuring rapid progress in their respective fields. This is particularly crucial during times of health and climate challenges, where timely dissemination of findings is essential.

Increased Visibility for Preprints

I am pleased to share that Clarivate recognizes the significance of preprints and has taken a crucial step to enhance their visibility. Clarivate has added the Preprint Citation Index to the Web of Science, encompassing preprints published not only on but also on other reputable repositories.

Looking ahead, the future of preprints appears promising, bolstered by the recent indexing announcement from the Web of Science. As a result, preprints will receive increased visibility, serving as a valuable resource for staying informed about the latest research developments.

Read more

What are Preprints?
The Pros and Cons of Preprints
Preprints and COVID-19
Preprints—The Future of Open Access Publishing?

Coming Together for Science

The First International Conference on Antioxidants: Sources, Methods, Health Benefits and Industrial Applications

In this edition of ‘Coming Together for Science,’ I am pleased to highlight the First International Conference on Antioxidants organized by our conference team in the beautiful city of Barcelona, Spain. The conference attracted over 130 attendees, who engaged in 42 talks, and 89 poster presentations spread across several sessions.

Working Together

Under the leadership of Prof. Dr. Alessandra Napolitano (Department of Chemical Sciences, University of Naples ‘Federico II’, Naples, Italy) and Prof. Dr. Rosa M. Lamuela Raventos (Department of Nutrition, Food Sciences and Gastronomy, University of Barcelona, Spain) as chairs, and supported by the committee members, 10 invited keynote speakers, poster presenters, and all the attendees, this dedicated group of academics came together to discuss the natural sources, methodologies, health benefits, and industrial applications of antioxidants.

Especially noteworthy is the positive feedback received from attendees, with 94% rating the overall organization of the conference as good or excellent. I particularly love the picture above, capturing the gathering of some of the participants. You can browse through more photos in the event gallery located here.

Managing Events With Sciforum

If you are considering hosting your own academic event, I highly recommend checking out Sciforum, MDPI's event management platform. Sciforum simplifies the entire process, making it easy to host your own event by allowing you to focus on what really matters: Science!

Read more

Sciforum: forthcoming events
Spotlight on Antioxidants

Closing Thoughts

Stefan Tochev, Dr. Shu-Kun Lin, Dr. Eric O. Freed, Peter Roth, Wynne Wang, Allison Yang

Viruses and Editorial Quality: Acknowledging the Dedication of our Viruses Journal Team

During a June meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief of our journal Viruses, I was reminded of the exceptional dedication of our editorial board. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal. Over the course of two days, we gained a deep understanding of the journal’s expectations and focus on strategic growth, editorial board representation, and engagement.

I am pleased to share that Viruses holds a CiteScore of 7.1 (an increase of 7.57% versus the 2021 metric) and an Impact Factor of 4.7. You can view the journal statistics here. Viruses publishes highly cited papers, and is indexed in renowned databases such as Scopus, SCIE (Web of Science), PubMed, and others, and maintains affiliations with prestigious societies. Moreover, the Viruses team has recently announced an exciting upcoming event titled ‘Viruses 2024 – A World of Viruses,’ scheduled to take place in Barcelona, Spain, from 14–16 February 2024.


If you notice my enthusiasm regarding our editorial service, it’s because the surveys and testimonials we receive speak volumes about the experiences of our authors, reviewers, and guest editors who collaborate with MDPI. The purpose of these letters is to highlight the exceptional work that we do and the experiences we create for the scholars – thus, let me end with this testimonial from an author:

“It was a great pleasure to publish in Viruses Special Issue [Emerging Viruses in Aquaculture]. The submission process was easy. Guest editors were very helpful and provided all the guidance and support as needed. The handling of the manuscript by the Editorial Team was very fast, efficient, and professional. The reviewer’s comments were insightful, and the publication processes were remarkably rapid.”
Ms. Magdalena Stachnik, Państwowy Instytut Weterynaryjny | PIWet

Article in Viruses: Emerging Viral Pathogens in Sturgeon Aquaculture in Poland: Focus on Herpesviruses and Mimivirus Detection

Stefan Tochev
Chief Executive Officer

29 June 2023
Meet Us at the ESMO Congress 2023, 20–24 October 2023, Madrid, Spain

MDPI will attend the ESMO Congress 2023 as an exhibitor. This conference will be held in Madrid, Spain, from 20 to 24 October 2023.

The ESMO Congress is the most influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. They will disseminate the latest cutting-edge data, provide high-quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth #724. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit

28 June 2023
2022 Impact Factors for MDPI Journals

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.

Journal Impact Factor Rank Quartile Category
Vaccines 7.8 Q1 Immunology
Medicine, Research & Experimental
Antioxidants 7.0 Q1 Food Science & Technology
Biochemistry & Molecular Biology
Chemistry, Medicinal
Cells 6.0 Q2 Cell Biology
Nutrients 5.9 Q1 Nutrition & Dietetics
International Journal of Molecular Sciences 5.6 Q1 Biochemistry & Molecular Biology
Q2 Chemistry, Multidisciplinary
Journal of Theoretical and Applied Electronic Commerce Research 5.6 Q2 Business
Biomolecules 5.5 Q1 Biochemistry & Molecular Biology
Biosensors 5.4 Q1 Chemistry, Analytical
Instruments & Instrumentation
Q2 Nanoscience & Nanotechnology
Fractal and Fractional 5.4 Q1 Mathematics, Interdisciplinary Applications
Marine Drugs 5.4 Q1 Chemistry, Medicinal
Pharmacology & Pharmacy
Pharmaceutics 5.4 Q1 Pharmacology & Pharmacy
Nanomaterials 5.3 Q1 Physics, Applied
Q2 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Nanoscience & Nanotechnology
Cancers 5.2 Q2 Oncology
Foods 5.2 Q1 Food Science & Technology
Polymers 5.0 Q1 Polymer Science
Remote Sensing 5.0 Q1 Geosciences, Multidisciplinary
Q2 Remote Sensing
Imaging Science & Photographic Technology
Environmental Sciences
Antibiotics 4.8 Q1 Pharmacology & Pharmacy
Q2 Infectious Diseases
Drones 4.8 Q2 Remote Sensing
Journal of Functional Biomaterials 4.8 Q2 Engineering, Biomedical
Materials Science, Biomaterials
Biomedicines 4.7 Q1 Pharmacology & Pharmacy
Q2 Biochemistry & Molecular Biology
Medicine, Research & Experimental
Journal of Fungi 4.7 Q2 Mycology
Viruses 4.7 Q2 Virology
Bioengineering 4.6 Q2 Engineering, Biomedical
Gels 4.6 Q1 Polymer Science
Molecules 4.6 Q2 Chemistry, Multidisciplinary
Biochemistry & Molecular Biology
Pharmaceuticals 4.6 Q2 Pharmacology & Pharmacy
Chemistry, Medicinal
Toxics 4.6 Q1 Toxicology
Q2 Environmental Sciences
Biomimetics 4.5 Q1 Engineering, Multidisciplinary
Q2 Materials Science, Biomaterials
Microorganisms 4.5 Q2 Microbiology
Plants 4.5 Q1 Plant Sciences
Biology 4.2 Q2 Biology
Chemosensors 4.2 Q2 Instruments & Instrumentation
Chemistry, Analytical
Membranes 4.2 Q2 Engineering, Chemical
Materials Science, Multidisciplinary
Chemistry, Physical
Polymer Science
Toxins 4.2 Q1 Toxicology
Q2 Food Science & Technology
Metabolites 4.2 Q2 Biochemistry & Molecular Biology
Batteries 4.0 Q2 Electrochemistry
Materials Science, Multidisciplinary
Q3 Energy & Fuels
Catalysts 3.9 Q2 Chemistry, Physical
Journal of Clinical Medicine 3.9 Q2 Medicine, General & Internal
Land 3.9 Q2 Environmental Studies
Sensors 3.9 Q2 Instruments & Instrumentation
Chemistry, Analytical
Engineering, Electrical & Electronic
Sustainability 3.9 Q2 Environmental Sciences (SCIE)
Environmental Studies (SSCI)
Q3 Green & Sustainable Science & Technology (SCIE)
Green & Sustainable Science & Technology (SSCI)
Buildings 3.8 Q2 Construction & Building Technology
Engineering, Civil
Agronomy 3.7 Q1 Agronomy
Q2 Plant Sciences
Fermentation 3.7 Q2 Biotechnology & Applied Microbiology
Pathogens 3.7 Q2 Microbiology
Agriculture 3.6 Q1 Agronomy
Diagnostics 3.6 Q2 Medicine, General & Internal
Genes 3.5 Q2 Genetics & Heredity
Journal of Intelligence 3.5 Q2 Psychology, Multidisciplinary
Lubricants 3.5 Q2 Engineering, Mechanical
Processes 3.5 Q2 Engineering, Chemical
Coatings 3.4 Q2 Materials Science, Coatings & Films
Physics, Applied
Q3 Materials Science, Multidisciplinary
ISPRS International Journal of Geo-Information 3.4 Q2 Geography, Physical
Q3 Computer Science, Information Systems
Remote Sensing
Materials 3.4 Q2 Metallurgy & Metallurgical Engineering
Physics, Applied
Physics, Condensed Matter
Q3 Materials Science, Multidisciplinary
Chemistry, Physical
Micromachines 3.4 Q2 Instruments & Instrumentation
Physics, Applied
Chemistry, Analytical
Q3 Nanoscience & Nanotechnology
Water 3.4 Q2 Water Resources
Environmental Sciences
Brain Sciences 3.3 Q3 Neurosciences
Energies 3.2 Q3 Energy & Fuels
Fire 3.2 Q1 Forestry
Q2 Ecology
Life 3.2 Q2 Biology
Current Issues in Molecular Biology 3.1 Q3 Biochemistry & Molecular Biology
Horticulturae 3.1 Q1 Horticulture
Animals 3.0 Q1 Agriculture, Dairy & Animal Science
Veterinary Sciences
Insects 3.0 Q1 Entomology
Atmosphere 2.9 Q3 Meteorology & Atmospheric Sciences
Environmental Sciences
Electronics 2.9 Q2 Engineering, Electrical & Electronic
Physics, Applied
Q3 Computer Science, Information Systems
Forests 2.9 Q1 Forestry
Inorganics 2.9 Q2 Chemistry, Inorganic & Nuclear
Journal of Marine Science and Engineering 2.9 Q1 Engineering, Marine
Q2 Oceanography
Engineering, Ocean
Metals 2.9 Q2 Metallurgy & Metallurgical Engineering
Q3 Materials Science, Multidisciplinary
Tropical Medicine and Infectious Disease 2.9 Q2 Tropical Medicine
Q3 Infectious Diseases
Universe 2.9 Q2 Astronomy & Astrophysics
Physics, Particles & Fields
Healthcare 2.8 Q2 Health Policy & Services (SSCI)
Q3 Health Care Sciences & Services (SCIE)
Applied Sciences 2.7 Q2 Engineering, Multidisciplinary
Physics, Applied
Q3 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Crystals 2.7 Q2 Crystallography
Q3 Materials Science, Multidisciplinary
Entropy 2.7 Q2 Physics, Multidisciplinary
Magnetochemistry 2.7 Q2 Chemistry, Inorganic & Nuclear
Q3 Chemistry, Physical
Materials Science, Multidisciplinary
Symmetry 2.7 Q2 Multidisciplinary Sciences
Actuators 2.6 Q2 Instruments & Instrumentation
Engineering, Mechanical
Aerospace 2.6 Q1 Engineering, Aerospace
Behavioral Sciences 2.6 Q2 Psychology, Multidisciplinary
Current Oncology 2.6 Q3 Oncology
Machines 2.6 Q2 Engineering, Mechanical
Q3 Engineering, Electrical & Electronic
Medicina 2.6 Q3 Medicine, General & Internal
Separations 2.6 Q3 Chemistry, Analytical
Minerals 2.5 Q2 Mining & Mineral Processing
Geochemistry & Geophysics
Children 2.4 Q2 Pediatrics
Diversity 2.4 Q2 Biodiversity Conservation
Q3 Ecology
Journal of Cardiovascular Development and Disease 2.4 Q3 Cardiac & Cardiovascular Systems
Mathematics 2.4 Q1 Mathematics
Photonics 2.4 Q3 Optics
Veterinary Sciences 2.4 Q1 Veterinary Sciences
Fishes 2.3 Q2 Marine & Freshwater Biology
Axioms 2.0 Q2 Mathematics, Applied
Systems 1.9 Q2 Social Sciences, Interdisciplinary
Tomography 1.9 Q3 Radiology, Nuclear Medicine & Medical Imaging

Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.

Source: 2022 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2023)


15 June 2023
Cells | Promotional Video

15 June 2023
Cells Receives an Increased CiteScore of 9.0

We are pleased to inform you that Cells (ISSN: 2073-4409) has received an updated CiteScore of 9.0, an increase of 34% compared with the 2021 metric. The 2022 CiteScore™ was released recently, making an assessment of the scientific influence of journals in the 2019 to 2022 period.

Cells’ CiteScore ranks 34/212 among 212 titles (Q1) in the “General Biochemistry, Genetics and Molecular Biology” category.

For more journal statistics, please visit

Excellent performance is inseparable from the support and dedication of all journal editors, reviewers, authors, and readers. We would like to take this opportunity to thank all of you who have contributed to the journal.

5 June 2023
Meet Us at the 42nd Annual Meeting of the American Society for Virology, 24–28 June 2023, Athens, Georgia, USA

MDPI journals will be attending the 42nd annual meeting of the American Society for Virology as an exhibitor. This meeting will be held in Athens, Georgia, USA from 24 to 28 June 2023.

The American Society for Virology (ASV) is a wonderful community that brings together virologists from all areas of the field. As a result, the annual meetings are rich in diverse scientific offerings and they can be quite large (sometimes over 1600 attendees). This conference is hosted by the University of Georgia and held at the Classic Center; the scientific program will include symposia, concurrent workshops, poster sessions, exhibits, and special events. Professional development activities and social events will be interspersed throughout the meeting.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference and our booth, please visit:

26 May 2023
Cells Webinar | Systems Biology of Apoptotic and Non-apoptotic Signaling, Held on 15 June 2023

On 15 June 2023, MDPI and Cells (ISSN: 2073-4409) organized a webinar on cells, titled Systems Biology of Apoptotic and Non-apoptotic Signaling. The webinar focused on contemporary views on the intricate crosstalk of apoptotic and non-apoptotic networks in cell-regulating life/death decisions.

Life/death decisions in a cell are regulated by the balance between apoptotic and non-apoptotic signaling pathways. Although these pathways have been studied relatively well, their quantitative regulation has, until recently, been poorly understood. In this regard, the construction of mathematical models of apoptotic and non-apoptotic signaling pathways led to enormous progress in the quantitative understanding of cell fate control. Prof. Dr. Inna Lavrik first dissected the quantitative regulation of cell fate decisions in death receptor networks. Then, Prof. Boris Zhivotovsky showed us programmed cell death in the past, present, and future. Finally, Prof. Olga Lavrik presented poly(ADP-ribose)polymerases as dynamic triggers for biomolecular condensate formation. The three scholars comprehensively discussed the contemporary view on the intricate crosstalk of apoptotic and non-apoptotic networks in the cell regulating life/death decisions.

Please note that this webinar is associated with a Special Issue in Cells, “Systems Biology of Apoptotic and Non-apoptotic Signaling”. The deadline is 30 September 2023.

You can watch the recorded webinar at the following link:

Webinar Chair and Keynote Speakers:

  • Prof. Dr. Inna Lavrik, Translational Inflammation Research, Medical Faculty, Center of Dynamic Systems, Otto von Guericke University Magdeburg, Magdeburg, Germany;
  • Prof. Boris Zhivotovsky, Institute of Environmental Medicine, Division of Toxicology, Karolinska Institute, Solna, Sweden;
  • Prof. Olga Lavrik, Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.

25 May 2023
Meet Us at the 60th European Renal Association (ERA) Congress, 15–17 June 2023, Milan, Italy

Conference: 60th European Renal Association (ERA) Congress

Date: 15–17 June 2023

Location: Milan, Italy

MDPI will be attending the 60th ERA Congress as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference is being organized by the European Renal Association, and it will offer a clearly structured scientific program, combining presentations of cutting-edge research with a broad view of the currently most relevant fields in the prevention, detection, and treatment of kidney disease. At the conference, specialists will share knowledge on the clinical assessment and treatments of renal diseases to improve disease prevention and patients’ quality of life.

The following MDPI journals will be represented:

  • JCM;
  • JPM;
  • Kidney and Dialysis;
  • Diagnostics;
  • Clinics and Practice;
  • Uro;
  • Cells;
  • BioChem;
  • Transplantology.
If you are planning to attend this conference, please do not hesitate to talk with us online. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website:

25 May 2023
Meet Us at the 64th Annual Spring Meeting of the Japanese Society of Clinical Cytology, 9–11 June 2023, Nagoya, Japan

MDPI will be attending the 64th Annual Spring Meeting of the Japanese Society of Clinical Cytology, which will be held from 9 to 11 June 2023 in Nagoya, Japan, at the Nagoya Congress Center.

The conference is the official annual meeting of the Japanese Society of Clinical Cytology (JSCC), which is an academic organization consisting of physicians specializing in cytology and cytotechnologists who perform cytology for the purposes of cancer diagnosis and screening. Physicians specializing in cytology that belong to the society include gynecologists, surgeons, internists, and pathologists as well as cytotechnologists.

In light of current trends, the theme of this annual meeting is “Be fascinated with the mastery of cytology!—Mastering the art and passing it on to the next generations”. Cytology is deeply related to cervical cancer screening in Japan. Raising the screening rate, improving and adhering to the screening management guidelines, including colposcopy, and increasing the vaccination rate are important issues for the eradication of cervical cancer. These preventive strategies for cervical cancer will be propagated in this meeting.

The following MDPI journals will be represented:

Please do not hesitate to reach out ([email protected]) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website:

16 May 2023
Meet Us at the 19th Annual International Conference of the Metabolomics Society, 18–22 June 2023, Niagara Falls, Ontario, Canada

Conference: 19th Annual International Conference of the Metabolomics Society

Date: 18–22 June 2023

Place: Niagara Falls Convention Centre, 6815 Stanley Avenue, Niagara Falls, Ontario, Canada L2G 3Y9

Booth: #T12

MDPI will be attending the 19th Annual International Conference of the Metabolomics Society, which will be held from 18 to 22 June 2023 in downtown Niagara Falls, Canada, at the Niagara Falls Convention Centre.

The conference is the official annual meeting of the Metabolomics Society, and the largest metabolomics meeting worldwide. It will cover the major scientific themes of: technology advances; computational metabolomics, statistics, and bioinformatics; metabolomics in health and disease; and metabolomics of plants, food, environment and microbes. A special theme for this conference will focus on mental health, drug addiction and medicinal cannabis. The scientific program will include plenary and keynote talks, three parallel scientific sessions, interactive poster sessions, sponsor lunches, other networking events and a specially organized parallel session to promote metabolomics research in industry. A strong line-up of both introductory and advanced workshops will take place on Sunday, 18 June, and the morning of Monday, 19 June. To complement the exciting scientific program, the conference will offer a welcome reception, vibrant early career events, a conference dinner and other engaging social activities.

The following MDPI journals will be represented:

Please do not hesitate to reach out ([email protected]) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website:

30 March 2023
Meet Us at the 29th Congress of the European Association for Cancer Research, 12–15 June 2023, Torino, Italy

29th Congress of the European Association for Cancer Research
Date: 12–15 June 2023
Place: Torino, Italy

MDPI will be attending the 29th Congress of the European Association for Cancer Research, held in Torino, Italy, from 12 to 15 June 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of cancer research over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest ideas with us.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit

30 March 2023
Meet Us at the European Human Genetics Conference 2023 (ESHG 2023), 10–13 June 2023, Glasgow, UK

MDPI will be attending the European Human Genetics Conference 2023 (ESHG 2023), held in Glasgow, UK, from 10 to 13 June 2023.

The following MDPI journals will be represented:

If you plan on attending this conference, feel free to stop by our booth #824. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please visit the following link:

17 March 2023
Cells | Issue Cover Articles in 2022

The articles below have been selected as 2022 Issue Cover Articles by the Editorial Office of Cells (ISSN: 2073-4409). These articles are from multiple fields within the scope of Cells, and we hope they can provide insights and references for scholars in related fields.

1. “Epithelial and Neural Cadherin in Mammalian Fertilization: Studies in the Mouse Model”
by Gustavo Luis Verón, María Florencia Veiga, Mónica Cameo, Clara Isabel Marín-Briggiler and Mónica Hebe Vazquez-Levin
Cells 2022, 11(1), 102;
Available online:

2. “Transient Exposure of Endothelial Cells to Doxorubicin Leads to Long-Lasting Vascular Endothelial Growth Factor Receptor 2 Downregulation”
by Silvia Graziani, Luca Scorrano and Giovanna Pontarin
Cells 2022, 11(2), 210;
Available online:

3. “LEAP-2 Counteracts Ghrelin-Induced Food Intake in a Nutrient, Growth Hormone and Age Independent Manner”
by Javier Lugilde, Sabela Casado, Daniel Beiroa, Juan Cuñarro, Montserrat Garcia-Lavandeira, Clara V. Álvarez, Rubén Nogueiras, Carlos Diéguez and Sulay Tovar
Cells 2022, 11(3), 324;
Available online:

4. “Radon Improves Clinical Response in an Animal Model of Rheumatoid Arthritis Accompanied by Increased Numbers of Peripheral Blood B Cells and Interleukin-5 Concentration”
by Lisa Deloch, Stephanie Hehlgans, Michael Rückert, Andreas Maier, Annika Hinrichs, Ann-Sophie Flohr, Denise Eckert, Thomas Weissmann, Michaela Seeling and Falk Nimmerjahn et al.
Cells 2022, 11(4), 689;
Available online:

5. “CRISPR/Cas9-Mediated Models of Retinitis Pigmentosa Reveal Differential Proliferative Response of Müller Cells between Xenopus laevis and Xenopus tropicalis
by Karine Parain, Sophie Lourdel, Alicia Donval, Albert Chesneau, Caroline Borday, Odile Bronchain, Morgane Locker and Muriel Perron
Cells 2022, 11(5), 807;
Available online:

6. “Biallelic Variants in ENDOG Associated with Mitochondrial Myopathy and Multiple mtDNA Deletions”
by Alessia Nasca, Andrea Legati, Megi Meneri, Melisa Emel Ermert, Chiara Frascarelli, Nadia Zanetti, Manuela Garbellini, Giacomo Pietro Comi, Alessia Catania and Costanza Lamperti et al.
Cells 2022, 11(6), 974;
Available online:

7. “Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells”
by Piper A. Robida, Clayton H. Rische, Netali Ben-Baruch Morgenstern, Rethavathi Janarthanam, Yun Cao, Rebecca A. Krier-Burris, Wouter Korver, Alan Xu, Thuy Luu and Julia Schanin et al.
Cells 2022, 11(7), 1138;
Available online:

8. “N-VEGF, the Autoregulatory Arm of VEGF-A”
by Marina Katsman, Aviva Azriel, Guy Horev, Yitzhak Reizel and Ben-Zion Levi
Cells 2022, 11(8), 1289;
Available online:

9. “SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility”
by Francesca P. Luongo, Filippo Dragoni, Adele Boccuto, Eugenio Paccagnini, Mariangela Gentile, Tamara Canosi, Giuseppe Morgante, Alice Luddi, Maurizio Zazzi, Ilaria Vicenti et al.
Cells 2022, 11(9), 1431;
Available online:

10. “SMER28 Attenuates PI3K/mTOR Signaling by Direct Inhibition of PI3K p110 Delta”
by Marco Kirchenwitz, Stephanie Stahnke, Silvia Prettin, Malgorzata Borowiak, Laura Menke, Christian Sieben, Carmen Birchmeier, Klemens Rottner, Theresia E. B. Stradal and Anika Steffen
Cells 2022, 11(10), 1648;
Available online:


11. “Cigarette Smoke Extract Disturbs Mitochondria-Regulated Airway Epithelial Cell Responses to Pneumococci”
by Mahyar Aghapour, Christy B. M. Tulen, Mohsen Abdi Sarabi, Sönke Weinert, Mathias Müsken, Borna Relja, Frederik-Jan van Schooten, Andreas Jeron, Rüdiger Braun-Dullaeus and Alexander H. Remels et al.
Cells 2022, 11(11), 1771;
Available online:

12. “Nuclear Transporter IPO13 Is Central to Efficient Neuronal Differentiation”
by Katarzyna A. Gajewska, John M. Haynes and David A. Jans
Cells 2022, 11(12), 1904;
Available online:

13. “PKC-Mediated Orai1 Channel Phosphorylation Modulates Ca2+ Signaling in HeLa Cells”
by Ericka Martínez-Martínez, Víctor Hugo Sánchez-Vázquez, Daniel León-Aparicio, Jose Sanchez-Collado, Martín-Leonardo Gallegos-Gómez, Juan A. Rosado, Juan M. Arias and Agustin Guerrero-Hernández
Cells 2022, 11(13), 2037;
Available online:

14. “CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints”
by Martin Böttcher, Romy Böttcher-Loschinski, Sascha Kahlfuss, Michael Aigner, Andreas Gießl, Andreas Mackensen, Ursula Schlötzer-Schrehardt, Thomas Tüting, Heiko Bruns and Dimitrios Mougiakakos
Cells 2022, 11(14), 2176;
Available online:

15. “Hyperoxaluria Induces Endothelial Dysfunction in Preglomerular Arteries: Involvement of Oxidative Stress”
by Javier Saenz-Medina, Mercedes Muñoz, Claudia Rodriguez, Cristina Contreras, Ana Sánchez, María José Coronado, Elvira Ramil, Martin Santos, Joaquín Carballido and Dolores Prieto
Cells 2022, 11(15), 2306;
Available online:

16. “USP29 Deubiquitinates SETD8 and Regulates DNA Damage-Induced H4K20 Monomethylation and 53BP1 Focus Formation”
by Yeray Hernández-Reyes, María Cristina Paz-Cabrera, Raimundo Freire and Veronique A. J. Smits
Cells 2022, 11(16), 2492;
Available online:

17. “The CaMKII/MLC1 Axis Confers Ca2+-Dependence to Volume-Regulated Anion Channels (VRAC) in Astrocytes”
by Maria Stefania Brignone, Angela Lanciotti, Antonio Michelucci, Cinzia Mallozzi, Serena Camerini, Luigi Catacuzzeno, Luigi Sforna, Martino Caramia, Maria Cristina D’Adamo and Marina Ceccarini et al.
Cells 2022, 11(17), 2656;
Available online:

18. “The ABA-LANCL1/2 Hormone-Receptors System Protects H9c2 Cardiomyocytes from Hypoxia-Induced Mitochondrial Injury via an AMPK- and NO-Mediated Mechanism”
by Sonia Spinelli, Lucrezia Guida, Tiziana Vigliarolo, Mario Passalacqua, Giulia Begani, Mirko Magnone, Laura Sturla, Andrea Benzi, Pietro Ameri, Edoardo Lazzarini et al.
Cells 2022, 11(18), 2888;
Available online:

19. “Brain Endothelial Cells in Contrary to the Aortic Do Not Transport but Degrade Low-Density Lipoproteins via Both LDLR and ALK1”
by Sofia Kakava, Eveline Schlumpf, Grigorios Panteloglou, Flavia Tellenbach, Arnold von Eckardstein and Jerome Robert
Cells 2022, 11(19), 3044;
Available online:

20. “Decreased Oligodendrocyte Number in Hippocampal Subfield CA4 in Schizophrenia: A Replication Study”
by Andrea Schmitt, Laura Tatsch, Alisa Vollhardt, Thomas Schneider-Axmann, Florian J. Raabe, Lukas Roell, Helmut Heinsen, Patrick R. Hof, Peter Falkai and Christoph Schmitz
Cells 2022, 11(20), 3242;
Availble online:

21. “Chromatin Accessibility and Transcriptional Differences in Human Stem Cell-Derived Early-Stage Retinal Organoids
by Melissa K. Jones, Devansh Agarwal, Kevin W. Mazo, Manan Chopra, Shawna L. Jurlina, Nicholas Dash, Qianlan Xu, Anna R. Ogata, Melissa Chow and Alex D. Hill et al.
Cells 2022, 11(21), 3412;
Available online:

22. “Microglia–Neutrophil Interactions Drive Dry AMD-like Pathology in a Mouse Model
by Maeve Boyce, Ying Xin, Olivia Chowdhury, Peng Shang, Haitao Liu, Victoria Koontz, Anastasia Strizhakova, Mihir Nemani, Stacey Hose, J and Samuel Zigler, Jr., et al.
Cells 2022, 11(22), 3535;
Available online:

23. “Extracellular Vesicles from Human Umbilical Cord-Derived MSCs Affect Vessel Formation In Vitro and Promote VEGFR2-Mediated Cell Survival
by Ana Muñiz-García, Bettina Wilm, Patricia Murray and Michael J. Cross
Cells 2022, 11(23), 3750;
Available online:

24. “Polymerized Laminin-521: A Feasible Substrate for Expanding Induced Pluripotent Stem Cells at a Low Protein Concentration
by Fernanda C. P. Mesquita, Eliel S. Leite, Jacquelynn Morrissey, Catarina Freitas, Tatiana Coelho-Sampaio and Camila Hochman-Mendez
Cells 2022, 11(24), 3955;
Available online:

16 March 2023
Meet Us at the Chinese Academic Conference on Tumor Biomarker, 7–9 April 2023, Shanghai, China

MDPI will be attending the Chinese Academic Conference on Tumor Biomarker, held in Shanghai, China, from 7 to 9 April 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of tumor markers over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest inspirations with us.

The following MDPI journals will be represented:

  • Biomedicines;
  • Cancers;
  • Cells;
  • Diagnostics;
  • Current Oncology;
  • JPM;
  • JCM;
  • Onco;
  • CIMB;
  • BioMedInformatics.

If you plan on attending this conference, feel free to stop by our booth, #B155. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please follow the link below:

13 March 2023
MDPI’s Newly Launched Journals in December 2022

As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.

In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.


Founding Editor-in-Chief

Journal Topics (Selected)

Prof. Dr. Fabio Gresta, University of Messina, Italy| Editorial | view inaugural issue

grass/forage/turf production; grassland management; pasture monitoring; grazing and livestock; grass agro-ecosystems| view journal scope | submit an article

Prof. Dr. Christos G. Athanassiou, University of Thessaly, Greece| Editorial | view inaugural issue

pesticides; fungicides; herbicides; fertilizers; soil conditioners| view journal scope | submit an article

Prof. Dr. Stephen H. Safe, Texas A&M University, USA| Editorial | view inaugural issue

receptor structure; receptor function; receptor signaling; receptor expression and regulation; receptor interactions with drugs| view journal scope | submit an article

Dr. Jean Jacques Vanden Eynde, University of Mons-UMONS, Belgium| Editorial | view inaugural issue

drug discovery; medicinal chemistry; preclinical and clinical research; marketed drugs; intellectual property and regulatory affairs| view journal scope | submit an article

Prof. Dr. Heather Kanuka, University of Alberta, Canada| Editorial | view inaugural issue

higher education; tertiary education; policy and practice in higher education; educational leadership in higher education; educational administration and management in higher education| view journal scope | submit an article

If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to [email protected].

7 March 2023
Displaying Co-Authors’ Email Addresses on the Webpage of Published Papers

MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page. 

We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system ( if co-authors would prefer for their email addresses not to be displayed.

16 February 2023
Increasing Visibility for – Clarivate adds the Preprint Citation Index to the Web of Science

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.

The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.

As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own

MDPI's Preprints Platform –

To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.

During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.

We invite you to join the ranks of the over 100k researchers using and share your research.

For more information, please visit

14 February 2023
Meet Us at the 11th National Conference on Bioinformatics and Systems Biology, 25–27 February 2023, Guangzhou, China

: 11th National Conference on Bioinformatics and Systems Biology
Date: 25–27 February 2023
Place: Guangzhou, China

MDPI will be attending the 11th National Conference on Bioinformatics and Systems Biology (CCBSB2023) as the exhibitor. The National Academic Conference on Bioinformatics and Systems Biology has been successfully held for ten sessions since its first session in 1998. It is a national event with the highest academic level and the greatest influence in the field of bioinformatics research in China. The theme of the conference is "The Latest Frontier Research of Bioinformatics and Systems Biology and Their Applications", and the topics cover translational informatics and data sharing security, biomedical data mining and computing, genome informatics, artificial intelligence and life sciences, group bioinformatics and integrated biology, non-coding RNA and RNA informatics, network biology, major disease omics informatics, biological macromolecular structure prediction and simulation, bioinformatics algorithm research, biological data resources, bioinformatics and drugs discovery, computational synthetic biology, agricultural and forestry informatics and other bioinformatics, and other frontier directions.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit

22 December 2022
Special Issue Mentor Program

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

  • Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
  • Writing a brief promotion plan for the Special Issue;
  • Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
  • Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

  • Conducting a final check before the Special Issue is published online;
  • Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
  • Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
  • Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
  • Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows:

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

21 December 2022
Editorial Board Members from Cells Featured in the 2022 Highly Cited Researchers List Published by Clarivate

Recently, ClarivateTM revealed its 2022 list of Highly Cited ResearchersTM composed of individuals at universities, research institutes and commercial organizations.

The scientists who were selected into this year’s list of Highly Cited Researchers have published papers in the 10-year period from January 2011 to December 2021 with a citation frequency in the top 1% of academic subjects based on Web of Science Citation data from the same time period. This year, 6938 researchers from across the globe have been awarded Highly Cited Researcher 2022 designations. These researchers have demonstrated a disproportionate level of significance and broad influence in their chosen field(s) over the last decade. The list is truly global, spanning 69 countries or regions and spread across a diverse range of research, from applied sciences to social sciences.

Nine members of the Editorial Board of Cells (ISSN: 2073-4409) have been listed as Highly Cited Researchers by Clarivate in 2022. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields. The Cells journal office sincerely congratulates all elected Editorial Board Members and hopes that they continue to have an academically productive relationship with the journal.



Prof. Dr. Caroline Robert

Universite Paris Saclay, France

Prof. Dr. Balazs Gyorffy

Semmelweis University, Hungary

Prof. Dr. Luca Scorrano

University of Padua, Italy

Prof. Dr. Lorenzo Galluzzi

Cornell Medical Center, USA

Prof. Dr. David C. Rubinsztein

University of Cambridge, UK

Prof. Dr. Rudolph E. Tanzi

Massachusetts General Hospital, USA

Prof. Dr. Giuseppe Remuzzi

IRCCS Mario Negri, Italy

Prof. Dr. Guido Kroemer

Universite de Paris Cite, France

Prof. Dr. Suleyman Allakhverdiev

К.А. Timiryazev Institute of Plant Physiology RAS, Russia

21 December 2022
Meet Us at the 100th Anniversary Annual Meeting of The Physiological Society of Japan, 14–16 March 2023, Kyoto, Japan

Conference: The 100th Anniversary Annual Meeting of The Physiological Society of Japan
Date: 14–16 March 2023
Venue: Kyoto International Conference Center *Hybrid Format, Kyoto, Japan

MDPI will be attending the 100th Anniversary Annual Meeting of The Physiological Society of Japan as the exhibitor. This meeting will take place from 14 to 16 March 2023 in Kyoto, Japan.

This meeting has been organized by the Physiological Society of Japan (PSJ), and will thus mark the 100th meeting of the society—the 100th Memorial meeting. This meeting has been given the theme of “Homeostasis for Sustainability—Toward the Next Century of Physiological Sciences”.

The following MDPI journals will be represented:

If you are planning to attend this conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person and answering any questions you may have.

For more information about the conference, please visit the following website:

14 December 2022
"Thanks a Million!" – One Million Articles Published in MDPI Journals

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

1 Million Infographic

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

9 December 2022
Cells | Selected Papers in 2020–2021

We are pleased to invite you to read the selected papers in Cells (ISSN: 2073-4409) in 2020 and 2021, where they have been listed by the following Sections. You are welcome to read manuscripts in your research areas by clicking on the titles of the following Sections.

Cell and Gene Therapy
Plant, Algae and Fungi Cell Biology
Cellular Aging
Cell Microenvironment
Cellular Metabolism
Stem Cells (I)
Stem Cells (II)
Stem Cells (III)
Stem Cells (IV)
Cell Nuclei: Function, Transport and Receptors (I)
Cell Nuclei: Function, Transport and Receptors (II)
Cells of the Cardiovascular System
Cells of the Nervous System (I)
Cells of the Nervous System (II)
Organelle Function (I)
Organelle Function (II)
Organelle Function (III)
Cellular Immunology (I)
Cellular Immunology (II)
Cellular Immunology (III)
Cellular Immunology (IV)
Cellular Immunology (V)
Cellular Immunology (VI)
Cell Signaling (I)
Cell Signaling (II)
Cell Signaling (III)
Cell Signaling (IV)
Cell Signaling (V)
Cell Signaling (VI)
Autophagy (I)
Autophagy (II)
Cellular Pathology (I)
Cellular Pathology (II)
Cellular Pathology (III)
Cellular Pathology (IV)
Cellular Pathology (V)
Cellular Pathology (VI)
Cellular Pathology (VII)
Cellular Pathology (VIII)
Cellular Biophysics
Cell Proliferation and Division
Cell Motility and Adhesion
Tissues and Organs
Cell Methods
Reproductive Cells and Development
Regular (I)
Regular (II)
Regular (III)
Regular (IV)
Regular (V)
Regular (VI)
Regular (VII)
Regular (VIII)
Regular (IX)

8 December 2022
MDPI Sustainability Foundation: New Look and Nominations for the 2023 Sustainability Awards Now Open

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

23 November 2022
Cells | Selected Papers in 2020–2021 (IX)

We are pleased to invite you to read the selected papers from Cells (ISSN: 2073-4409). The paper list is as follows: 

"CD276-Positive Circulating Endothelial Cells Do Not Predict Response to Systemic Therapy in Advanced Colorectal Cancer"
by Elske C. Gootjes, Jaco Kraan, Tineke E. Buffart, Lotte Bakkerus, Barbara M. Zonderhuis, Cornelis Verhoef, Henk M. W. Verheul and Stefan Sleijfer
Cells 2020, 9(1), 124;
Available online:

"Mmi1, the Yeast Ortholog of Mammalian Translationally Controlled Tumor Protein (TCTP), Negatively Affects Rapamycin-Induced Autophagy in Post-Diauxic Growth Phase"
by Jana Vojtova and Jiri Hasek
Cells 2020, 9(1), 138;
Available online:

"Norrin Protects Retinal Ganglion Cells from Excitotoxic Damage via the Induction of Leukemia Inhibitory Factor"
by Stefan Kassumeh, Stephanie Leopold, Rudolf Fuchshofer, Carina N. Thomas, Siegfried G. Priglinger, Ernst R. Tamm and Andreas Ohlmann
Cells 2020, 9(2), 277;
Available online:

"The LisH Domain-Containing N-Terminal Fragment is Important for the Localization, Dimerization, and Stability of Katnal2 in Tetrahymena"
by Ewa Joachimiak, Ewa Waclawek, Michal Niziolek, Anna Osinka, Hanna Fabczak, Jacek Gaertig and Dorota Wloga
Cells 2020, 9(2), 292;
Available online:

"The Phenotype and Functional Activity of Mesenchymal Stromal Cells in Pediatric Patients with Non-Malignant Hematological Diseases"
by Zyrafete Kuҫi, Christiane Jordan, Sibylle Wehner, Jan Sörensen, Andrea Jarisch, Emilia Salzmann-Manrique, Lisa-Marie Pfeffermann, Thomas Klingebiel, Peter Bader and Selim Kuҫi
Cells 2020, 9(2), 431;
Available online:

"Phosphorylation-Dependent Differences in CXCR4-LASP1-AKT1 Interaction between Breast Cancer and Chronic Myeloid Leukemia"
by Elke Butt, Katrin Stempfle, Lorenz Lister, Felix Wolf, Marcella Kraft, Andreas B. Herrmann, Cristina Perpina Viciano, Christian Weber, Andreas Hochhaus, Thomas Ernst et al.
Cells 2020, 9(2), 444;
Available online:

"A 12-mer Peptide of Tag7 (PGLYRP1) Forms a Cytotoxic Complex with Hsp70 and Inhibits TNF-Alpha Induced Cell Death"
by Elena A. Romanova, Tatiana N. Sharapova, Georgii B. Telegin, Alexei N. Minakov, Alexander S. Chernov, Olga K. Ivanova, Maxim L. Bychkov, Lidia P. Sashchenko and Denis V. Yashin
Cells 2020, 9(2), 488;
Available online:

"Convolutional Neural Networks–Based Image Analysis for the Detection and Quantification of Neutrophil Extracellular Traps"
by Aneta Manda-Handzlik, Krzysztof Fiok, Adrianna Cieloch, Edyta Heropolitanska-Pliszka and Urszula Demkow
Cells 2020, 9(2), 508;
Available online:

"Analysis of Killer Immunoglobulin-Like Receptor Genes in Colorectal Cancer"
by Roberto Diaz-Peña, Patricia Mondelo-Macía, Antonio José Molina de la Torre, Rebeca Sanz-Pamplona, Víctor Moreno and Vicente Martín
Cells 2020, 9(2), 514;
Available online:

"Calcium- and Voltage-Dependent Dual Gating ANO1 is an Intrinsic Determinant of Repolarization in Rod Bipolar Cells of the Mouse Retina"
by Sun-Sook Paik, Yong Soo Park and In-Beom Kim
Cells 2020, 9(3), 543;
Available online:

"Yeast as a Model to Understand Actin-Mediated Cellular Functions in Mammals—Illustrated with Four Actin Cytoskeleton Proteins "
by Zain Akram, Ishtiaq Ahmed, Heike Mack, Ramandeep Kaur, Richard C. Silva, Beatriz A. Castilho, Sylvie Friant, Evelyn Sattlegger and Alan L. Munn
Cells 2020, 9(3), 672;
Available online:

"Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease"
by Alma D. Del Angel-Pablo, Ivette Buendía-Roldán, Mayra Mejía, Gloria Pérez-Rubio, Karol J. Nava-Quiroz, Jorge Rojas-Serrano and Ramcés Falfán-Valencia
Cells 2020, 9(3), 691;
Available online:

"Total mRNA Quantification in Single Cells: Sarcoma Cell Heterogeneity"
by Emma Jonasson, Lisa Andersson, Soheila Dolatabadi, Salim Ghannoum, Pierre Åmanand Anders Ståhlberg
Cells 2020, 9(3), 759;
Available online:

"Characterization of Sialic Acid-Binding Immunoglobulin-Type Lectins in Fish Reveals Teleost-Specific Structures and Expression Patterns"
by Kim F. Bornhöfft, Joan Martorell Ribera, Torsten Viergutz, Marzia T. Venuto, Ulrike Gimsa, Sebastian P. Galuska and Alexander Rebl
Cells 2020, 9(4), 836;
Available online:

"Acid Sphingomyelinase Downregulation Enhances Mitochondrial Fusion and Promotes Oxidative Metabolism in a Mouse Model of Melanoma"
by Marco Coazzoli, Alessandra Napoli, Paulina Roux-Biejat, Clara De Palma, Claudia Moscheni, Elisabetta Catalani, Silvia Zecchini, Vincenzo Conte, Matteo Giovarelli, Sonia Caccia et al.
Cells 2020, 9(4), 848;
Available online:

"The Molecular Mechanisms Underlying Prostaglandin D2-Induced Neuritogenesis in Motor Neuron-Like NSC-34 Cells"
by Hiroshi Nango, Yasuhiro Kosuge, Nana Yoshimura, Hiroko Miyagishi, Takanori Kanazawa, Kaname Hashizaki, Toyofumi Suzuki and Kumiko Ishige
Cells 2020, 9(4), 934;
Available online:

"Neural Crest-Derived Chondrocytes Isolation for Tissue Engineering in Regenerative Medicine"
by Monica Salamone, Salvatrice Rigogliuso, Aldo Nicosia, Marcello Tagliavia, Simona Campora, Paolo Cinà, Carmelo Bruno and Giulio Ghersi
Cells 2020, 9(4), 962;
Available online:

"Abnormal Reinnervation of Denervated Areas Following Nerve Injury Facilitates Neuropathic Pain"
by Hodaya Leibovich, Nahum Buzaglo, Shlomo Tsuriel, Liat Peretz, Yaki Caspi, Ben Katz, Shaya Lev, David Lichtstein and Alexander M. Binshtok
Cells 2020, 9(4), 1007;
Available online:

"The β-carboline Harmine Induces Actin Dynamic Remodeling and Abrogates the Malignant Phenotype in Tumorigenic Cells"
by Ronan Le Moigne, Frédéric Subra, Manale Karam and Christian Auclair
Cells 2020, 9(5), 1168;
Available online:

"UBQLN2 Promotes the Production of Type I Interferon via the TBK1-IRF3 Pathway"
by Tianhong Chen, Wenjuan Zhang, Bo Huang, Xuan Chen and Cao Huang
Cells 2020, 9(5), 1205;
Available online:

"Isoleucine 44 Hydrophobic Patch Controls Toxicity of Unanchored, Linear Ubiquitin Chains through NF-κB Signaling"
by Jessica R. Blount, Kozeta Libohova, Gustavo M. Silva and Sokol V. Todi
Cells 2020, 9(6), 1519;
Available online:

"Circulating Tumor Cell Migration Requires Fibronectin Acting through Integrin B1 or SLUG"
by Jeannette Huaman and Olorunseun O. Ogunwobi
Cells 2020, 9(7), 1594;
Available online:

"Characteristics and Possible Role of Bovine Sperm Head-to-Head Agglutination"
by Kohei Umezu, Shouhei Kurata, Hironori Takamori, Takashi Numabe, Yuuki Hiradate, Kenshiro Hara and Kentaro Tanemura
Cells 2020, 9(8), 1865;
Available online:

"Y-Box Binding Protein 1 Expression in Trophoblast Cells Promotes Fetal and Placental Development"
by Nicole Meyer, Anne Schumacher, Urs Coenen, Katja Woidacki, Hannah Schmidt, Jonathan A. Lindquist, Peter R. Mertens and Ana C. Zenclussen
Cells 2020, 9(9), 1942;
Available online:

"Focus on Hypoxia-Related Pathways in Pediatric Osteosarcomas and Their Druggability"
by Marina Pierrevelcin, Quentin Fuchs, Benoit Lhermitte, Melissa Messé, Eric Guérin, Noelle Weingertner, Sophie Martin, Isabelle Lelong-Rebel, Charlotte Nazon, Monique Dontenwill et al.
Cells 2020, 9(9), 1998;
Available online:

"Cytokines Explored in Saliva and Tears from Radiated Cancer Patients Correlate with Clinical Manifestations, Influencing Important Immunoregulatory Cellular Pathways"
by Lara A. Aqrawi, Xiangjun Chen, Håvard Hynne, Cecilie Amdal, Sjur Reppe, Hans Christian D. Aass, Morten Rykke, Lene Hystad Hove, Alix Young, Bente Brokstad Herlofson et al.
Cells 2020, 9(9), 2050;
Available online:

"Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction"
by Douâa Moussa Agha, Redouane Rouas, Mehdi Najar, Fatima Bouhtit, Hussein Fayyad-Kazan, Laurence Lagneaux, Dominique Bron, Nathalie Meuleman, Philippe Lewalle and Makram Merimi
Cells 2020, 9(9), 2053;
Available online:

"Alterations in Progesterone Receptor Isoform Balance in Normal and Neoplastic Breast Cells Modulates the Stem Cell Population"
by María Sol Recouvreux, María Inés Diaz Bessone, Agustina Taruselli, Laura Todaro, María Amparo Lago Huvelle, Rocío G. Sampayo, Mina J. Bissell and Marina Simian
Cells 2020, 9(9), 2074;
Available online:

"Attempts at the Characterization of In-Cell Biophysical Processes Non-Invasively—Quantitative NMR Diffusometry of a Model Cellular System "
by Weronika Mazur and Artur T. Krzyżak
Cells 2020, 9(9), 2124;
Available online:

"T3 Critically Affects the Mhrt/Brg1 Axis to Regulate the Cardiac MHC Switch: Role of an Epigenetic Cross-Talk"
by Francesca Forini, Giuseppina Nicolini, Claudia Kusmic, Romina D’Aurizio, Alberto Mercatanti, Giorgio Iervasi and Letizia Pitto
Cells 2020, 9(10), 2155;
Available online:

"LPS-Induced Endotoxemia Evokes Epigenetic Alterations in Mitochondrial DNA That Impacts Inflammatory Response"
by Björn Koos, Eva Lotta Moderegger, Katharina Rump, Hartmuth Nowak, Katrin Willemsen, Caroline Holtkamp, Patrick Thon, Michael Adamzik and Tim Rahmel
Cells 2020, 9(10), 2282;
Available online:

"The miRNA Profile in Non-Hodgkin’s Lymphoma Patients with Secondary Myelodysplasia"
by Yuliya Andreevna Veryaskina, Sergei Evgenievich Titov, Igor Borisovich Kovynev, Tatiana Ivanovna Pospelova and Igor Fyodorovich Zhimulev
Cells 2020, 9(10), 2318;
Available online:

"Hypothermia Advocates Functional Mitochondria and Alleviates Oxidative Stress to Combat Acetaminophen-Induced Hepatotoxicity"
by Yeong Lan Tan and Han Kiat Ho
Cells 2020, 9(11), 2354;
Available online:

"The Interplay among Subunit Composition, Cardiolipin Content, and Aggregation State of Bovine Heart Cytochrome c Oxidase"
by Erik Sedlák, Tibor Kožár and Andrey Musatov
Cells 2020, 9(12), 2588;
Available online:

"Effect of SUV39H1 Histone Methyltransferase Knockout on Expression of Differentiation-Associated Genes in HaCaT Keratinocytes"
by Barbara Sobiak and Wiesława Leśniak
Cells 2020, 9(12), 2628;
Available online:

"Cell Sheets Restore Secretory Function in Wounded Mouse Submandibular Glands"
by Harim T. dos Santos, Kyungsook Kim, Teruo Okano, Jean M. Camden, Gary A. Weisman, Olga J. Baker and Kihoon Nam
Cells 2020, 9(12), 2645;
Available online:

"Effect of a Lens Protein in Low-Temperature Culture of Novel Immortalized Human Lens Epithelial Cells (iHLEC-NY2)"
by Naoki Yamamoto, Shun Takeda, Natsuko Hatsusaka, Noriko Hiramatsu, Noriaki Nagai, Saori Deguchi, Yosuke Nakazawa, Takumi Takata, Sachiko Kodera, Akimasa Hirata et al.
Cells 2020, 9(12), 2670;
Available online:

"t(8;21) Acute Myeloid Leukemia as a Paradigm for the Understanding of Leukemogenesis at the Level of Gene Regulation and Chromatin Programming"
by Sophie Kellaway, Paulynn S. Chin, Farnaz Barneh, Constanze Bonifer and Olaf Heidenreich
Cells 2020, 9(12), 2681;
Available online:

"Endothelium-Derived Extracellular Vesicles Associate with Poor Prognosis in Metastatic Colorectal Cancer"
by Afroditi Nanou, Linda Mol, Frank A. W. Coumans, Miriam Koopman, Cornelis J. A. Punt and Leon W. M. M. Terstappen
Cells 2020, 9(12), 2688;
Available online:

"Separation of Coiled-Coil Structures in Lamin A/C Is Required for the Elongation of the Filament"
by Jinsook Ahn, Soyeon Jeong, So-Mi Kang, Inseong Jo, Bum-Joon Park and Nam-Chul Ha
Cells 2020, 10(1), 55;
Available online:

"SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells"
by Roland Kotolloshi, Martin Hölzer, Mieczyslaw Gajda, Marc-Oliver Grimm and Daniel Steinbach
Cells 2021, 10(1), 80;
Available online:

"Role of Chitinase 3-Like 1 Protein in the Pathogenesis of Hepatic Insulin Resistance in Nonalcoholic Fatty Liver Disease"
by Songhua Zhang, Aryanna Sousa, Mengqui Lin, Ayako Iwano, Rishubh Jain, Bing Ma, Chang Min Lee, Jin Wook Park, Suchitra Kamle, Rolf Carlson et al.
Cells 2021, 10(2), 201;
Available online:

"Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts"
by Carolina Venturoli, Ilaria Piga, Matteo Curtarello, Martina Verza, Giovanni Esposito, Santina Venuto, Filippo Navaglia, Angela Grassi and Stefano Indraccolo
Cells 2021, 10(2), 325;
Available online:

"Tumor Evolution and Therapeutic Choice Seen through a Prism of Circulating Tumor Cell Genomic Instability"
by Tala Tayoun, Marianne Oulhen, Agathe Aberlenc, Françoise Farace and Patrycja Pawlikowska
Cells 2021, 10(2), 337;
Available online:

"Cell Line Models for Acquired Resistance to First-Line Osimertinib in Lung Cancers—Applications and Limitations"
by Shuta Ohara, Kenichi Suda and Tetsuya Mitsudomi
Cells 2021, 10(2), 354;
Available online:

"Knowledge-Guided “Community Network” Analysis Reveals the Functional Modules and Candidate Targets in Non-Small-Cell Lung Cancer"
by Fan Wang, Shuqing Han, Ji Yang, Wenying Yan and Guang Hu
Cells 2021, 10(2), 402;
Available online:

"Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma"
by Joanna Bartosińska, Joanna Purkot, Agnieszka Karczmarczyk, Michał Chojnacki, Joanna Zaleska, Paulina Własiuk, Norbert Grząśko, Marta Morawska, Adam Walter-Croneck, Lidia Usnarska-Zubkiewicz et al.
Cells 2021, 10(2), 411;
Available online:

"Pitfalls and Caveats in Applying Chromogenic Immunostaining to Histopathological Diagnosis"
by Yutaka Tsutsumi
Cells 2021, 10(6), 1501;
Available online:

"Effects of Macro-/Micro-Channels on Vascularization and Immune Response of Tissue Engineering Scaffolds"
by Nolan Wen, Enze Qian and Yunqing Kang
Cells 2021, 10(6), 1514;
Available online:

"Heme Oxygenase-1 Contributes to Both the Engulfment and the Anti-Inflammatory Program of Macrophages during Efferocytosis"
by Éva Fige, Judit Szendrei, László Sós, Izabela Kraszewska, László Potor, József Balla and Zsuzsa Szondy
Cells 2021, 10(3), 652;
Available online:

"Graphene Oxide–Silver Nanoparticle Nanocomposites Induce Oxidative Stress and Aberrant Methylation in Caprine Fetal Fibroblast Cells"
by Yu-Guo Yuan, He-Qing Cai, Jia-Lin Wang, Ayman Mesalam, Abu Musa Md Talimur Reza, Ling Li, Li Chen and Chen Qian
Cells 2021, 10(3), 682;
Available online:

"Regulation of TGFβ Signalling by TRPV4 in Chondrocytes"
by Steven Woods, Paul A. Humphreys, Nicola Bates, Sophie Alice Richardson, Shweta Yogesh Kuba, Imogen R. Brooks, Stuart A. Cain and Susan J. Kimber
Cells 2021, 10(4), 726;
Available online:

"Antidepressant Screening Demonstrated Non-Monotonic Responses to Amitriptyline, Amoxapine and Sertraline in Locomotor Activity Assay in Larval Zebrafish"
by Michael Edbert Suryanto, Gilbert Audira, Boontida Uapipatanakul, Akhlaq Hussain, Ferry Saputra, Petrus Siregar, Kelvin H.-C. Chen and Chung-Der Hsiao
Cells 2021, 10(4), 738;
Available online:

"Mechanism of Na-K-ATPase Inhibition by PGE2 in Intestinal Epithelial Cells"
by Niraj Nepal, Subha Arthur, Jennifer Haynes, Balasubramanian Palaniappan and Uma Sundaram
Cells 2021, 10(4), 752;
Available online:

"Quantification of Circulating Cell Free Mitochondrial DNA in Extracellular Vesicles with PicoGreen™ in Liquid Biopsies: Fast Assessment of Disease/Trauma Severity"
by Michela Marcatti, Jamal Saada, Ikenna Okereke, Charles E. Wade, Stefan H. Bossmann, Massoud Motamedi and Bartosz Szczesny
Cells 2021, 10(4), 819;
Available online:

"Cruciate Ligament Cell Sheets Can Be Rapidly Produced on Thermoresponsive poly(glycidyl ether) Coating and Successfully Used for Colonization of Embroidered Scaffolds"
by Ingrid Zahn, Daniel David Stöbener, Marie Weinhart, Clemens Gögele, Annette Breier, Judith Hahn, Michaela Schröpfer, Michael Meyer and Gundula Schulze-Tanzil
Cells 2021, 10(4), 877;
Available online:

"ZINC40099027 Promotes Gastric Mucosal Repair in Ongoing Aspirin-Associated Gastric Injury by Activating Focal Adhesion Kinase"
by Sema Oncel, Rashmi Gupta, Qinggang Wang and Marc D. Basson
Cells 2021, 10(4), 908;
Available online:

"The Role of RhoH in TCR Signalling and Its Involvement in Diseases"
by Ana Masara Ahmad Mokhtar, Ilie Fadzilah Hashim, Muaz Mohd Zaini Makhtar, Nor Hawani Salikin and Syafinaz Amin-Nordin
Cells 2021, 10(4), 950;
Available online:

"Lithium Chloride Protects against Sepsis-Induced Skeletal Muscle Atrophy and Cancer Cachexia"
by Ji-Hyung Lee, Seon-Wook Kim, Jun-Hyeong Kim, Hyun-Jun Kim, JungIn Um, Da-Woon Jung and Darren R. Williams
Cells 2021, 10(5), 1017;
Available online:

"DNA-RNA Hybrid (R-Loop): From a Unified Picture of the Mammalian Telomere to the Genome-Wide Profile"
by Minoo Rassoulzadegan, Ali Sharifi-Zarchi and Leila Kianmehr
Cells 2021, 10(6), 1556;
Available online:

"Molecular Functions of WWOX Potentially Involved in Cancer Development"
by Karim Taouis, Keltouma Driouch, Rosette Lidereau and François Lallemand
Cells 2021, 10(5), 1051;
Available online:

"New Stable Cell Lines Derived from the Proximal and Distal Intestine of Rainbow Trout (Oncorhynchus mykiss) Retain Several Properties Observed In Vivo"
by Rolando Pasquariello, Nicole Verdile, Radmila Pavlovic, Sara Panseri, Kristin Schirmer, Tiziana A. L. Brevini and Fulvio Gandolfi
Cells 2021, 10(6), 1555;
Available online:

"Metabolite Biomarkers of Leishmania Antimony Resistance"
by Sneider Alexander Gutierrez Guarnizo, Zemfira N. Karamysheva, Elkin Galeano and Carlos E. Muskus
Cells 2021, 10(5), 1063;
Available online:

"The Type and Source of Reactive Oxygen Species Influences the Outcome of Oxidative Stress in Cultured Cells"
by Steffi Goffart, Petra Tikkanen, Craig Michell, Trevor Wilson and Jaakko L. O. Pohjoismäki
Cells 2021, 10(5), 1075;
Available online:

"Codon Bias Can Determine Sorting of a Potassium Channel Protein"
by Anja J. Engel, Marina Kithil, Markus Langhans, Oliver Rauh, Matea Cartolano, James L. Van Etten, Anna Moroni and Gerhard Thiel
Cells 2021, 10(5), 1128;
Available online:

"Transcriptomic Analysis of Human Brain -Microvascular Endothelial Cell Driven Changes in -Vascular Pericytes"
by Lisa Kurmann, Michal Okoniewski and Raghvendra K. Dubey
Cells 2021, 10(7), 1784;
Available online:

"Physiological Fitness and the Pathophysiology of Chronic Lymphocytic Leukemia (CLL)"
by Andrea Sitlinger, Michael A. Deal, Erwin Garcia, Dana K. Thompson, Tiffany Stewart, Grace A. MacDonald, Nicolas Devos, David Corcoran, Janet S. Staats, Jennifer Enzor et al.
Cells 2021, 10(5), 1165;
Available online:

"Culturing Keratinocytes on Biomimetic Substrates Facilitates Improved Epidermal Assembly In Vitro"
by Eve Hunter-Featherstone, Natalie Young, Kathryn Chamberlain, Pablo Cubillas, Ben Hulette, Xingtao Wei, Jay P. Tiesman, Charles C. Bascom, Adam M. Benham, Martin W. Goldberg et al.
Cells 2021, 10(5), 1177;
Available online:

"Deoxynivalenol and Zearalenone: Different Mycotoxins with Different Toxic Effects in the Sertoli Cells of Equus asinus"
by Jun-Lin Song and Guo-Liang Zhang
Cells 2021, 10(8), 1898; htt